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In view of the increasing use of amniotic fluid for
the antenatal diagnosis of fetal abnormality there was a
need for information about the biology of amniotic fluid
cells in tissue culture. The behaviour of these cells
in primary and long term culture has been documented,
cytogenetic studies have been carried out to assess the
reliability of this technique and the characteristics of
some lysosomal enzymes in normal amniotic fluid cell
strains have been studied. Two new findings were made
and investigated during this study, the increase in
amniotic fluid macrophages in anencephaly and the ability
of urine cells to proliferate in tissue culture.
A high degree of success was achieved in initiating
primary cultures from amniotic fluid cells. Success in
culture was found to be independent of the source of the
amniotic fluid with the exception that fluids collected
at induction of labour at term could not be reliably
cultured. Fluids from Rhesus iso-immunised pregnancies
grew well in culture and their growth characteristics
were unrelated to the severity of this disease. Studies
on the methods of primary culture indicated that the
maintenance schedule of the cultures was not relevant to
the rate of cell growth and that amniotic fluid itself
was not as good as conventional culture media for
initiating cell growth in primary culture. The
morphology of the cells in amniotic fluid cultures was
studied.
The behaviour of amniotic fluid cell strains
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throughout serial culture to the stage of senescence was
documented. Changes in cell morphology with time in
culture were monitored. It was found that faster
growing cell strains survived a greater number of sub¬
cultures than did the slower growing ones. Some
cytogenetic studies on the longest surviving cell strains
demonstrated that karyotype stability was a feature of
these cell strains except in the senescent phases when
chromosome abnormalities similar to those seen in senescent
fibroblast-like cell strains were seen. The time
required to produce enough cells for biochemical studies
of cultured amniotic fluid was measured and the problem
of achieving this in sufficient time is discussed.
Cytogenetic studies on amniotic fluid from
pregnancies in which the fetus was considered to be at
risk for a chromosome abnormality were carried out and
the antenatal diagnosis of trisomy 18 was documented.
This study indicated that antenatal chromosome analysis
is a simple, rapid and reliable means of establishing
the fetal karyotype and would be applicable to selective
population screening to reduce the incidence of
chromosome abnormality at birth.
It was found that amniotic fluid from anencephalic
pregnancies had greatly increased numbers of fetal
macrophages and the possibility of using this finding
as a test for the antenatal diagnosis of anencephaly
has been explored. Amniotic fluid from two spina bifida
amniotic fluids had slightly increased numbers of
macrophages. Rhesus iso-immunised amniotic fluids had
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slightly increased macrophage counts and this may be
associated with the increase in placental Hofbauer cells
in this condition.
The levels of 10 lysosomal enzymes in cultured
amniotic fluid cells were studied. The normal range of
these enzyme levels was established, It was found that
there were great fluctuations in the levels of these
enzymes within single cell strains assayed at different
stages of culture. Possible explanations for these
fluctuations were sought by studying the effects of pH
of the culture medium, type of culture medium and serum
concentration used on the levels of the enzymes.
Thirteen cell strains were produced from one sample of
amniotic fluid and assayed to study the enzyme variation
due to the culture methods used. Pregnancies at risk
for maple-syrup-urine disease, metachromatic leukodystrophy
and Sandhoff 's disease were monitored to assess the status
of the fetus.
It was found that cells from the urine of newborn
infants would grow in tissue culture. The behaviour and
morphology of these cells were markedly similar to those
cultured from amniotic fluid. The lysosomal enzyme
biochemistry of urine cell strains was more similar to
that of amniotic fluid cell strains than that of connective
tissue derived fibroblast-like cell strains. The
hypothesis that the cells which grow from amniotic fluid
are derived, at least in part, from the fetal urinary
tract is discussed.
An appendix contains 14 papers published or accepted
7
for publication during this study. These have made
significant contributions in documenting the behaviour of
amniotic fluid cell strains, in the discovery of the
ability of urine cells to grow in culture and in the
finding of fetal macrophages in anencephalic amniotic
fluid. The papers on lysosomal enzyme studies of
cultured amniotic fluid cells constitute the bulk of
published work in this field.
Chapter 1
Introduction and Historical Background
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INTRODUCTION
The prediction of disease in the human fetus
sufficiently early to allow for the subsequent
termination of affected pregnancies was little more than
a eugenicist's dream until 1955. In that year, several
groups independently showed that sex chromatin, and
hence the sex of the fetus, could be determined by
examination of the cells present in amniotic fluid.
This finding was the first step in the development of
methods for detecting a number of diseases in the fetus
in utero.
In 1963 it was reported that amniotic fluid cells
could be cultivated in tissue culture. Following this
achievement two areas of study using cultured cells were
opened up, namely cytogenetics and human biochemical
genetics. For the reliable antenatal diagnosis of
genetic disorders cultured amniotic fluid cells are
almost always necessary. Hence it is essential that the
behaviour and properties of these cells in tissue culture
be well known.
The aim of this study was to achieve a deeper under¬
standing of the biology of amniotic fluid cells in tissue
culture, using a number of projects each directed towards
this general goal but each with its own specific aim:
1. To study amniotic fluid cells in tissue culture
and identify factors affecting growth in primary culture.
2. To study the cell strains derived from primary
amniotic fluid cultures and to see how they relate to
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other human diploid cell strains,
3. To perfect methods for obtaining chromosome
preparations from amniotic fluid suitable for the
diagnosis of fetal chromosome abnormalities before mid
pregnancy. For this purpose a diagnostic service was
established for karyotyping amniotic fluids referred from
genetic and obstetric clinics.
4. Towards the end of this work it was found that
amniotic fluid from two anencephalic pregnancies
contained large numbers of macrophages. Further studies
have been carried out on the macrophage content of normal
and abnormal amniotic fluids.
5. To study a number of lysosomal enzymes in
cultured amniotic fluid cell strains and investigate the
variables in tissue culture which may affect the activities
of the enzymes. This investigation would provide a
knowledge of these particular enzymes, all except one of
which are involved in inborn errors of metabolism.
6. Early in this work it was discovered that the
cells from urine of neonates could be grown in tissue
culture. As a result of this finding urine cells were
cultured and compared with amniotic fluid cells in an
attempt to ascertain whether fetal urine contributes
significantly to the cellular content of amniotic fluid.
The feasibility of using cultured urine cells, rather
than fibroblast-like cells cultured from skin biopsy, as
a model for the biochemical study of inborn errors of
metabolism was investigated. The use of urine cell
strains may be more suitable for such studies which might
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have to be extrapolated to amniotic fluid cells for
antenatal diagnosis.
This thesis records the observations made on
amniotic fluid cells in tissue culture and relates these
observations to antenatal diagnosis of genetic disease.
In summary it records a study of the anatomy and
physiology of amniotic fluid cells in tissue culture -
essential knowledge for the study of their pathology.
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HISTORICAL BACKGROUND
There has long been interest in the amniotic fluid,
its origins and composition. Writing in the seventeenth
century Portal (quoted by Williams, 1930) supported the
view that amniotic fluid was composed of fetal urine.
The first study of the composition of amniotic fluid to
be reported in the English language was made by Rees in
1833. He analysed four samples of fluid, all from
pregnancies of about 7\ months gestation, for water,
albumen and organic and inorganic matter in aqueous and
alcoholic extracts. He concluded: "Whether or not the
liquor amnii varies in concentration at different periods
of utero-gestation remains to be shewn: it is certainly
pretty constant at l\ months." The first major work on
the composition of amniotic fluid was made by Prochownick
in 1877. In a comprehensive paper he reported
quantitative and qualitative analyses of protein, fats,
other organic materials, urea, salts and total inorganic
matter in a series of amniotic fluids ranging in
gestational age from 6 weeks to term. He was of the
opinion that amniotic fluid was a product of fetal
metabolism. The next major work on the composition of
amniotic fluid was that of Uyeno (1919) who studied a
number of components including pH, inorganic ions, sugars
and other organic compounds as well as its physical
properties. In 1927 Taussig reviewed the composition of
amniotic fluid and stated that there was " no
reasonable doubt that amniotic fluid is secreted by the
amnion". He did, however, allow that there may have been
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some admixture of fetal urine shortly before labour.
Up to the mid 1930's a few papers appeared on the
composition of amniotic fluid, some compared the levels
of various constituents in the amniotic fluid and
maternal blood (Makepeace et al., 1931; Cantarow et al.,
1933; Shrewsbury, 1933). There was little of
importance published on the composition of amniotic fluid
from this time until 1950.
The first application of the study of amniotic fluid
was in the management of fetuses suffering from Rhesus
iso-immunisation. Brevis (1950, 1952) studied the
composition of amniotic fluid in this condition. The
clinical application of amniotic fluid bile pigment
measurements in the management of pregnancies complicated
by Rhesus iso-immunisation was developed by Liley (1961).
The use of amniotic fluid for this purpose has become so
universal that Scrimgeour (1973) was able to review 21,000
amniocenteses from series published between 1952 and 1970.
Parrish et al. (1958) discussed the obstetric problems
involved in collecting amniotic fluid prior to delivery
and introduced the term "transabdominal amniocentesis"
for the procedure.
The mid 1960's saw an explosion in the number of
papers published on the composition of amniotic fluid and
Bonsnes (1966) reviewed the findings up to this stage.
Much of the work since this time has been aimed at finding
a component which will correlate with fetal respiratory
maturity and hence improve obstetric care. One such
parameter is the lecithin/sphygomyelin ratio (Whitfield
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et al. 1972).
Some amniotic fluid biochemistry has however been
aimed at measuring the levels of components which could
be expected to alter if the fetus was suffering from a
particular inborn error of metabolism. Fuchs (1960)
suggested this as a possible approach to the antenatal
diagnosis of inborn errors of metabolism. Compounds
measured in this regard include enzymes (Bonsnes, 1966;
Butterworth et al., 1972, 1974; Fluharty et al., 1973;
Sutcliffe et al., 1972), amino acids (Emery et al., 1970 ;
Cockburn et al., 1970), electrolytes (Emery, 1970) and
steroid hormones (Jeffcoate et al., 1965).
The use of studies on amniotic fluid alone as the
basis for antenatal diagnosis of inborn errors of
metabolism has been strongly criticised for most inborn
errors with a possible exception being methymalonic
acidaemia (Morrow et al., 1970). There is one case
report which suggests that enzyme studies on amniotic
fluid should be diagnostic in Sandhoff's disease
(Desnick et al., 1973). The most promising approach to
the antenatal diagnosis of fetal abnormality by a study
of amniotic fluid has been that of Brock and Sutcliffe
(1972). They showed elevated levels of a-fetoprotein
in amniotic fluid from pregnancies where the fetus had
anencephaly.
Interest in the cells in amniotic fluid was first
shown by Daniel (1904) who studied the cytology of 38
amniotic fluids obtained by rupture of the membranes at
delivery. In the mid 1950*s there were at least six
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independent reports (see Emery, 1970 for references)
of the finding of sex chromatin in amniotic fluid cells.
The ability to sex the fetus before birth was thus
finally achieved after centuries of speculation based on
a host of folk recipes going back to those used by the
ancient Greeks and Egyptians (Blakely, 1937).
Cederqvlst and Fuchs (1970) have reviewed the historical
development of antenatal sex determination.
The ability to sex the fetus was first used
genetically by Riis and Fuchs (1960) to manage the
pregnancies of two women who were carriers of
haemophilia. Few laboratories have achieved 100%
success in sexing amniotic fluid using either sex
chromatin or Y-fluorescence methods (see Nelson, 1973a
for analysis of success rates) and it is generally
recommended that fetal sex be determined from the
chromosomes (e.g., Nadler and Gerbie, 1971).
In 1960 Fuchs, and Fuchs and Riis, in two articles
in the same copy of Nordisk Medicin suggested that it
might be possible to culture amniotic fluid cells and
detect chromosome abnormalities in the fetus. This
was a truly remarkable suggestion coming in the same year
as the classic paper of Moorhead et al. on the technique
for making chromosome preparations and at a time when
tissue culture was largely the preserve of highly
specialised units. In addition, at this time the
extent of chromosome abnormalities was not known as it
was only a year since the description of the first
chromosome abnormalities in man (see Sutherland, 1970
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for references) . Three years later Fuchs and Philip
(1963) reported that they had successfully cultured the
cells from 2 out of 3 samples of amniotic fluid but that
their experiments had to be discontinued before
chromosome studies could be attempted.
Another two years elapsed before the culture of
amniotic fluid cells was documented, the prediction of
Fuchs (1960) and Fuchs and Riis (1960) was fulfilled and
the work of Fuchs and Philip (1963) confirmed. There
is controversy about who was the first to grow amniotic
fluid cells in tissue culture, the work of Fuchs and
Philip (1963) apparently having been lost in the
literature. The first full report was that of Steele
and Breg (1966) who quoted a personal communication from
Klinger (1965), the one generally credited with being
the first to grow these cells. Jacobson has claimed to
be the first to culture these cells (Jacobson, 1965
quoted by Jacobson and Barter, 1967). However
examination of the claim suggests that misquotation has
occurred, the paper of Jacobson (1965) consists of three
short paragraphs in a drug company newspaper in which it
is stated that experiments were taking place in an
effort to try and grow amniotic fluid cells; their
successful culture had not been achieved. Macintyre
(1971) claimed to be the co-discoverer of amniotic fluid
culture with, but independently of, Klinger. There
appears to be no report in the scientific literature to
support Macintyre's claim.
Although there is one unconfirmed report of a fetal
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karyotype having been produced from uncultured amniotic
fluid cells (Hughes et al. 1971), cytogenetic studies of
amniotic fluid have developed in parallel with the
culture of amniotic fluid cells i The series of cases
in which antenatal chromosome analysis has been performed
for diagnostic purposes up to 1971 have been summarised
by Sutherland (1972, appendix III). Since this time a
number of series have been published, e.g., Milunsky et
al. (1972); Therkelsen et al. (1972); Epstein et al.
(1972) .
The cells present in amniotic fluid do not appear to
have been subjected to biochemical studies until about
1968. Dancis (1968) assayed uncultured cells for a
number of enzymes but could detect only minimal amounts
of valine transaminase and no activity of other enzymes
tested. He readily detected valine transaminase in
cultured amniotic fluid cells but again no other enzymes.
Nadler and Gerbie (1969) presented qualitative results
for a range of enzymes in both uncultured and cultured
amniotic fluid cells. Sutcliffe and Brock (1971)
assayed a number of enzymes in uncultured cells and
concluded that this was inadequate material on which to
base diagnoses. Berman et al. (1969) suggested that if
the activity of one enzyme was related to that of another,
rather than to protein, reasonably consistent results
could be obtained from such material. There is general
agreement in the literature that uncultured amniotic
fluid cells are not suitable material on which to base
antenatal diagnosis of inborn errors of metabolism.
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The first quantitative values for an enzyme in
cultured amniotic fluid cells were given by Nadler (1968b)
for glucose 6-phosphate dehydrogenase. Nadler (1968b)
claimed to have assayed 8 enzymes in cultured amniotic
fluid cells and stated that the levels did not change
throughout pregnancy. Not a single assay value is given
in support of this claim. It was claimed in the same
paper that glucose 6-phosphate dehydrogenase decreased
with time in culture when cells cultivated from amniotic
fluid from 10 weeks female fetuses were assayed. This
claim has never been verified and is strongly criticised
by Brock (1973). Nadler (1968a) and Fujimoto et al.
(1968) showed that the biochemical defect in some inborn
errors of metabolism was present in cultured amniotic
fluid cells. Since this time a number of enzymes have
been measured in cultured amniotic fluid cells (see Brock,
1973, for references) . However, these have usually been
in small numbers of cell strains. Often antenatal
diagnoses of inborn errors have led to a few "control"
cell strains being assayed (e.g., Nadler and Messina,
1969) .
There are no systematic studies in the literature of
the behaviour of an enzyme or group of enzymes in cultured
amniotic fluid cells. The normal values of enzyme
activity quoted are based on studies of small numbers of
cell strains . The levels of some enzymes in amniotic
fluid cell strains have been compared with those in
cultured skin fibroblast-like cells by Uhlendorf and Mudd
(1968), Kabak and Leonard (1970) and others (see Brock,
19
1973 for references). This work emphasised the
necessity of defining the "'normal characteristics' of
cultivated amniotic fluid cells" (Nadler, 1969), and
cautioned against the extrapolation of biochemical
findings in fibroblast-like cell strains to cultured
amniotic fluid cells.
Towards the end of this study of amniotic fluid
cells in tissue culture, it was found that amniotic fluid
from two anencephalic pregnancies contained large numbers
of cells which appeared to be fetal macrophages
(Sutherland et al., 1973b, appendix HI). Since fetal
macrophages had never been previously described in
amniotic fluid the macrophage content of normal and
abnormal amniotic fluids was studied.
The foregoing summarises the background against
which this work commenced. There were large gaps in
knowledge of the behaviour of amniotic fluid cells in
tissue culture, both primary and long term. The bio¬
chemistry of amniotic fluid cell strains had not been
studied systematically for even a single component.
The antenatal diagnosis of gross open lesions of the
central nervous system was not possible. The culture of
cells from the urine of fetuses and neonates had not
been reported. A more detailed examination of previous
work in each facet of this investigation is given at the
beginings of the relevant chapters.
Chapter 2
The Primary Culture of Amniotic Fluid Cells
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BACKGROUND
The first documented report of the culture of
amniotic fluid cells by Steele and Breg (1970) involved
the use of several different types of culture medium and
culture vessel. The only conclusions these workers
reached were that the best serum supplement was probably
fetal calf serum and that the presence of an irradiated
feeder layer of fibroblasts increased the number of
points of cellular outgrowth. Their method embodied the
general principles of subsequent methods. These
principles are, the separation of the cells from the
amniotic fluid by centrifugation and their transfer to a
vessel with tissue culture medium, followed by their
incubation at 37°C. The cells then attach to the surface
of the vessel and begin proliferation.
Later in 1966 Thiede et al. described a similar method
to that of Steele and Breg (1966). In 1967, Jacobson and
Barter described the first variation on the basic method
of Steele and Breg. They did not centrifuge the amniotic
fluid to separate the cells, but added equal volumes of
amniotic fluid and tissue culture medium (type
unspecified, supplemented with 30% fetal calf serum) to a
culture vessel. They allowed the cells to settle for 8
or 24 hours (not clear which) then decanted the medium
and unattached cells and debris and added fresh medium.
The medium was subsequently changed every three days.
Gray et al. (1971) concluded that centrifugation of the
amniotic fluid was not necessary, and may even have been
detrimental, a view supported by Kntirr-G&rtner and HHrle
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(1972). Gray et al. (1971) used only amniotic fluid as
their culture medium, i.e., their method was simply to
add amniotic fluid to a culture vessel, incubate and wait
for cell proliferation to become "well established".
Chitham et al. (1973) failed to culture amniotic fluid
cells using amniotic fluid as the culture medium.
Nadler (1968a) described a method which has been
slightly modified by a number of workers (e.g., Ferguson-
Smith et al. 1971; Nelson and Emery, 1970; Valenti et
al. 1969). After centrifugation the cells were
resuspended in a small volume of fetal calf serum (in some
cases a mixture of amniotic fluid and fetal calf serum),
placed in a Petri dish, covered with a coverslip and left
for about half an hour before tissue culture medium was
added. Petri dish cultures were usually incubated in an
atmosphere of 5% COg in air at 37°C.
The maintenance schedule has varied from that of
Nadler (1968a) who changed the medium daily, through that
of Ferguson-Smith et al. (1971) who changed it every
three days, to that of Nelson and Emery (1970) who left
the culture undisturbed for an initial period of one week,
changed the medium, left it for another week and thereafter
changed the medium every three or four days. Other
methods have been described but vary only in detail, such
as placing the amniotic fluid cells suspended in the
fetal calf serum on top of the coverslip rather than
beneath it (Abbo and Zellweger, 1970). A more
interesting variation was that described by Lee et al.
(1970) who claimed that heavy red blood cell contamination
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can slow down or completely inhibit cell growth. They
lysed the red blood cells by treating the cells from
amniotic fluid with ammonium chloride prior to culture.
Attempts have been made to stimulate the growth of
amniotic cells in culture by various means, all
unsuccessful. Steele and Breg (1966) tried to stimulate
growth with phytohaemagglutinin using a method similar to
that of Moorhead et al. (1960). Nelson and Emery (1970)
tried to stimulate growth with human pituitary extract
and steroid hormones. They also tried culture medium
taken from a rapidly growing culture and setting up
cultures on a collagen substrate. Nadler (1969)
reported that the use of human fetal albumin, instead of
fetal calf serum, as a medium supplement reduced by 70%
the time required for a cytogenetic result. Lisgar et
al. (1970) were not able to confirm this. Nelson and
Emery (1973) reported a large series of experiments in
which they tried to stimulate growth of amniotic fluid
cells using different amounts of fetal calf serum, young
calf serum, tryptose phosphate broth, chicken embryo
extract, thymine, dialysed urine from leukaemic patients
and bovine amniotic fluid. None of these variations in
culture medium had any effect. Chitham et al. (1973)
used human embryo extract to try and improve cell growth
but concluded that it had no advantage over chicken
embryo extract.
Most workers have favoured a tissue culture medium
enriched with non-essential amino acids and vitamins and
supplemented with 25 or 30% fetal calf serum. This has
24
been achieved by using commercially available enriched
media such as Ham's FIO, by supplementing minimal media
such as Eagle's minimal essential medium with the non¬
essential amino acids and vitamins (e.g., Epstein et al.
1972) or by adding supplements such as bovine embryo
extract ultrafiltrate to medium "cocktails" (e.g.,
Santesson et al. 1969).
The culture vessels used have varied. The majority
of workers have, however, favoured Leighton tubes or
disposable plastic Petri dishes. Amniotic fluid culture
has usually been attempted primarily for cytogenetic
studies. As primary growth on a coverslip can be
harvested for chromosome preparations, many of the Petri
dishes and Leighton tubes have contained coverslips.
Nelson and Emery (1973) investigated the use of open and
closed culture vessels. They found that "open" Carrel
flasks were superior to "closed" vessels but not different
from Petri dishes when cell growth at 14 days or less was
used as the criterion of success. They concluded that
the size of culture dishes and their nature (plastic or
glass) did not affect success rates of culture.
The degree of success achieved in the culture of
amniotic fluids has varied greatly and has been defined
differently by different workers. Perhaps the most
liberal definition has been that of Nelson and Emery
(1970) who defined success as "the presence of growing
cells within three weeks of a culture being set up".
In a later paper (Nelson and Emery, 1973) they had
reduced their time limit to two weeks. The most
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rigorous definition is that of Nadler (1968a) who did not
deem a culture successful unless he could "maintain the
culture after two subcultures". The first definition is
adequate only for the purpose of deciding whether or not
amniotic fluid cells have the potential to proliferate in
culture but has little relevance to establishing success
rates for a diagnostic test such as fetal chromosome
analysis. Nadler*s (1968a) criterion is too strict if
only a cytogenetic result is required as this can be
obtained from the primary culture or after the first
subculture.
Success rates, by any of these criteria, have varied
widely. Steele and Breg (1966) obtained cell growth in
12 of 62 cultures and obtained a chromosome result in two.
Nelson and Emery (1970) using their criterion of success
obtained cell growth in 49 out of 90 cultures. Jacobson
and Barter (1967) had 57 successful cultures out of 85
and achieved chromosome results in 33. Later workers
have reported much higher success rates. In a series of
30 pregnancies in which antenatal chromosome studies were
undertaken Ferguson-Smith et al. (1971) achieved
cytogenetic results in 29, but they required repeat
amniocenteses in 5 cases. The same authors were not so
successful in culturing a series of 24 samples of
amniotic fluid taken at hysterotomy; cell growth was
achieved from 21 samples and a karyotype analysis was
possible from 17. Therkelsen et al. (1971) karyotyped
41 out of 45 third trimester amniotic fluids and all of
18 second trimester samples. The most remarkable success
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rates have been those achieved by Gerbie et al. (1971).
They karyotyped 237 out of 250 amniotic fluids taken from
231 patients during 238 pregnancies. Hence they
achieved a culture success rate of 94.8% and an overall
antenatal diagnosis success rate of 99.6%.
There has been some discussion of the relationship
between the stage of pregnancy from which the amniotic
fluid is taken and the success rate. Nelson and Emery
(1970) reported no difference in success rates between
those fluids from pregnancies earlier than 20 weeks
gestation and those from later ones. Ferguson-Smith et
al. (1971) reported that fluids from pregnancies earlier
than 14 weeks and possibly later than 30 weeks were less
satisfactory than those obtained from within this range.
Nelson (19733) reported that amniotic fluids from severe
Rhesus-incompatible cases taken serially throughout the
last half of pregnancy required progressively longer to
culture and the success rate fell as pregnancy
progressed. Nadler and Gerbie (1971) stated that third
trimester amniotic fluids collected from women with Rh
problems were ".... quite difficult to cultivate".
Nelson and Emery (1973) concluded that ".... the main
possible factor influencing the changes in growth (of
amniotic fluid cell cultures) is serum". They
recommended that when "good" batches of fetal calf serum
were identified they should be stored and kept for
important cultures.
From this survey of published methods, especially
the more recent ones, it is clear that there is fairly
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general agreement about the following:
1. Petri dishes are the preferred type of culture
vessel.
2. 5% C02 in air at 37°C is the most widely used
incubation condition.
3. Volume and cell count of the amniotic fluid are not
closely related to success in culture»
4. The use of vital stains such as trypan blue are of
little or no value in assessing the growth potential of
amniotic fluid cells.
It is also clear that there is either controversy or
lack of adequate data on the following.
1. Does centrifugation have a detrimental effect?
Is amniotic fluid itself the best culture medium fox'
growing amniotic fluid cells?
2. What is the best maintenance schedule once a
primary culture has been established? Should it be left
strictly alone for about one week or should medium
changes start 1 to 2 days later?
3. Does the means of or reason for collection or
gestational age of the amniotic fluid affect the ability
of the cells to grow in culture?
4. What parameters of an amniotic fluid affect
the rate at which success is achieved?
Answers to these questions have been sought in the
study of amniotic fluid cells in primary culture.
28
MATERIALS AND METHODS
Amniotic fluids were obtained from a number of
sources. These included samples taken from hysterotomy
specimens, from women with Rhesus-isoimmunisation, at
artificial rupture of membranes via a Drew-Smythe
catheter and fluids collected via transabdominal
amniocentesis for the purpose of antenatal diagnosis of
fetal disease. The methods of collection of amniotic
fluid are beyond the scope of this thesis (see Scrimgeour,
1973, for a review of the techniques of collection of
amniotic fluid).
The basic method of establishing primary cultures
throughout this work was as follows unless otherwise
stated.
The amniotic fluid was transported to the laboratory
with minimal delay. Relevant details about the fluid,
such as gestation of the pregnancy, means of collection,
reasons for collection etc. were noted and the fluid was
treated as follows:
1. Centrifuged at 1000 rpm for 5 minutes.
2. Supernatant decanted and saved for biochemical
studies (Butterworth et al., 1972, 1974).
3. The cell pellet was resuspended in 10 ml. of
tissue culture medium and transferred to two 50 mm.
plastic Petri dishes which contained four or five 6 x 22
mm. glass coverslips. The cells from about 5 ml. of
amniotic fluid were used for each Petri dish. The
tissue culture medium was Ham's F10 supplemented with
30% fetal calf serum. Antibiotics incorporated in the
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medium were kanamycin (lOOjig/ml) or penicillin
(60|jg/ml) and streptomycin (100fig/ml) in combination.
(See appendix I for details of plastic and glassware
used and preparation of the culture medium.)
4. The cultures were incubated at 37°C in an
atmosphere of 5% C02 in air (see appendix I for details
of method of incubation).
5. Half the medium in each Petri dish was replaced
after 2 or 3 days and thereafter half the medium was
replaced 3 times per week.
6. The cultures were inspected regularly under
the inverted microscope, using either bright field or
phase contrast optics, for signs of cell proliferation.
When cell proliferation was adequate a coverslip was
harvested for chromosome studies (see chapter 4 for
details) and/or the culture was subcultured to produce a
primary amniotic fluid cell strain (see chapter 3 for
details). Cellular morphology was monitored by direct
observation with the inverted microscope and by removal
of coverslips for fixation in methanol and staining with
Giemsa.
The effect of the maintenance schedule was studied
by setting up cultures in duplicate as in the standard
method. One culture was maintained as in the standard
method, the other was not touched for 7 days when half
the medium was changed. Half the medium was
subsequently changed three times per week. The first
culture to produce a cytogenetic result was judged to be
the most successful. These methods correspond to
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methods III and II respectively in Sutherland et al.
(1974b, appendix III) . When large volumes of amniotic
fluid were available these two methods were tested
against the method of Gray et al. (1971) which




The results are based on the study of 132
consecutive amniotic fluids received in the two year
period 1.12.71 to 30.11.73. Each sample was given a
number on arrival (Laboratory number, appendix II).
Data on each amniotic fluid received, including reasons
for collection, gestational age and some aspects of its
behaviour in tissue culture are detailed in appendix II.
Some of this data is summarised in table 2.1. Seven of
these samples (3 in category vi and 4 in category v) were
from anencephalic pregnancies and will not be considered
beyond table 2.1 in this chapter. The largest group of
amniotic fluids were from Rhesus iso-immunised pregnancies
Table 2.1. Reasons for collection and gestational ages




























Induction of labour 10
132
27.7 ± 4.8 18-35
16.70 ± 3.5 11-23






Hence, together with samples collected for other reasons
the series of amniotic fluids studied spanned the
gestational range from 11 weeks to term.
The outcome of the primary cultures is shown in
table 2.2 for each category of amniotic fluid. From
this table it can be seen that the success rates are
high for all categories except iv and vi, In category
iv two primary cultures degenerated, one leading to
failure of an antenatal diagnosis (42) and the other (2S4),
which was grossly blood-stained, required a repeat
amniocentesis one week later which resulted in a
successful culture. Except for two cultures lost to
primary contamination and another to secondary
contamination before assessment, category vi contained
the only primary cultures in the whole series which did
not show any sign of cellular proliferation.
The quality of success can be measured by the time
taken to achieve a cytogenetic result (when this was
done in the minimum time) and by the time in primary
culture. Unfortunately, both these times are
subjective in that they rely on the experience of the
operator and are not continuous because cytogenetic
harvesting was usually only done twice a week and sub-
culturing three times per week. However, since almost
all these operations were done by one person the only
trend is perhaps a shortening of the time taken to
achieve a cytogenetic result as a proportion of the
time in primary culture. As there is no other measure¬
ment of the quality of success achieved, the times to a
33
Table 2.2. Numbers of primary amniotic fluid cultures in
each category which were harvested for cytogenetic studies
in the minimum time required and the number which were sub-


















































Total 125 75 108
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LABORATORY NUMBER OF AMNIOTIC FLUID SPECIMEN
Fig. 2.1. Minimum times required to achieve a cyto¬
genetic result from amniotic fluid samples in the sequence
in which they were received. (H.S. - hysterotomy specimen;
Rh.S. - Rhesus iso-immunised specimen; D.C.S. - diagnostic
cytogenetic specimen; D.A.F.P.S. - diagnostic a-feto-
protein specimen; A.R.M. - specimen collected at induction
of labour at term).
cytogenetic result and the times in primary culture of
amniotic fluid cultures in each category are shown in
table 2.3 and 2.5.
The time to chromosome result data shall be considered
first. From Fig. 2.1 it can be seen that after the first
10 or so samples there was a fall in the time required for
such a result. This most probably represents early
inexperience in obtaining chromosome preparations from
amniotic fluid cultures. After this initial fall there
were marked fluctuations in the time required from 7 days
(136) up to 38 days (220). These fluctuations appeared
35
Table 2.3. Times taken to achieve a cytogenetic result
from 75 amniotic fluid cultures according to category of
sample.
Category No. Days to cytogenetic result
Mean ± S.D. Range
i 28 17.4 ± 6.2 7-33
ii 16 19.2 ± 8.8 12-49
iii 23 15.1 ± 6.0 7-38
V 7 15.1 ±4.5 11-24
vi 1 19 -
Total 75 16.9 ± 6.7 7-49
Total - first 10 65 15.5 ± 5.0 7-38
First 10 10 26.0 ± 9.4 16-49
to be random around a mean of about 15 days with a few
marked deviations down and slightly more up.
The times taken to achieve cytogenetic results have
been analysed according to the category of the amniotic
fluid (Table 2.3). With the exception of category vi
which only contained one result, Student's t-tests were
carried out between each group and the values obtained
are shown in table 2.4. The figures from this table and
table 2.3 indicate that apart from the first 10 results
which took longer to obtain than those for any of the
other groups, the origin of the amniotic fluid does not
affect the time taken to achieve a cytogenetic result.
The significant difference between the results from the
hysterotomy specimens and the last 65 samples is artefact.
Seven of the hysterotomy samples were included in the
first 10 results; if these 7 are excluded from the
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Table 2.4. Student's t-test scores from comparisons of
the times taken for a cytogenetic result according to
the category of the sample.
Category (i) (ii) (iii) (V) Total Total -
first 10
(ii) 0.776 -
(iii) 1.332 1.714 -
(v) .911 1.145 N.D. _
Total 0.359 1.169 1.139 0.682 -
Total -
first 10 1.554 2.217* N.D. N.D. 1.355






.001 N.D. - not done
hysterotomy series and the t value recalculated then it is
no longer significant (t = 0.384). Since this first
group of 10 results are different from the remaining 65
they will be excluded from further consideration. Although
chromosome results were not attempted in the minimum time
from all cases, there was no conscious selection involved.
All cases where the result was of clinical significance
were completed in the minimum time, whether this was done
for other cases depended on pressure of work, vacations
etc., not the behaviour of the culture.
There were no significant correlations between
gestational age and time to result either within the
categories or for the group as a whole. In addition, the
time to result from fluids collected from pregnancies of
20 weeks' gestation or less were not significantly
different from that required from pregnancies of more
37
Table 2.5. Times in primary culture for 107 amniotic







(i) 58 28.57 + 8.1 18-55
(ii) 18 27.61 ± 7.8 18-49
(iii) 18 25.83 ± 4.3 17-34
(iv) 3 25.67 ± 4.5 21-30
(v) 8 24.3 ± 6.3 19-36
(vi) 3 29.0 + 2 .6 27-32
Total 108 27.56 ± 7.2 17-55
than 20 weeks* gestation.
The times in primary culture according to category
are shown in table 2.5. The times in primary culture
did not show the same initial decline as did the times to
chromosome result. Hence it was not necessary to
exclude any cultures from consideration. Student's
t-tests were carried out between some of the categories
and the values are shown in table 2.6. None of these
values are significant. Hence time in primary culture
was unrelated to the origin of the amniotic fluid. In
addition there was no correlation between gestational
age of the amniotic fluid and time in primary culture.
The data were examined to ascertain whether there
was any relationship between the cellular content of the
amniotic fluid and the time to chromosome result or the
time in primary culture. The cell counts of the
amniotic fluids ranged from less than 1000 cells/ml
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Table 2.6. Student's t-test scores from comparisons of
the times taken for a cytogenetic result according to
category.
Category (i) (ii) (iii) (V)
(ii) 0.443 -
(iii) 1.373 0.846 -
(v) 1.450 1.072 0.748 -
Total 0.818 - 0.984 1.259
(these were arbitrarily given a value of 1000 cells/ml. as
this was the lower limit of sensitivity of the method
used - see appendix I) up to 200,000 cells/ml. In spite
of this range the cell count was not related to the
behaviour of the primary culture.
The availability of serial samples of amniotic fluid
collected from Rhesus iso-immunised patients afforded the
opportunity of studying the effect of this disease on the
growth characteristics of amniotic fluid cells. The
behaviour in primary culture of amniotic fluid cells
derived from eight such patients are shown in table 2.7.
There is no significant correlation between the O.D.D.
and the time to a chromosome result or to the time in
primary culture. By inspection the time to chromosome
result is obviously unrelated to both O.D.D. and
gestation. The data are not clear for the time in
primary culture. The results for patients 1 and 5 show
a progressive increase in time in primary culture
associated with a progressive decrease in O.D.D. Patient
1 had an affected child whereas patient 5 had an
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Table 2.7. Behaviour in primary culture of serial
samples of amniotic fluid collected from eight patients.
Patient Gestation Days to Days in 1° O.D.D.
Number (weeks) chromosome culture
result
1 18 28 0.16
22 26 24 0.20
24 12 20 0.18
33 21 49 0.08
35 19 36 0.08
2 23 _ 18 .16
26 - 26 .28
28 14 28 .50
3 19 7 31 0.12
30 13 20 0.07
33 26 — 0.05
4 24 .. 34 0.20
30 - 27 0.11
32 14 43 0.11
5 20 17 20 0.14
23 21 28 0.14
26 13 31 0.08
29 - 36 0.06
33 30 41 0.04
6 20 12 43 0.12
27 12 30 0.07
30 — 33 0.05
7 19 _ 18 0.09
30 - 26 0.11
32 - 26 0.11
8 27 12 29 0.12
34 26 27 0.27
* Optical density difference at 450 mp (Robertson, 1969).
unaffected child. Patient 2 had a severely affected
child, but in this case the time in primary culture inc¬
reased with a corresponding increase in O.D.D. More
such series of amniotic fluids would have to be studied
to determine which, if any of these apparent associations
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are significant.
There was little opportunity to study the effect of
gross blood contamination of the amniotic fluid on the
growth of the primary cultures, Only 6 heavily blood¬
stained samples were received and two of these were from
the same patient. The first (284) showed poor growth
in culture but the second (286), collected a week later,
and just as heavily blood-stained was cultured successfully.
The main problem associated with blood-stained samples in
primary culture was that the red cells made observation of
the culture with the inverted microscope difficult.
These red cells were progressively removed by medium
changes and after about two weeks no longer interfered.
The results of the comparison of the two schedules
of maintenance during the first week of primary culture
(methods II and III, Sutherland et al., 1974b; appendix
III) are shown in table 2.8. The differences between
the two methods are not significant either for the time
taken to achieve a cytogenetic result or the time in
primary culture. It is, however, noteworthy that the
duplicate cultures showed considerable variation. For
269, one culture took more than twice as long as the
other to achieve a cytogenetic result and for 123 one
culture degenerated even though both achieved cytogenetic
results in the same time. Early in this work it became
apparent that the initial maintenance schedule was of
little importance to the success of the culture and,
apart from the experimental cultures, the first medium
change was usually carried out after three to five days,
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Table 2.8. Times taken to achieve a cytogenetic result
and times in primary culture for duplicate cultures using
maintenance methods II and III.
Number Days to Days in
cytogenetic result primary culture
Method III Method II Method III Method II
89 18 12 33 29
94 15 15 25 28
115 19 19 36 29
119 14 16 20 20
121 14 18 20 23
123 21 20 49 *
127 22 19 38 36
176 17 19 20 24
200 16 18 30 30
246 14 10 28 26
247 15 15 26 28
260 14 20 18 27
261 10 10 18 26
263 15 10 25 21
268 13 13 26 28
269 10 24 30 39
271 15 15 25 34
274 9 9 17 17
276 10 11 32 20
277 9 10 32 20
Mean ±S.D. 14.5 ±3.7 15.2 ±4.4 27.0 ±8.0 26.8 ±5.6
* Culture degenerated and could not be subcultured.
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whenever most convenient.
The results of the study on a large volume of
amniotic fluid from which 15 primary cultures were set up
using the three methods outlined in Sutherland et al.
(1974b, appendix III) are shown in table 2.9. Cyto¬
genetic preparations were not actually harvested from all
these cultures and the time to cytogenetic result was the
time at which there were sufficient cells on a coverslip
which could have been harvested. It can be seen from
these results that there is little difference between
methods II and III but that method I is inferior to these
two. These results are valid for only this one sample
Table 2.9. Time taken to achieve a cytogenetic result
and time in primary culture for 15 cell strains set up
from one sample of amniotic fluid using three different
methods.
Method and cell Days to Days in













































* Culture b showed only minimal evidence of growth,
degenerated before there were sufficient cells for
a chromosome result and could not be subcultured.
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of amniotic fluid. It was not possible to obtain other
large volumes of amniotic fluid to repeat this experiment.
Studies on the morphology of the cells seen in
primary cultures of amniotic fluid have been published
(Sutherland et al., 1974a, appendix III).
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DISCUSSION
The main feature of these results is the high
success rate attained for the culture of amniotic fluid
cells. Much early work on amniotic fluid cell culture
implied that these cells were difficult to culture and
success rates were low. Nelson and Emery (1971)
successfully cultured only 49 out of 90 amniotic fluids.
Success rates and times taken to achieve chromosome
results in the early series have been reviewed by Nelson
(1973a). In table 2.10 the overall success in the present
series is compared with series published in 1971 or later
which included more than 20 amniotic fluid cultures.
Success rates ranged from 55 to 100% but those series
with the highest success rates were both small. The low
overall success rates in some series (Robinson et al., 1973;
Turnbull et al., 1973) were mainly due to failures in the
early part of the series; both these series had success
rates greater than 90% towards the end. The success
rate of the present series compares very favourably with
other series, especially since four of the failures were
from 7 amniotic fluids collected at the induction of
labour. Other series did not have such samples included
in them with the exception of Mulcahy and Jenkyn (1973)
whose series included 4 samples collected at term.
In view of the high success rate any attempt to study
the effect of various treatments on the growth of amniotic
fluid cells had to be assessed in terms of time to a
cytogenetic result or time to subculture. Most series
do not contain data on these parameters of cell growth.
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Table 2.10. Series of amniotic fluid cultures which
have been published in 1971 or later and which included





















































































Present Series 125 120 96 (from table 2.2)
a
- success defined as cytogenetic result, otherwise
success defined as the observation of cell growth.
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Only five of the series in table 2.10 have details of the
time required to achieve a cytogenetic result and these
are shown in table 2.11. The shortest time required was
by Gray et al. (1971). The only other report of such
rapid results being consistently obtained was by Lisgar
et al. (1970) who required an average of 8.3 days (range
3-26) to achieve cytogenetic results from 19 amniotic
fluid cultures. Cederqvist et al. (1973) did not obtain
their results in the minimum time but routinely harvested
for cytogenetic studies after 14 days. Epstein et al.
(1972) required from 2| to 5§ weeks (mean 4 weeks) early
in their series but this time fell to about three weeks
towards the end of the series. Therkelsen et al. (1972)
found that the time required decreased as their series
progressed. This decrease in time, also found in the
Table 2.11. Minimum times required to produce cyto-





































Present series 65 15.5 7-38 (table 2.3, page
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present series, probably represents an increase in the
expertise of the operator rather than any increase in the
growth rate of the cells especially where the techniques
used are not changed.
There are no data in the literature on the time in
primary culture for amniotic fluid cells. This may well
vary with the growth surface area of the culture vessel
used. Presumably cultures initiated in, say, small
Leighton tubes would be ready for subculture before those
grown in Petri dishes ot T-flasks. Possibly because of
this lack of data on time in primary culture there is
little information on degeneration of primary cultures.
This was the main reason for failure of primary cultures
in the present series, apart from microbial contamination.
Most early reports of amniotic fluid cell culture
indicated that more cultures showed cellular proliferation
a
than yielded cytogenetic results. Nadler (1968) reported
that 3 out of 27 primary cultures, which grew well, could
not be successfully subcultured. Turnbull et al. (1973)
reported that although 40% of the first 241 fluids they
studied showed growth in culture only 25% grew well
enough to produce a cytogenetic result; this presumably
means that the cultures degenerated. The reasons why
cells cease to divide once they have started remain
unknown but inadequate culture conditions is one
possibility.
The behaviour of the amniotic fluid cells in primary
culture was independent of the cell count, gestation, and
the reason for which the fluid had been collected. The
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one exception was the difficulty experienced in culturing
cells from term amniotic fluids. Mulcahy and Jenkyn
(1973) were only able to culture two out of five samples
of amniotic fluid collected at term. This difficulty
with such fluids may be due to contamination with
obstetric antiseptics (Scrimgeour, personal communication)
or to the build up of waste products in amniotic fluid
towards term, producing a situation similar to that for
urine (see discussion chapter 8). Samples grossly
contaminated with blood were found to grow as well as
other samples, a finding in agreement with Gerbie et al.
(1971) and Robinson et al. (1973) but not with most other
authors. The degree of severity of Rhesus iso-
immunisation (as expressed by the O.D.D. at 450 mfi) had
no consistent effect on the quality of success of cell
culture. This finding does not agree with most other
published series in which such fluids were included, but
these were mainly early series with lower success rates.
Nelson (197^) reported that repeated samples from
severely Rhesus iso-immunised pregnancies take
progressively longer to grow in culture. Nadler and
Gerbie (1971) found cells from third trimester Rhesus
iso-immunised pregnancies difficult to cultivate. Further
series of such fluids would need to be studied to refute
these claims but the present series lends them no support.
Studies on the morphology of the cells in amniotic
fluid cultures are presented and discussed in Sutherland
et al. (1974a, appendix III). The only additional
study of this nature is that of Kaback and Leonard (1972)
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whose findings are essentially similar to those in the
present series.
The experiments on the maintenance schedule of the
cultures indicated that this did not affect the rate of
cell growth. The wide variations in the maintenance
schedule amongst published methods of primary amniotic
fluid cell cultures suggest that this is certainly not an
important consideration.
The effect of lack of centrifugation of the amniotic
fluid and the consequent use of amniotic fluid alone or
as a high proportion of the culture medium was not
adequately investigated due to the lack of suitable
material (large volumes of amniotic fluid). The only
fluid which was studied in this regard did not support the
use of amniotic fluid alone as a culture medium (Gray et
al. 1971). Other methods have since been published
which do not include centrifugation (Cederqvist et al.,
1973; Knorr-Gartner and Harle, 1972) but these do not
use amniotic fluid alone as a culture medium. Nakagome
et al. (1972) did not centrifuge but found that using
amniotic fluid alone as the culture medium for longer
than "overnight" before replacing it with more
conventional culture medium was "less satisfactory".
Hence only Gray et al. (1971) have obtained good results
using amniotic fluid itself as a culture medium.
Furthermore, no others have produced data which indicate
that centrifugation of amniotic fluid, as carried out in
many primary culture methods, is detrimental to cell
growth. The only others who have achieved cytogenetic
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results as quickly as Gray et al. (1971) are Lisgar et al.
(1970) who centrifuged their amniotic fluids at 250g for
15 minutes. Further controlled studies similar to the
one performed on fluid 264 are required to establish
whether centrifugation is harmful and whether amniotic
fluid alone is an adequate culture medium. Since the
experiment on 264 did not test lack of centrifugation in
combination with the use of conventional tissue culture
medium, this experiment should be redesigned such that
the three groups of cultures would be (a) no centrifugation
and amniotic fluid alone as a culture medium for one week,
(b) no centrifugation but equal parts amniotic fluid and
culture medium and, (c) standard method.
The results of the studies reported in this chapter,
together with those in the literature indicate that
cellular proliferation should be observed in virtually
100% of amniotic fluid cell cultures provided that the
fluid is not collected at induction of labour. For
reasons which remain unknown about 5% of cultures will
degenerate in the primary culture, some leading to failure
of cytogenetic studies and all failing to produce cell
strains. All attempts to stimulate amniotic fluid cells
to more rapid growth have failed. The times taken to
achieve cytogenetic results will decrease as the operator
becomes more experienced in handling these cultures. The
rate at which cultures proliferate is probably dependent
on close attention to the various details of tissue
culture technology rather than on any single factor.
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SUMMARY
The behaviour of 125 amniotic fluid samples in
primary culture has been studied4 The times required
to achieve cytogenetic results in the minimum time was
established in 75 cases. The primary cultures were
subcultured to produce 108 amniotic fluid cell strains.
The behaviour of the amniotic fluids in tissue culture
has been analysed with respect to reason for collection
of the fluid, gestational age, cell count and degree of
Rhesus iso-immunisation. Variations in the method of
establishing the primary cultures were examined. The
morphology of the cells which proliferate in these
primary cultures of amniotic fluid have been studied.
Chapter 3
The Serial Cultivation of
Amniotic Fluid Cell Strains
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BACKGROUND
The classic papers of Hayflick and Moorhead (1961)
and Hayflick (1965) finally dispelled long-held ideas
that human diploid cell strains were immortal (Medawar,
1958). This concept of immortality was supported by
reports (e.g., Paul, 1965) that Carrel had maintained a
cell strain, derived from chick embryo heart, in serial
culture for 34 years. Hayflick (1965) has suggested
that this "cell strain" only survived because it was
being supplemented with new cells in the chick embryo
extract component of the culture medium. (Paul, 1965,
gives a detailed account of the early development of
tissue culture.)
It is now accepted that human diploid cell strains
have a limited life jUi vitro, compared with cell lines
which have unlimited lives ^n vitro. Criteria for
differentiating between cell lines and strains have been
presented by Hayflick and Moorhead (1961). It should be
noted that the concept of the "Hayflick limit" has been
challenged. Moore and McLimans (1968) claim that
lymphoblastic cell strains qualify as diploid, are not
transformed, and can be cultured indefinitely. Hay (1970)
has suggested that the apparent limited life may be due
to inadequate tissue culture conditions. The ability of
Litwin (1972) to increase the number of passages to which
cell strains can be cultivated by supplementing the
culture medium with excess tyrosine supports Hay's
suggestion.
There is no report in the literature which documents
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the behaviour of amniotic fluid cell strains in
prolonged serial cultivation. Nadler and Gerbie (1970)
implied that they could not subculture 25% of 155
successful primary amniotic fluid cell cultures more
than three times. Melancon et al. (1971) stated that
amniotic fluid cell cultures contained two cell types,
an epithelial type which can be subcultured only two to
five times and a fibroblast-like cell which can be sub-
cultured for more than 30 passages. Littlefield (1971)
has claimed that " .... six to eight weeks of rapid
culture can approach the limit of the growth potential
of amniotic fluid cells". Gray et al. (1971) established
cell strains from 23 amniotic fluids which had been sub-
cultured from one to twelve times and " .... continue to
grow vigorously". Wallace (1972) found that of the
cell types present in primary amniotic fluid cultures
only fibroblast-like cells " .... grew luxuriantly and
could be successfully passaged".
The lack of information on the behaviour of amniotic
fluid cell strains prompted this study. A knowledge of
the behaviour of these cell strains is important as
biochemical assays may require large numbers of cultured
cells. In the antenatal diagnosis of an inborn error of
metabolism this may mean that the cell strain has to be
subcultured three or four times before there are
sufficient cells for a biochemical assay. It is essential
to know the time required for, and the probability of,
producing enough cells for a biochemical diagnosis. As
Brock (1973) when discussing antenatal diagnosis commented
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" t0 the 1- -ore elusive than
success to the cytogeneticist".
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MATERIALS AND METHODS
The cell strains were developed by subculturing the
primary cultures described in chapter 2.
There were three main aspects of this study of the
serial cultivation of amniotic fluid cell strains:
1. Observations of the behaviour of these cell
strains when serially cultured until senescent. This
included studies of cell morphology and karyology. The
methods are as in Sutherland et al. (1974a, appendix III)•
It should be noted that those cell strains described in
Sutherland et al. (1974a, appendix III) were serially
cultured using Ham's F10 tissue culture medium with 30%
fetal calf serum supplement. The cell strains cultured
since that series was completed had the fetal calf serum
supplement in the culture medium reduced from 30% to 15%.
2. Measurement of the time required to produce
enough cells for a biochemical assay was carried out.
The methods are as in Sutherland and Bain (1973), appendix
III. The cell strains in this published series were
grown with a 30% serum supplement in the culture medium
except for the last 15 in the series where a 15% serum
supplement was used. All subsequent cell strains were
grown in medium with a 15% serum supplement.
3. Two experiments were set up to study the effect
of the amount of serum supplement and type of culture
vessel on the behaviour of the cell strains. Duplicate
cultures of two amniotic fluids (numbers 246 and 247,
appendix II) were set up. The cultures were split as
in Fig. 3.1 to produce six substrains from each amniotic
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amniotic fluid sample
Figure 3.1. Schematic representation of the way six
cell strains were obtained from amniotic fluids number
246 and 247. Substrains a and b were cultured in baby
feeding bottles using medium with a 15% serum supplement.
Substrains c and d were similarly maintained but a 30%
serum supplement was used. Substrains e and f were
maintained in T-flasks using medium with a 30% serum
supplement.
fluid. Four were serially cultured in baby feeding
bottles, two using medium with a 30% serum supplement and
two with a 15% serum supplement. Two were serially
cultured in Nunclon T-flasks with a growth surface area
2
of 25 cm . When the cells in the first T-flask were
subcultured the flask was not discarded but fresh culture
medium was added to it and it was incubated so that the
cells not removed could continue growth. When the cells
in this flask became confluent the procedure was repeated
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and the cells removed with trypsin were used to prepare a
flying coverslip. This routine was performed until the
cells would no longer grow to confluency. Hence the one
culture flask was maintained over several months with
those cells which could be readily removed with trypsin
being continually discarded. This produced a cell strain
with cell types which were "trypsin resistant".
One large volume of amniotic fluid (264) was used to
set up 15 primary cultures using three different methods
(Sutherland et al., 1974b, appendix III). This allowed
comparison of the three methods (see chapter 2) and was
intended for use to study the reproducibility of the




The results of the first series of cultures on which
long term studies were completed are presented in
Sutherland et al. (1974a, appendix III)- This report
covered samples numbered from 47 to 127 inclusive
(appendix II), and will henceforth be referred to as the
first series. Samples prior to number 47 were excluded
from the first series because of inexperience in tissue
culture. Those samples not included in Sutherland et al.
(1974a), but coming into the consecutive series from 47 to
127, and the reasons for their exclusion are shown in
table 3.1. Hence the first series of 31 cell strains
were derived from 41 consecutive amniotic fluids.
All tissue culture was discontinued for a short period
after the detection of mycoplasma contamination. After
resumption of tissue culture, mycoplasma testing was
Table 3.1. Reasons for exclusion of 10 amniotic fluid




Cell strain not cultured
to senescence
49, 110 2
Cell strain had possible
inborn error of metabolism
62 1






Mycoplasma contamination 111, 122 2
Primary culture showed no
signs of cell growth
108 1
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consistently negative until cell strain number 264 had
been in culture for some time. Hence the cultures in
the second series, on which long term studies had been
completed, were numbered from 152 to 247. There were
35 amniotic fluids in this series, but there were only
18 cell strains on which long term studies were completed.
The reasons for exclusion of 17 are shown in table 3.2.
As can be seen from this table there was a problem with
microbial contamination. This was due to a Gram
negative organism in a batch of medium. Routine sterility
testing failed to detect this organism before the medium
was used. All cultures in this particular series lost to
microbial contamination were in this one episode.
Since there were only 4 cell strains in this second
series of 18 which did not originate from Rhesus iso-
Table 3.2. Reasons for exclusion of 17 amniotic fluid





Cell strain not cultured 181, 186, 231 3
to senescence
Cell strain had an inborn 205
error of metabolism
1










Primary culture could not 217, 180
be subcultured
2
Primary culture showed no 169
signs of cell growth
1
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immunised fluids, all 18 will be considered together.
The justification for this is that in the first series
the origin of the amniotic fluid did not affect the
behaviour of the cell strains in culture. The properties
of the cell strains in the second series have been
analysed similarly to the first series. The 18 cell
strains were derived from amniotic fluid samples
collected from 13 women, i.e., one woman contributed 3
samples and three women contributed 2 samples each.
Seventeen of the cell strains had normal karyotypes,
chromosome studies were not carried out on the cells
grown from one sample (fluid number 168). Table 3.3
compares some features of the amniotic fluids in the two
series. As can be seen there is no significant
difference between the mean gestational ages in the two
series. The sex ratios are reversed from the first
series to the second but this is obviously due to the
small numbers involved as the combined sex ratio is not
Table 3.3. Gestational ages and chromosomal sexes of
the amniotic fluids which yielded cell strains in the
first and second series.
Series Number in Gestation (weeks) Chromosomal Sex
Series
Male Female
First 31 25.6a 12 19
ll-39b
Second 18 25.7a ii* 6*
15-40b
mean; - range.
chromosome studies not carried out on one sample.
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Table 3.4. Data on the amniotic
cultured to senescence in the two




Days as a Mean sub-
cell strain culture inter¬
val (days)
1 13.90 ± 6.52a 26.32 ± 5.43 91.94 ± 35.01 7.19 ± 2.07
3-29b 18-41 19-146 3.0-12.0
2 15.67 ± 15.76 32.00 ± 10.15 101.67± 54.35 8.98 ± 3.22
2-55 20-55 25-248 3.8-14.4




Table 3.4 compares some properties of the cell strains
in the two series. The differences between the two series
are not significant for the number of days as a cell strain
(interval between subculture of the primary culture and
death of the cell strain) or for the number of passages
for which the cell strain could be cultured prior to death.
The number of days in primary culture was significantly
longer (P < .05) for the second series. The mean interval
between subcultures was also significantly longer (P < .05)
for the second series than for the first series.
Similarly to the first series, there was no
correlation between gestational age and time in primary
culture, number of passages or the mean subculture
interval. There was however a significant (P < .05)
correlation (r = -0.48) between the time in primary
culture and the number of passages. The significance of
this correlation is due to the results for laboratory
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Fig. 3.2. Relationship between the number of passages
for which a cell strain could be cultured prior to death
and the mean interval between subcultures.
as outliers. If the results for these two cell strains
are omitted from the calculation the correlation is no
longer significant, being in agreement with the first
series. As in the first series the correlation between
number of passages and mean interval between subculture is
significant (r = -0.796; P < .001). This relationship
is shown for both series in Fig. 3.2. Since the growth
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DAYS IN CULTURE
Fig. 3.3. Growth curves of three amniotic fluid cell
strains which are typical for longer surviving (119) and
intermediate surviving (75 and 63) cell strains.
curve for amniotic fluid cell strains is not linear,
showing an initial lag phase and a final slowing down
(Fig. 3.3) it is possible that the calculation of mean
interval between subcultures as carried out produces this
correlation artefactually. In addition those cell strains
which survive only for a small number of passages may
unduly influence this correlation. Hence the mean
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Mean interval between subcultures (Days)
Fig. 3.4. Relationship between the number of passages
for which a cell strain could be cultured prior to death
and the mean interval between subcultures over all
passages and over only the middle passages. Only cell
strains which survived for more than 10 passages are
included.
interval between subcultures was recalculated. The first
two passages were excluded to allow for any lag phase and
the last four to allow for the final slowing down. Only
those cell strains which survived for more than 10
passages were considered, these comprised 30 cell strains
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taken from both series. The reason for omitting those
surviving for less than 10 passages was to allow the mean
interval between subcultures to be estimated over at
least five such intervals. The thirty cell strains
showed the correlation between these two parameters on
the original data (r = -0.612, P < 0.001). The adjusted
mean interval values still showed the correlation
(r - -0.498; P < 0.01) (Fig. 3.4).
The distribution of the number of passages for the
two series is different. Although the means for each
group are not significantly different the standard
deviation in the second group is much greater. This is
because three cell strains (176, 190 and 247) all lived
much longer than the others. The distribution of the
number of passages for each series and for the combined
49 cell strains are shown in table 3.5.
The serial samples of amniotic fluid collected from
the four women yielded cell strains with properties as
shown in table 3.6. These results from the second
series add little to those of the first series. Again
there is no more similarity within a group than there is
between them and there are no trends within the groups
Table 3.5. Distribution of the number of passages for
each series of cell strains and for the two series
combined.
No. of passages
0-4 5-8 9-12 13-16 17-20 21-24 > 25
Series 1 3 3 8 7 5 3 2
Series 2 2 6 4 2 1 3
Series 1+2 5 9 12 9 5 4 5
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Table 3.6. Data on 9 amniotic fluid cell strains
derived from 4 pregnancies.
Group Labor¬ Gestation Days in 1° No. of Days Mean




1 176 20 20 35 142 4.1
189 23 28 9 84 9.3
203 26 31 11 98 8.9
2 179 23 23 8 115 14.4
195 26 41 8 72 9.0
3 191 20 43 2 25 12.5
225 30 33 16 82 5.1
4 202 22 46 6 67 11.2
206 26 55 8 71 8.9
a b
Fig. 3.5. Chromosome aberrations in senescent amniotic
fluid cell strains; a - strain 176, 34th passage, cell
showing 3? + chromosome; b - strain 247c, 49th passage,




Whilst a number of the cell strains in the second
series were stored in the liquid nitrogen unit none were
put back into culture and cultured to senescence.
The karyology of the second series was not monitored
except for three of the longest lived cell strains (176,
190 and 247c) which were studied in more detail than those
in the first series. The results of the chromosome
analyses for these three cell strains are shown in table
3.7 and Fig. 3.5. It should be noted that the chromosome
count is a centromere count, hence a dicentric is counted
as two and an acentric is not counted. The quality of
the chromosome preparations, both in terms of mitotic
index and metaphase quality, declined as the cell strains
approached death. Hence it was possible to score many
more metaphases for ploidy than could be analysed. The
three strains, especially 247c, showed an increase in
structural aberrations in the last few passages prior to
death. There appeared to be an increase in polyploidy
as death approached but unfortunately there were too few
mitoses in the late stages to establish this. Meta¬
phases with less than 45 chromosomes were not included
as these are most likely the result of artefact. The
metaphases with 45 chromosomes are considered in table 3.8.
If the expected number of chromosomes missing in each
group is directly related to the number of chromosomes in
each group then the findings in table 3.8 depart from
2
expectation (X g = 79.4; P < .001). There is an overall
deficiency of cells with chromosomes missing in all groups
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Table 3.7, Cytogenetic data at various passages of three
cell strains.
Strain Passage Chromosome counts Abnormal cells
45 46 47 Total Poly¬
ploidy
176 1° 1 10 11 45,XY,-C
11 15 15 1/200 46,XY,+ace
12 1 19 20 °/200 45,XY-C,+ace
23 22 22 °/200 46,XY,F?+
26 1 7 8 °/30 45,XY,-C
34 3 12 15 1/120 46,XY,3?+; 45,XY,-G
45,XY,-G,+ace;
45,XY,-2,+ace,+ace.
190 34 7 43 50 4/400 (45,XX,-F)x3;
(45,XX,-G)x3;
45,XX,-C.
39 4 45 1 50 Vsoo (45,XX,-F)x3;
(45,XX,-C)x2;
47,XX,+16.
51 7 43 50 5/400 (45,XX,-F)x3;
(45,XX,-E)x2;
45,XX,-C; 45,XX,-G.
55 2 6 8 3/20 45,XX,-F; 45,XX,-G.
247c 1° 1 14 15 45,XY,-C
20 2 48 50 6/200 45,XY,-G,45,XY,-Q+a<




47 2 2 2/ll




51 4 4 8 °/12 (45,XY;-G)x4;
46,XY,-G,-E,+dic.
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Table 3.8. Distribution of the chromosomes missing from
hypodiploid cells with 45 chromosomes for the three cell
strains studied.
Strain Chromosome Group
A B C D E F G Total
176 1 - 3 - - - 2 6
190 - - 4 - 2 9 5 20
247c - - 3 1 - - 11 15
Total 1 - 10 1 2 9 18 41
except for F and G although this deficiency is probably
not significant for the C group. The excess of F group
chromosomes missing is most marked for strain 190 and the
excess of G group missing is most noticeable for strain
247c.
The second series did not contribute anything new in
the way of cell morphology which was not seen in the first
series.
The first series had two cell strains excluded
because of In vitro chromosome changes (table 3.1, page 59).
These were found at the time of the first outbreak of
mycoplasma contamination although these two cell strains
did not yield mycoplasma on testing. In addition two
urine cell strains showed chromosome abnormalities at
this time and both of these strains yielded mycoplasma on
testing. It is convenient to present the observations
A2 vitro chromosome changes in both amniotic fluid and
urine cell strains in this chapter.
The first amniotic fluid cell strain to show a
possible in vitro change was number 70. At the fourth
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passage 10 metaphases were analysed and all had a normal
karyotype 46,XX. At the 22nd passage only eleven cells
could be analysed but two of these had an extra F group
chromosome. The cell strain died at the 25th passage
and further chromosome preparations were unsuitable for
analysis.
The second amniotic fluid cell strain to show an in
vitro chromosome change was number 115. Chromosome
results for this cell strain are shown in table 3.9. As
can be seen from the table this strain was showing normal















































Fig. 3.6. Banded karyotype of cell from the l^ch passage
of culture of amniotic fluid cell strain 115. Note extra
material on the short arm of chromosome number 4.
karyology at the eleventh passage, yet by the 20th passage
most dividing cells had extra material on the short arm of
chromosome number 4 (Fig. 3.6). The strain was discarded
at the 23th passage due to suspected mycoplasma
contamination.
The first urine cell strain to show in vitro
chromosome changes was number 53. The results of
chromosome analyses for this strain are shown in table
3.10. After the appearance of cells with abnormal kary¬
otypes, cells from the strain which had been stored in the
liquid nitrogen unit at the 5th passage were brought back
into culture for chromosome studies. These showed only
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Fig. 3.7. Banded karyotype of cell from the 10th
passage of culture of urine cell strain 53. Note trans¬
location t(2;16)(pl3;q24) and pericentric inversion
lnv(6)(pllq21).
explanation of these findings is that a clone of abnormal
cells which carried an inversion and a translocation
(Fig. 3.7) arose. This clone must have been at a
selective advantage under the conditions of tissue
culture and began to replace the normal cells. Mycoplasma
arginini was recovered from the 16th passage and the cell
strain was discarded in the 18th passage in a state of
advanced senescence.
The most extensive chromosome changes were shown by
urine cell strain 66. The results of initial chromosome
studies are shown in table 3.11. After the 23rd passage
most cells were very heteroploid, there were many
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Table 3.11. Results of initial chromosome studies on
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Fig. 3.8. Banded karyotype from the 13th passage of
culture of urine cell strain 66. Note extra material
on the short arm of chromosome number 2.
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dicentrics, bizarre endoreduplication figures and cells
with very large numbers of chromosomes (Figs. 3.8, 3.9,
3.10 and 3.11). This cell strain was reported to contain
Mycoplasma arginini when first tested in the 21st passage
and also from passage 19/1F. The mycoplasma
contamination did not apparently inhibit cell growth and
the strain was discarded in a state of senescence at the
35th passage. The presence of the initial chromosome
abnormality in passage 9/1F indicates that this clone
21 > iti » Of
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Fig. 3.9. Karyotype of a cell from the 27th passage of
urine cell strain 66. Note apparent loss of three A-
group chromosomes, one C-group chromosome and one E-group
chromosome. Note presence of two dicentric chromosomes,
small acentric fragment (minute) and large marker
chromosome. This cell is representative of the early
stages of heteroploidy shown by this cell strain.
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Fig. 3.10. Two heteroploid metaphases from 31st passage
of urine cell strain 66. Note (i) grossly heteroploid
cell with high chromosome number and dicentric chromosomes
and (ii) cell showing pulverisation of small chromosomes -
this metaphase contains mainly long chromosomes with
variable numbers of centromeres and minutes, there are
only few intermediate-sized chromosomes.
arose prior to storage of the cell strain, at the 6th
passage, in the liquid nitrogen unit.
The results of the second major phase of this study
on amniotic fluid cell strains have been published in
part (Sutherland and Bain, 1973, appendix III). This
study of the time required to achieve an arbitrary
quantity of cells for a hypothetical antenatal diagnosis
of an inborn error of metabolism covered all amniotic
fluids up to and including number 195, with the exception
of those collected at induction of labour at term. This
report (henceforth referred to as the first year's results)
covered those amniotic fluids received in the period
1.12.71 to 30.11.72. The results will now be presented
(ii)
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Fig. 3.11. Portion of an endoreduplicated metaphase
from the 31st passage of urine cell strain 66. Note
bizarre chromosome configurations produced by chromatid
exchange and number of "minutes".
for the second year, 1.12.72 to 30.11.73. All amniotic
fluids received in this period are included except for
those collected at induction of labour at term, those
collected from anencephalic pregnancies and for numbers
293 and 286 which were not continued beyond the first
passage. Hence the second year *s results pertain to 52
amniotic fluids.
The origins of the amniotic fluids in the second
year's results were different from those of the first year.
There were no H.S. but there were specimens collected for
diagnostic chromosome studies (D.C.S.), estimation of
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ot-fetoprotein levels (A.F.P.S.) and three specimens
actually collected for the antenatal diagnosis of an
inborn error of metabolism (D.B.S.). Data on the origin
and cultural behaviour of the 52 amniotic fluids in the
second year's study are shown in table 3.12 and Fig. 3.12.
There were some apparent differences in the times
taken to achieve a biochemical result for the amniotic
fluids of different origin. The Rh.S. were longer in
primary culture and took longer to reach a biochemical
result than did the other groups. These differences are
however not significant statistically.
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Fig. 3.12. Distribution of times taken to achieve
sufficient cells for biochemical studies from the
amniotic fluid cultures in the second year's study.



















observed using the inverted microscope with the exception
of one culture (214) which was lost to microbial
contamination before it could be assessed. Two cultures
failed to produce enough cells for a cytogenetic result
(217 and 284). Hence the cytogenetic success rate would
have been 49/52 if these studies had been required on all
cultures. There were 5 primary cultures lost to
microbial contamination after cytogenetic studies had
been completed but before the primary culture could have
been subcultured. No cell strains degenerated between
the first subculture and the stage where there were
enough cells for a biochemical result. If the time taken
to produce enough cells for a biochemical assay was not a
relevant factor, there were 44/52 successful cultures.
If a time limit of 8 week? was to be imposed then the
success rate fell to 40/52 and if this was further reduced
to 6 weeks then the success rate fell to 32/52 (61%). As
in the first year's results the time taken to achieve a
biochemical result was independent of gestational age
(both within the various groups and for the series as a
whole) and whether or not a coverslip had been removed
from the culture for cytogenetic studies.
There were three rhesus iso-immunised pregnancies
from which more than 3 serial samples had been collected
and the data was available for analysis. These data are
shown in table 3.13. The conclusions reached from the
first year's results are supported by the second year's
results. These results also demonstrate that, with one
exception, the time in primary culture is responsible for
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Table 3.13. Times required for biochemical and cyto¬
genetic results and time in primary culture of amniotic
fluid cell strains derived from serial samples of
amniotic fluid collected from three pregnancies.
Pregnancy Gestation Days to Days in Days to
biochemical primary cytogenetic
result culture result
1 19 30 18 N
30 64 26 N
32 32 28 N
2 * 20 28 20 17
* 23 41 28 21
26 46 31 13
29 43 36 N
33 41 30 N
3 * 20 69 43 12
27 46 30 12
30 46 33 N
* from first year's results •
N cytogenetic preparations not made in the
minimum time.
more than half the time required for a biochemical result.
This feature of the results is also shown in table 3.12.
The essential features of the two series are compared
in table 3.14. The differences between these two series
are minimal. In spite of the loss of 6 primary cultures
to microbial contamination in the second year, which
resulted in a lower overall success rate, the success rate
at 6 weeks was virtually identical for the two series.
This was due in some part to the slightly shorter time
required to reach results in the second year.
The results of the study of the effect of the level of
serum supplement to the culture medium and the type of
culture vessel used on behaviour of amniotic fluid cell
strains are shown in table 3.15. The number of passages
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Table 3.14. Comparison of the first and second years1
results for the time to culture sufficient cells for a
biochemical assay.






24.2 to to • o
Number of failures 6 8
Mean time to result
(days)
41.4 37.2
Overall success 56/62 (90%) 44/52 (85%)
Success at 8 weeks 49/62 (79%) 40/52 (77%)
Success at 6 weeks 36/62 (58%) 32/52 (61%)
is remarkably constant for each set of substrains despite
the number of other variables. The type of culture
vessel used appeared to be unrelated to cell strain
behaviour. Although the mean interval between subculture
was greatest for the substrains maintained in T-flasks the
numbers involved are too small to attach significance to
this. The shortest lived substrain in each set was
cultured in a T-flask but, for 247, the longest lived was
also cultured in a T-flask. The amount of serum supple¬
ment did not appear to affect any of the parameters
examined. The one factor which did appear to have
affected the number of passages was the primary culture
from which the substrains were derived. In the case of
246, substrains a, c and e survived for a lower number of
passages than those derived from the other primary culture.
The reverse was true for 247.
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(ii) a (ii) b
Fig. 3.13. Flying coverslip preparations to show the
effect of differential trypsinisation on cell strain
morphology (Stain Giemsa, x 100).
(i) Substrain 246f in the 16th passage (a) of serial
cultivation showing mainly epithelioid type III
cells. The "trypsin resistant" substrain (b) 246f
which has been in culture for the same length of
time shows mostly type II cells including some
which are multinucleate.
(ii) Substrain 247e in the 27th passage (a), and (b)
"trypsin resistant" substrain in culture for the
same period of time.
The effects of differential trypsinisation on the
morphology of the substrains maintained in T-flasks is
shown in Fig. 3.13. The effect on the two substrains of
247 was minimal. These were composed mainly of
fibroblast-like cells from the early passages, but the
"trypsin resistant" substrains retained a small number of
epithelioid type II cells. The effects on the substrains
of 246 were more marked. This strain started as a
mixture of the three types of epithelioid cells. The
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substrains serially subcultured lost the majority of the
type II cells and eventually were composed mainly of
type III cells. The "trypsin resistant" substrains
however tended to do the opposite in that they were soon
comprised of type II cells with few type III cells. This
indicates that serial subculture can have a major effect
on the morphology of amniotic fluid cell strains.
Unfortunately, some of the substrains of 264 became
Table 3.16. Data on the early behaviour of cell strains


























this primary culture degenerated and could not be
subcultured.
this cell strain only survived one subculture.
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Fig. 3.14. Flying coverslip preparations showing the
effects of the method of primary culture and of sub-
culturing on cell strain morphology (Stain Giemsa, x 100).
(i) Second passage of substrain h, predominantly
epithelioid type III cells.
(ii) Second passage of substrain i, there are considerable
numbers of both type II and type III cells.
(iii) Second passage of substrain o.
(iv) Second passage of substrain e, predominantly type II
cells.
(v) Tenth passage of substrain i, morphology is not
changed from that in the second passage.
(vi) Tenth passage of substrain o, morphology is not
different from that in the second passage.
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contaminated with Mycoplasma hyorhinis hence the long-
term culture results from this experiment are not valid.
However, since this contamination did not occur until
late in culture the results for the time to reach a
biochemical result are valid as are some studies on cell
morphology. The data on time required to achieve a
biochemical result are shown in table 3.16. Method I
was not as successful as methods II and III for producing
amniotic fluid cell strains. It failed on two out of
five occasions and when cell strains were produced the
time taken was longer.
Examples of the morphology of the cell strains
derived from primary cultures established by each of the
methods are shown in Fig. 3.14. These strains were a
mixture of epithelioid cells type II and III. Sub-
culturing had little effect on the morphologies of these
cell strains. It can be seen from Fig. 3.14 that the
method used to establish the primary culture did not




Two phases of this work have already been discussed
(Sutherland and Bain, 1973, Sutherland et al., 1974a,
appendix III) and there is little to add to the
individual aspects considered in these two papers except
where additional data has been produced or other relevant
work has been published.
The serial culture studies suffer from not having
been carried out on cell strains derived from consecutive
amniotic fluids. Although the first series of 31 strains
came from 41 consecutive fluids, the exclusion of some
cell strains because they were not cultured to senescence,
for reasons such as microbial contamination or jLn vitro
chromosome changes, introduces a degree of bias.
Obviously the longer a cell strain survives the greater
are the chances of it becoming contaminated. Even though
the two cultures contaminated by bacteria were only in the
first passage the others excluded due to mycoplasma
contamination or chromosome changes were past the
twentieth passage. Had these been included in the first
series the mean number of passages and time as a cell
strain would both have been greater. Hence, to a certain
extent, the results for both series of cell strains
cultured to senescence underestimate the growth potential
of cultured amniotic fluid cell strains.
It is difficult to attribute biological significance
to the statistical differences found between the two
series. The cell strains in each series were in culture
at different times, using different batches of culture
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media and sera. The second series had 15% fetal calf
serum supplement in the culture medium compared with 30%
in the first series. It is tempting to attribute the
statistical differences between the two series to this
difference in serum supplement but such conclusion would
not be valid. Todaro and Green (1964) found that adult
skin fibroblast-like cell strains survived for a greater
number of passages when the serum concentration was 30%
than when it was 10%. Eagle (1973) found that the
growth rate of human fibroblast-like cells increased with
serum concentration over the range from 0.2 to 20%. The
results of the present study do not support these findings
for amniotic fluid cell strains but, because this effect
of serum was not specifically tested in the two series,
cannot be used as evidence against such an effect.
However the experiment in which cell strains from two
amniotic fluids (246 and 247) were grown in parallel in
serum concentrations of 15 and 30% indicated that this
factor does not influence the number of passages for
which amniotic fluid cell strains can be cultured. This
finding is in agreement with Litwin (1970) who found
that increasing the serum concentration above 10% had no
effect on growth rate or longevity of human fetal lung
fibroblast-like cell strains.
An unexpected finding in both series of cell strains
cultured to senescence is the highly significant
correlation between the number of passages and the mean
interval between subculture. This correlation was still
significant when only those cell strains which survived
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for more than 10 passages were considered and if the
slower phases of growth, the initial and final passages,
were excluded. The amniotic fluid cell strains showed
the type of growth curve described by Hayflick and
Moorhead (1961) for human diploid cell strains derived
from fetal lung. It is possible that the correlation
between growth rate and longevity found for amniotic
fluid cell strains would also apply to diploid cells
cultured from other tissues; indeed it does hold for
urine cell strains (see chapter 7). There is no
reference to such a correlation in the literature but
Todaro and Green (1964) found that they could stimulate
hampster fibroblasts to divide more rapidly and to
survive a much greater number of passages before death
by the addition of albumin to the culture medium. They
found that human fibroblast-like cells survived for a
greater number of passages but did not divide more
rapidly under such conditions. Litwin (1970) studying
human fetal lung fibroblast-like cell strains found that
some " .... had a much slower growth rate and appeared
to reach senescence earlier." He suggested that these
may have been infected with some unascertained agent,
however the present study indicated that the stage at
which senescence is reached is continuous from
degeneration in the primary culture to more than 50
passages. Miles (1964) had the impression that
"
.... more frequent passage enhanced the life span of
cell strains ...." but was unable to quantitate this
effect. It is not surprising that no other references
91
to this correlation have been made as there has been
little work done on the serial cultivation of human
diploid cell strains since that of Hayflick (1965).
Even this work of Hayflick (1965) which fully established
the limited in vitro lifespan of human diploid cells was
based on studies of only 13 separate fetal cell strains.
The biological basis of the correlation between lifespan
in culture and rate of cell growth remains unknown and
is worthy of further study.
The studies on cell strains derived from serial
samples of amniotic fluid collected from Rhesus iso-
immunised pregnancies in the second series add little to
the corresponding work in the first series.
The main findings of relevance in the second series
are the details of the karyology of the longest lived
cell strains. These demonstrate that amniotic fluid
cell strains can be regarded as diploid. The finding
of dicentric and other structurally abnormal chromosomes
in the senescent phases of the cultures is very similar
to the findings of Saksela and Moorhead (1963) and
Yoshida and Makino (1963) for human diploid cell strains
of fetal origin. The distribution of the chromosomes
missing from the hypodiploid cells is of interest.
There is an excess of cells with F and G group chromosomes
missing and a deficiency of cells with other chromosomes
missing. Examination of the data of Yoshida and Makino
(1963) revealed that very few hypomodal cells were found
and the chromosomes missing from them were not identified.
Analysis of the data of Saksela and Makino (1963) indicated
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that the distribution of the chromosomes missing from
the hypomodal cells accords with the expectation that
the chances of any chromosome being absent are the same
(Xg * 9.2; N.S.). Rask-Madsen and Philip (1970)
presented data on hypodiploid cells with 45 chromosomes
found in cultures of human endometrium; the patterns of
aneuploidy in these cells were similar to that found in
the amniotic fluid cells in the present study. Court-
Brown et al. (1966) found an excess of G and E 17/18
group chromosomes missing from hypodiploid cells from
blood lymphocyte cultures. Hence the karyological
findings in amniotic fluid cells indicate that the nature
and quantity of aneuploid cells in this material are
similar to those found in other human diploid cells in
culture.
The in vitro chromosome changes seen in two amniotic
fluid and two urine cell strains are of particular
interest. These occurred at a time of mycoplasma
contamination although mycoplasma was only identified
positively in the urine cell strains. Chromosome
abnormalities have been induced in cultured cells by
infecting them with mycoplasmas (Fogh and Fogh, 1965;
Aula and Nichols, 1967; Stanbridge et al., 1969;
Kundsin et al., 1971). A variety of chromatid
aberrations have been described along with an increased
frequency of dicentrics and translocations. The study
in which mycoplasma infected cultures of WI-38 were
maintained and subcultured (Stanbridge et al., 1969) did
not reveal the appearance of clones of chromosomally
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abnormal cells. Kundsin et al. (1967) have claimed
amnion cell cultures can be naturally infected with T
strain mycoplasmas. If this is the case then it is
conceivable that amniotic fluid could also be naturally
infected with these organisms.
There are a number of other possible explanations of
the jLn vitro chromosome changes not necessarily involving
mycoplasmas. The cell populations which arose in vitro
may not have been clones. The same abnormality may have
been induced in a number of cells at the same time. This
is unlikely as chromosome breakage is usually not at
specific points on the chromosome although it has been
shown that adenovirus type 12 can cause specific breakage
of chromosome 17q?21 (Zur Hausen, 1967; McDougall, 1971).
Hence it is possible that some agent capable of causing
specific chromosome breakage was contaminating these
cultures which showed in vitro chromosome changes.
Another possibility is that amniotic fluid and urine cell
strains may show chromosome instability (see chapter 4).
Such an explanation is not very plausible but in the two
amniotic fluid cell strains showing chromosome changes
attempts to isolate mycoplasma were unsuccessful. In
vitro chromosome changes, detected by the appearance of
clones of abnormal cells, in skin fibroblast-like cell
strains, were noted in a number of laboratories in the
U.K. at the same time as those in the present series
(Harnden, personal communication). These were not
associated with mycoplasma and an unknown metabolite in
the fetal calf serum used was suggested as a possible
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cause. Most of the commercially available fetal calf
serum in the U.K. comes from a single source.
The measurement of the times required to achieve a
biochemical result provided data which was not available
in the literature. The results of the second year
added little to those of the first year other than to
show that they were repeatable. One point which was
perhaps not emphasised sufficiently in the discussion of
the first year*s results (Sutherland and Bain, 1973,
appendix III) was that about two-thirds of the time delay
was in the primary culture. This accentuates the need
to develop microassay methods for enzymes involved in
inborn errors of metabolism. There has been some
progress in this direction. Jacoby et al. (1972) have
developed a semlmicroassay technique suitable for the
antenatal diagnosis of argininosuccinic aciduria.
Perhaps the ultimate in microassay techniques has been
developed by Galjaard et al. (1972; 1973). These
techniques make the assay of some lysosomal enzymes
possible on a single cultured cell. In practice they
can be used to perform the antenatal diagnosis of Pompe*s
disease within 7 to 10 days of amniocentesis using 70-250
cultured cells per assay. Such techniques will allow
for the antenatal diagnosis of inborn errors of
metabolism as quickly as, if not quicker than that of
chromosome abnormalities.
The establishment of 13 cell strains from a single
sample of amniotic fluid indicated that the time to a
biochemical result can be influenced by the method used
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to establish the primary culture; the method of Gray et
al. (1971) being inferior to the other two methods used.
Apart from the cultures in which the method of Gray et al.
(1971) was used there was remarkable uniformity in the
times required to produce enough cells for a biochemical
result. Unfortunately this experiment could not be
repeated because of the unavailability of large volumes
of amniotic fluid.
The studies on the morphology of the cells in
amniotic fluid cultures have been discussed in Sutherland
et al. (1974a, appendix HI). Results of further studies
have shown how the process of subculturing can select
against the epithelioid type II cells which have been
termed "trypsin resistant". Melancon et al. (1971)
separated epithelioid and fibroblast-like cells from
amniotic fluid cultures of mixed cell types by using
trypsin to selectively remove the fibroblast-like cells.
This differential sensitivity to trypsin has been
accentuated by the constant removal of the cells which
could be readily detached with trypsin. The effect was
more pronounced in the case of 246 than of 247 which
initially was a more fibroblast-like cell strain.
Studies on the morphology of the cell strains of 264
indicated that this was not dependent on the method used
to establish the primary culture. It is perhaps
surprising that the cell strains developed from this
sample were so similar in morphology since Gerbie et al.
(1972) managed to produce cell strains of predominantly
fibroblast-like and epithelioid morphologies from large
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volumes of amniotic fluid. However they had initial
volumes of fluid greater than the one in the present study
and presumably set up more primary cultures.
This study of the serial cultivation of amniotic fluid
cell strains has shown that there can be great similarities
but also marked differences between these and other fetal
fibroblast-like cell strains in growth characteristics,
morphology, karyology and lifespan in tissue culture.
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SUMMARY
This chapter on amniotic fluid cell strains in serial
culture included studies of cell morphology, karyology,
growth potential and time requirements for the antenatal
diagnosis of inborn errors of metabolism. A correlation
has been described between the growth potential and growth
rate of amniotic fluid cell strains. The karyology of
cell strains cultured to senescence has been monitored
and an increase found in chromosome aberrations in
senescent cultures. Jn vitro chromosome changes in two
amniotic fluid and two urine cell strains are described
and their possible origin discussed. The time required
to produce an arbitrarily defined quantity of cells
suitable for enzyme assay for the antenatal diagnosis of
inborn errors of metabolism has been measured and it was
found that although sufficient cells could usually be
cultivated the time required was often too long for the
results to be of practical value. Amniotic fluid samples
collected at different times throughout individual rhesus-
isoimmunised pregnancies yielded cell strains which were
no more similar to each other in behaviour than to cell
strains derived from different pregnancies. The type of
culture vessel used and the serum concentration in the
medium was found not to affect the lifespan of the cell
strains. The behaviour of 13 cell strains cultured from
a single amniotic fluid sample was studied. Three
methods which were used to establish the primary cultures
from which these cell strains were derived did not affect
the morphology of the cell strains but one of the methods
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was inferior for producing cells for biochemical studies.
A classification of the cell types in amniotic fluid
cultures has been proposed.
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ADDENDUM
Since this chapter was completed the work of
Greene et al. (1973) has become available. This is of
relevance in that it is one of very few reports to
present data on the behaviour of amniotic fluid cell
strains. Although principally concerned with
parameters affecting cryogenic storage these workers
cultured four cell strains to senescence, which was
reached between the 21st and 31st passage. If these
cell strains were representative of the group studied
then they would appear to have a greater average growth
potential than those in the present series. One
possible explanation for this difference is that Greene
et al. (1973) cultured their cells in a medium different
from that used in the present study. The four cell
strains which they cultured to senescence were found to
remain diploid, in agreement with present findings. The
time delay before their primary cultures were ready for
subculture averaged 11.7 days, much sooner than for the
primary cultures in the present study wherein the
average time in primary culture was about 27 days. The
reasons for this marked difference are unknown;
conditions of culture might be one factor but others
could include differences in the initial cell inoculum
into the culture vessel and the stage at which the
primary cultures were subcultured since this is
subjective and depends greatly on the operator.
Chapter 4
Cytogenetics of Amniotic Fluid
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BACKGROUND
The development of human cytogenetics has recently
been well summarised by Hamerton (1971). For many years
there was controversy over the actual number of
chromosomes in normal human cells. This was finally
settled by Tjio and Levan (1956) who were the first to
successfully apply the techniques of tissue culture to
human cytogenetics. Clinical cytogenetics had to await
the development of the simple leucocyte culture techniques
using phytohaemagglutinin and the air-drying technique for
preparing high quality metaphases. These techniques were
put together by Moorhead et al. (1960) who described the
first reliable method for preparing high quality
metaphases from human leucocyte culture. Since this
time, clinical cytogenetics has become a recognised
discipline and chromosome analysis is available as a
routine laboratory examination to most clinicians
practising in the developed countries.
Little further technical progress in human cyto¬
genetics was seen until the early 1970*s when the
identification of every chromosome in the human complement
became possible. This began with the work of Caspersson
et al. (1968) using fluorochromes to stain Chinese
hampster and Vicia chromosomes. The more useful
banding techniques were developed by Arrighi and Hsu
(1970) who were the first to produce C-bands (see Paris
Conference, 1971, for nomenclature). Their technique
was modified by a number of authors to produce G-bands
(e.g., Drets and Shaw, 1971; Sumner et al., 1971) which
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enabled each chromosome to be readily identified.
The development of amniotic fluid cytogenetics has
closely paralleled that of amniotic fluid cell culture as
the initial reason for culturing amniotic fluid was to
produce karyotypes. Klinger (1965) was the first to
karyotype an amniotic fluid and the fact that this
karyotype was male confirmed that he was indeed working
with fetal material. Steele and Breg (1966) were the
first to document chromosome analysis from amniotic fluid,
at the time they recorded their work on the culture of
amniotic fluid cells. The ability to karyotype amniotic
fluid was rapidly confirmed by several groups (e.g.,
Thiede et al., 1966; Jacobson and Barter, 1967).
The methods for making preparations suitable for
cytogenetic analysis have all used the same principles.
These are the exposure of the cells in tissue culture to
a mitotic arresting agent, the treatment of the cells
arrested in metapha.se by a hypotonic solution, and
fixation of the swollen cells followed by air-drying and
staining.
The technical approaches can be divided into two,
according to whether the cells are harvested as a
suspension or attached to the surface on which they are
growing. Either method can be used for primary cultures
or cell strains. However the harvest of primary cultures
as a cell suspension can be difficult and unreliable with
small cell populations. As a prompt result is required
in diagnostic antenatal karyotyping, the best method is
"
.... that technic which gives the greatest degree of
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success in the shortest amount of time ,(Macintyre,
1971). This can almost always be achieved by harvesting
primary cultures attached to the substrate (coverslip).
Regardless of which method is to be used, the first
step is to produce cells arrested in metaphase. Many
workers attempt to stimulate a wave of mitosis by sub-
culturing or changing the tissue culture medium the day
before harvesting. The metaphase arresting agent is
added 4-6 hours before harvesting. Most workers use
colchicine or colcemid for this purpose but some have used
vinblastine (e.g., Thiede et al., 1966). The amount of
colchicine (or colcemid) added varies about 500-fold.
Most workers use a final concentration from 0.1 to 1 fxg/ml.
In some cases, however, this has ranged up to the excessive
amounts used by Nelson (1973b) - 25 pg/ml., and by Valenti
and Kehaty (1969) - 60 fig/ml. It is perhaps surprising
that these workers were able to achieve success,
especially as Fitzgerald and Brehaut (1970) have shown
that 5-15 (ig/ml. of colchicine depresses DNA synthesis
and the mitotic index by increasing the length of the G2
period in lymphocyte culture.
Most workers who have harvested their cells in
suspension have used trypsin to remove them from the
growth surface although some prefer pronase (e.g., Epstein
et al. 1972).
A bewildering array of hypotonic treatments have
been described. Sodium citrate has been used in
concentrations ranging from 0.25% (Thiede et al., 1966)
to 1.12% (Ferguson-Smith et al., 1971) for times ranging
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from 10 to 45 minutes. Surprisingly the correlation
between duration of hypotonic treatment and the
concentration of sodium citrate appears to be small,
Abbo and Zellweger (1970) used 0,7% sodium citrate for
45 minutes whereas Ferguson-Smith et al. (1971) used 1.12%
citrate for 20 minutes. Other simple inorganic hypotonic
salt solutions have included 0.3% NaCl (time unspecified)
by Therkelsen et al. (1972) and 0.075 M KC1 for 50
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minutes by Nelson (1973). Tissue culture medium diluted
with water in varying proportions has also been used.
Nadler and Gerbie (1972) used a solution of 1 part medium
to 4 parts water for 30 minutes. Epstein et al. (1972)
used only 2 parts medium to 5 parts water for 5 minutes.
Gerbie et al. (1972) decided that epithelial-like and
fibroblast-like cells required different hypotonic treat¬
ments. The fibroblast-like cells were treated with 1
part fetal calf serum to 5 parts water for 30 minutes,
whereas the epithelial-like cells required the same treat¬
ment for 15 minutes followed by 15 minutes in a solution
of 1 part fetal calf serum to 10 parts water. Most
hypotonic solutions are used at 37°C. or when "warm".
The universal fixative for chromosome preparations
made by air-drying is 1 part acetic acid to 3 parts
absolute methanol. Some workers, however, then flood
their slides with 45 or 50% acetic acid and dry them
over a gentle flame (e.g., Gray et al., 1971; Gerbie et
al., 1972, for fibroblast-like cells only). Most
workers apparently transfer the cells, or coverslip,
directly into the fixative. Ferguson-Smith et al. (1971,
105
and personal communication) gently waved the coverslip
over the fixative before immersing it. Abbo and
Zellweger (1970) and Nelson (1973b) add fixative to the
hypotonic solution, hence gradually replacing the hypo¬
tonic solution by fixative. Most authors have used
Giemsa as a stain for chromosomes although a significant
minority have chosen acetic orcein.
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MATERIALS AND METHODS
The amniotic fluids on which cytogenetic studies
were carried out are those described in chapter II and
appendix II table I, which were received over the two
year period 1.12.71 to 30.11.73. Amniotic fluids which
were collected for antenatal chromosome analysis over the
additional period 1.12.73 to 28.2.74 are also included
(appendix II, table III).
The method of making preparations suitable for
chromosome analysis were as follows:
1. When a coverslip was seen to contain a suitable
area of proliferating cells the medium in the Petri dish
was changed.
2. The following morning the coverslip was removed
from the Petri dish and placed in a tube of medium which
contained 1 fig/ml. of colcemid.
3. About 5-6 hours later the medium was aspirated
from the tube and replaced with 0.075 M KC1 at room
temperature and left for 5 minutes. (Early preparations
were incubated at 37°C. but this was later found to be
unnecessary.)
4. Fixation and staining proceeded as in Sutherland
et al. (1973a , appendix III).
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RESULTS
Chromosome studies were not carried out on all
amniotic fluids. For practical purposes the fluids fell
into two groups. The first comprised those fluids taken
early enough in pregnancy for the chromosome result to
influence the management of the pregnancy. Results were
obtained from these specimens in the minimum possible
time. The second group comprised those fluids in which
chromosome studies were of little immediate clinical
relevance because of gestational age or because the
pregnancy had been terminated. Chromosome studies in
this group were not necessarily carried out in the minimum
time. Similarly, when there was more than one sample
from any pregnancy such studies were not necessarily
carried out on all samples.
Karyology of amniotic fluid samples
These results will be presented according to the
reason for collection or source of the amniotic fluid. All
results are based on examination of at least 10 metaphases.
Hysterotomy specimens: There were 20 amniotic fluids
collected from hysterotomy specimens in this series. All
these came from pregnancies terminated for social reasons,
with one exception (62) which was at risk for maple-syrup-
urine disease and where antenatal diagnosis had failed
(see chapter 6) . Chromosome results were achieved in 19
cases; there were 9 with normal male karyotypes and 10
with normal female karyotypes. The reason for failure in
one case (43) was degeneration of the primary culture;
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chromosome studies had been attempted but had failed.
There was no opportunity to check the results of the
chromosome studies with the sex of the fetus as this had
not been recorded except for number 62 in which case there
was no discrepancy.
Diagnostic a-fetoprotein samples: Details of the
chromosome studies on the seven samples in this group
which had normal a-fetoprotein levels are shown in table
2.1. With the exception of number 305 all these results
were regarded as being of clinical significance. No
abnormal karyotypes were detected.
Antenatal diagnosis of inborn error of metabolism: There
were 5 samples collected from 4 pregnancies in this group.
Table 4.1. Cytogenetic results on amniotic fluid














268 22 19 46,XX 14 12
276 25 16 46, XY 14 20
278 26 19 46, XX 12 25
280 23 18 46, XY 18 16
281 26 12 46,XX 24 20
305 26 34 46,XY 13 15
324 25 15 46,XX 16 20
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Three produced normal female karyotypes and two cultures
did not produce results due to degeneration. The sexes
of the three infants at birth were as predicted.
Samples collected at induction of labour: There were 7
samples in this group. Three amniotic fluids showed
normal male karyotypes and the other 4 fluids did not
yield results because of failure to show growth in
culture.
Rhesus specimens: The 61 specimens in this group were
collected from 36 pregnancies and chromosome results
were obtained for 33 of these. The reason for not
obtaining results from three pregnancies was that one
primary culture (214) and one culture at the first
passage (64) was lost to microbial contamination and
another culture (269) died before chromosome studies
had been attempted. There were 18 normal male karyotypes
and 13 normal female karyotypes. The sexes of the
infants, checked from hospital records, were consistent
with the predicted chromosomal sexes for 17 males and 9
females. One pregnancy had been terminated and the sex
of the fetus not recorded, one pregnancy continues and
three cases could not be traced. There were two
abnormal karyotypes detected; one apparently balanced
translocation (71), 46,XY,t(1,12)(p21;q21), (see Fig. 4.1)
and one 47,XXX (207). Both these fetuses with a
chromosome abnormality were stillborn. In the case of
the translocation heterozygote the only relevant post¬
mortem finding was hydrops fetalis associated with Rhesus
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Fig. 4.1. Banded karyotype from amniotic fluid 71
showing apparently balanced 46,XY,t(1.12)(p21;q21).
iso-immunisation. The 47,XXX fetus was not affected by
the Rhesus iso-immunisation and died from intrapartum
anoxia. Of the 28 pregnancies on which chromosome studies
had been completed records were available and the pregnancy
had been concluded, there were four which resulted in
stillbirths or neonatal deaths. Apart from the two with
chromosome abnormalities, there was one infant with
hydrocephalus and spina bifida who had died at a few days
of age, and another infant, unaffected by Rhesus iso-
immunisation who died from prematurity associated causes.
Cytogenetic diagnostic specimens: There were 33 amniotic
fluids from 32 pregnancies in this group, all received
over a period of two years and two months ending on
31.1.74 but with the majority (27) being received in the
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last year of this period. All samples were collected
from pregnancies of less than 21 weeks' gestation with
one exception (200), This was from a woman aged 41 years
at 35 weeks' gestation presenting with obstetric problems.
Caesarian section was being contemplated but would not
have been considered worthwhile if the fetus had been a
mongol. Details of this and the other amniotic fluids
in this group are in table III, appendix II,
One sample grew very slowly in culture and was
considered to have failed (217) but fortunately
amniocentesis was repeated and a result obtained. This
was the only pregnancy in this series where the fetus
had a chromosome abnormality (Gordon et al., 1974,
appendix III) . Another sample (220) grew very slowly
in culture and after one week was considered to have
failed. Repeated amniocentesis did not produce amniotic
fluid but the original culture eventually yielded three
metaphases after 38 days. A tentative diagnosis of
normal female fetal karyotype was made; a normal female
infant was born at term. One amniotic fluid was
referred for sexing only since the fetus was at risk for
X-linked muscular dystrophy. The fetus was diagnosed
as male, the pregnancy terminated and the antenatal
diagnosis of sex confirmed. All other cultures were
unremarkable and the times taken to achieve cytogenetic
results from the amniotic fluids in the sequence in which
they were received are shown in Fig. 4.2. The times
required to achieve results ranged from 7 to 38 days
(mean 14.5 days). However after the first 6 cultures
112
Fig. 4.2. Minimum times required to achieve cytogenetic
results from amniotic fluid samples collected for ante¬
natal chromosome analysis.
the mean time fell to 13.1 days and in no case was more
than 18 days required.
Quality of Result
There are three factors which contribute to the
quality of a chromosome result: the number of metaphases
studied, the number of non-modal cells present and the
quality of the metaphases available for study. This
last factor is subjective; it relates as much to the
skill of the cytogeneticist as to any absolute criterion,
is difficult to quantify and will not be further
considered.
All results for the non-diagnostic amniotic fluids
were based on the examination of at least 10 metaphases.
As these were of little clinical significance greater
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numbers of metaphases were examined only if a chromosome
abnormality was suspected from the first 10 cells.
Similarly the number of non-modal and polyploid cells in
this material were not studied in detail. Examination
of the amount of aneuploidy and polyploidy has been
carried out only on the cytogenetic diagnostic amniotic
fluids.
The degree of polyploidy ranged from nil in 6
cultures up to about 18% (293), although in most cases it
was less than 10%. Polyploidy was never a problem in
reaching a cytogenetic diagnosis. Aneuploidy was mainly
seen as hypodiploidy but occasional hyperploid and
pseudodiploid cells were seen. The additional or missing
chromosomes in the aneuploid cells are shown in table 4.2.
Apart from these there was one cell in which there was a
Dr and one cell, with missing D and C chromosomes, in
which there was an acentric fragment present. No other
structural aberrations were seen. The chromosome changes
in the aneuploid cells appeared to be random in all cases.
The number of cells on which the result was based was
small in some cases; six results were based on examination
of less than 10 metaphases. In all these cases except 220
Table 4.2. Distribution of additional or missing
chromosomes in aneuploid cells seen in primary cultures
of diagnostic amniotic fluids.
Chromosome group
C D E F G
Number missing 93539
Number extra 3 1
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further cells were examined so that eventually at least
20 cells were analysed. The chance of having to change
a cytogenetic result after the initial group of cells had
been studied was not regarded as great enough to warrant
delay of the report as maternal anxiety regarding the
outcome of the antenatal diagnosis was often considerable.
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DISCUSSION
The number of chromosome abnormalities which have
been detected in amniotic fluid is not great and the
majority of these have been cases of Down's syndrome,
either of regular or translocation karyotype (Milunsky,
1973). Very little attention has been paid to chromosome
abnormalities present in amniotic fluid collected from
pregnancies not normally considered to be at risk in this
regard. Ferguson-Smith et al, (1971) karyotyped 17
fluids collected from hysterotomy specimens and all had
normal karyotypes. Similarly Jacobson and Barter (1967)
karyotyped 27 amniotic fluids collected at the time of
therapeutic rbortion, but from fetuses which were not at
risk for chromosome abnormality, and these all had
presumably normal karyotypes. Nadler (1968a) reported
studies on 23 Rhesus iso-immunised amniotic fluids, those
which were karyotyped were presumably normal. Mintzer
and Reisman (1969) karyotyped 21 amniotic fluids and all
were normal. Therkelsen et al. (1972) successfully
karyotyped 41 out of 45 third trimester Rhesus iso-
immunised fluids, all of which were normal. Chitham
et al. (1973) found 3 chromosome abnormalities in 60
amniotic fluids, some, but not all, of which had been
collected from pregnancies at risk for such abnormalities.
The actual chromosome abnormalities were not identified
nor was the source of the amniotic fluid in which they
were found. Walker et al. (1971) diagnosed Klinefelter*s
syndrome by combined sex chromatin and quinacrine
fluorescence studies of amniotic fluid cells from an iso-
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immunised pregnancy of 33 weeks' gestation; this is the
only report of a chromosome abnormality having been
diagnosed from amniotic fluid collected from such
pregnancies.
In the present series two abnormal karyotypes were
detected amongst 33 Rhesus iso-immunised fluids and in
both these cases perinatal death occurred. The
significance of this finding is difficult to assess. The
incidence of major chromosome abnormality in a sample of
11,000 unselected newborns studied in Edinburgh was 1 in
140 (Ratcliffe and Keay, 1973). On this basis the
finding of 2 chromosome abnormalities from 33 fluids near
term is about 8 times more than expected. However it is
perhaps significant that the four perinatal deaths known
to have occurred in this group included the two with
chromosome abnormality. It has been shown (Sutherland et
al., 1973, 1974; Machin, 1974; Bauld et al., 1974) that
the incidence of chromosome abnormality in perinatal deaths
is about 10 times higher than that in unselected neonates.
In the present series no other chromosome
abnormalities were found in the low risk amniotic fluids.
Several authors have reported finding chromosome
abnormalities in amniotic fluids at risk for disorders
not of chromosomal etiology. O'Brien et al. (1972)
reported that a fetus at risk for Tay-Sachs disease was
aborted because it had a chromosome abnormality although
its N-acetyl-(3-D-glucosaminidase A level was normal.
Similarly Ferguson-Smith et al. (1971) found that a male
fetus aborted because of its risk of developing X-linked
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granulomatous disease had Down's syndrome. Once
amniotic fluid has been collected for any purpose in
early pregnancy chromosome studies should be carried out
to avoid the possibility that the fetus, although not
having the disorder of prime concern, may be born with a
chromosome abnormality.
Most series of amniotic fluid chromosome studies
have been concerned with cases regarded as being at an
increased risk for chromosome abnormalities. Some of
the early series are summarised in Sutherland (1972 ,
appendix III) and the main recent series are compared
with the findings in the present study in table 4.3.
The findings in the present study are consistent with
those found in the other series. It is not possible to
pool the numbers in the various series and assess the
incidence of chromosome abnormalities in fluids collected
for a particular reason since the series of Milunsky
(1973) contains some of the data of other series from
the U.S.A. and Canada. However inspection of table 4.3
shows that two features of the early series summarised
in Sutherland (1972 , appendix III) are no longer
apparent. The recurrence rate for Down's syndrome in
mothers who have previously had a child with this disease
is much lower than the early series indicated. The
number of unbalanced translocations produced by parents
who are balanced translocation heterozygotes has fallen
from the high level suggested by the early series but
would still appear to be greater than the maximum
recurrence rate of about 9% which epidemiological studies
*
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had suggested (Hamerton, 1970).
Apart from Down's syndrome there have been a number
of other chromosome abnormalities detected which are
known to increase in frequency with advanced maternal
age. These include Klinefelter*s syndrome (Mulcahy and
Jenkyn, 1973; Milunsky, 1973), Edward's syndrome (Hsu et
al., 1973a; Turnbull et al., 1973; Gordon et al., 1974,
appendix III) and Patau's syndrome (Butler et al., 1973).
Other chromosome abnormalities unrelated to maternal age
have also been detected, these include 47,XYY (Nadler and
Gerbie, 1971) and 45,X (Pers. comm. to Nadler, 1971) as
well as unbalanced reciprocal translocations (Butler and
Reiss, 1970; Machin, 1974). The types of chromosome
abnormalities which would be expected in advanced maternal
age have been examined in Sutherland (1972 , appendix III).
Inspection of table 4.3 shows that the chances of
finding a chromosome abnormality is greater than 1%
regardless of the reason for the amniocentesis with the
exception of the miscellaneous group. In this group more
than 200 amniotic fluids have been karyotyped and only one
abnormality found. This was a case of trisomy 22 which
was detected in a woman who had previously had a child
with the same abnormality (Milunsky, 1973). The
probability of such a rare chromosome abnormality occurring
spontaneously twice in one family must be extremely low
and a parental chromosome abnormality, possibly mosaicism,
must be strongly suspected. Hence it would appear that
where the indications for antenatal chromosome studies are
'miscellaneous* there is in fact no genetic indication for
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this procedure. The frequency of chromosome
abnormalities detected in this group so far does not
appear to be greater than would be expected in the
general population. Apart from genetic considerations,
other reasons such as maternal anxiety may well be valid
for performing amniocentesis in these cases.
In the present series of diagnostic cases there has
been only one chromosome abnormality detected, a case of
trisomy 18 diagnosed from the amniotic fluid of a 41
year old mother (Gordon et al., 1974, appendix III).
One fetus at risk for X-linked muscular dystrophy was
diagnosed as male and the pregnancy terminated; the ante¬
natal diagnosis was confirmed. A number of others have
terminated pregnancies at risk for this condition. Riis
and Fuchs (1966) monitored two at risk pregnancies and
terminated one of them after a male fetus had been
diagnosed.
The ultimate criterion of the quality of antenatal
chromosome analyses is how often they coincide with the
status of the fetus once this is known from conventional
extrauterine studies. Since the majority of antenatal
chromosome analyses indicate a normal fetus and are
readily confirmed the best assessment of quality of
results can be made from a study of mistakes which have
been made. Sex has been misdiagnosed in a number of
cases, in all instances a male fetus having been diagnosed
as female - this has occurred at least 7 times (Milunsky,
1973). The most probable explanation for this mistake
is that maternal cells rather than fetal cells have been
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cultured. It would be expected that maternal cells would
have been cultured in about an equal number of cases
where the fetus was a female. This type of error would
go undetected unless the fetus had a chromosome
abnormality which would not be diagnosed until birth.
Hence it would appear from the data of Milunsky (1973)
and Nadler (1970) that in about 1% of cases maternal
cells will be cultured rather than fetal cells. Harvesting
chromosome preparations from more than one culture may
help to overcome this but there is no data available on
this point. Macintyre (1971) reported that 1 culture
out of 7 grown from a single sample of amniotic fluid
contained a proportion of female cells, all the other
cultures contained only male cells.
Apart from the misdiagnosis of sex few other errors
have occurred. Kohn and Robinson (1970) terminated a
pregnancy on the grounds of total tetraploidy in an
amniotic fluid culture; in the light of subsequent
experience since this should not happen again. Most
amniotic fluid cultures contain a proportion of
tetraploid cells; this was always less than about 15%
in the present series. Walker et al. (1970) reported
that 23% of 110 amniotic fluid cultures contained more
than 10% polyploids but only 7% had more than 30%
polyploids and 3 of these contained only polyploid cells.
In 2 of these 3 cases other fetal material studied showed
that the fetuses were diploid. Hence tetraploidy in
cultured amniotic fluid cells is normal and not an
indication of fetal tetraploidy which, although extremely
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rare, would probably be undiagnosable at present,
Apparently polyploid cells should always be checked to
ensure that they are not triploid since triploid fetuses
are more common than tetraploids and triploid cells are
not normally found in amniotic fluid cultures.
A number of authors have discussed the problem of
aneuploidy in cells from normal individuals (see chapter
3). In the present study the degree of aneuploidy was
low and did not cause concern regarding the fetal
karyotype. Any discussion of the problem of aneuploidy
cannot be divorced from the problem of the diagnosis of
mosaicism. A number of antenatal diagnoses are based
on examination of a small number of metaphases, as few
as 3 in the present series and 4 in the series of
Ferguson-Smith et al. (1971). Others have counted
many cells, for example Mulcahy and Jenkyn (1973)
examined 112 cells from a single case. Nevertheless,
mosaicism has rarely been reported and when this has
occurred fetal studies have indicated that the diagnosis
of mosaicism was wrong. Hsu et al. (1973) and Kardon
et al. (1972 a,b) all recorded the same case of an
alleged XO/XY mosaic. Their first sample of amniotic
fluid contained only XO cells and the second only XY.
They further suggested that the XO cells had translocation
of Yq onto Bp but the argument in favour of this was most
unconvincing. The pregnancy was terminated and resulted
in a male fetus with no detectable abnormalities. The
explanation of these findings is not clear but it is
probable that misdiagnosis of mosaicism occurred. Lee
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et al, (1972) reported finding one cell in 50, in a
diagnostic amniotic fluid, which had an extra G group
chromosome, the pregnancy was allowed to continue and a
normal infant resulted. This is more a problem of the
interpretation of a single aneuploid cell than a
diagnosis of mosaicism. Kajii (1971) reported finding
four out of 64 cells from the amniotic fluid of a 15 week
fetus, collected at hysterotomy, with an extra C group
chromosome. Cytogenetic studies on cells cultured from
other fetal tissues had normal karyotypes. Kajii (1971)
suggested that a cell line with an extra C group
chromosome had arisen JLn vitro. Hence misdiagnosis of
fetal mosaicism had again occurred from studies on cells
cultured from amniotic fluid.
Hsu et al. (1973) reported two cases which might be
regarded as mosaics. In one case, after treatment of a
culture with amphotericin for a fungal infection, 8 out
of 10 cells had karyotype 46,XX,Dq-. In the second
case 3 out of 27 cells had a karyotype 46,XY,+D,-G with
the remaining cells being normal. Both infants were
presumably normal although chromosome studies were done
on only the latter. These two cases which were
considered by Hsu et al. (1973) to be due to in vitro
chromosome changes, together with that of Kajii (1971)
are qualitatively very similar to the chromosome changes
noted in two amniotic fluid and two urine cell strains
in the present series (see chapter 3). Do amniotic
fluid cells in culture have a tendency towards karyotype
instability? Extensive cytogenetic studies on a number
124
of cell strains throughout culture to senescence, in the
absence of antibiotics and with constant screening for
viruses, mycoplasma, etc., would be required to answer
this question. On the other hand these may not be
in vitro changes. The number of colonies in an amniotic
fluid culture is small and if one of the colony forming
cells had a chromosome abnormality this could explain the
findings. There is some evidence (Uhlendorf, 1970) from
the autoradiography of primary female amniotic fluid
cultures heterozygous for the Lesch-Nyhan syndrome that
the colonies in these cultures are actually clones.
In spite of the few errors which have been made in
antenatal cytogenetic studies it is worth remembering
that no case has been recorded of an infant being born
with an unsuspected chromosome abnormality. This is
however little cause for complacency and continuous
attention must be paid to the quality of the results of
antenatal cytogenetic analysis. The criteria suggested
by Hamerton (1971) for the diagnosis of mosaicism cannot
be fully applied to amniotic fluid cytogenetics and
such diagnosis in this field is very difficult. There
can be little doubt that before a pregnancy was to be
terminated on the grounds of fetal mosaicism that
amniocentesis should be repeated. In the light of
reported experience any diagnosis of mosaicism should be
regarded with considerable scepticism until confirmed by
extrauterine studies.
The present study of amniotic fluid cytogenetics
has, with other similar studies in the literature,
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demonstrated that amniotic fluid culture is a simple,
reliable and rapid means of establishing the fetal
karyotype. This technique is particularly useful for
screening pregnancies at high to medium risk of having
a chromosome abnormality and, now that its reliability
has been established, can be extended to selective
population screening (Sutherland, 1972; Bain and
Sutherland, 1972, appendix III) as a programme of
preventive medicine once the obstetric safety factors
have been fully ascertained.
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SUMMARY
Cytogenetic studies have been carried out on some
amniotic fluids not normally regarded as being at risk
for chromosome abnormality. Two cases of chromosome
abnormality were found in 33 Rhesus iso-immunised
pregnancies and the significance of this finding is
discussed. A series of 32 diagnostic cytogenetic ante¬
natal assessments were performed, one fetus with trisomy
18 was detected and the pregnancy was terminated. The
quality of cytogenetic results from amniotic fluid is
considered; findings of polyploidy and mosaicism are
discussed along with errors which have occurred in ante¬
natal diagnosis. It is concluded that antenatal
chromosome analysis is applicable to selective population
screening for the purpose of reducing the incidence of





In 1972 Brock and Sutcliffe reported that amniotic
fluid from a retrospectively studied series of amniotic
fluids collected from anencephalic pregnancies had
elevated levels of ct-fetoprotein. The measurement of
a-fetoprotein in amniotic fluid has subsequently become
routine for the antenatal diagnosis of anencephaly and,
probably, other defects of neural tube closure (see
Sutherland et al., 1973b, appendix III for references).
Since amniotic fluids are usually collected for
a-fetoprotein estimation early in the second trimester of
pregnancy, any other information which can be gained on
the condition of the fetus is of value. Hence the cells
from such specimens of amniotic fluid were cultured for
chromosome studies. Amniotic fluids from two cases of
anencephaly were found to contain large numbers of cells
which appeared to be fetal macrophages (Sutherland et al.,
1973b, appendix III). As the presence of fetal macro¬
phages in amniotic fluid had not been previously
described, further studies were clearly indicated.
The macrophages associated with the placenta are
known as Hofbauer cells (Hofbauer, 1903). These macro¬
phages have been shown by sex chromatin studies to be of
fetal origin (Bourne, 1962). In a cytological study,
Huisjes (1968) found no abnormal cells in the amniotic
fluid from two cases of anencephaly and one of spina
bifida although he did not recognise macrophages in normal
amniotic fluids as did Casadei et al. (1973). Fox (1967)
has shown that Hofbauer cells are increased in number in
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the placental villi from pregnancies complicated by
Rhesus iso-immunisation and diabetes mellitus. These
observations raise the following questions. Do the
increased numbers of Hofbauer cells seen in these
pregnancies show up as an increase in amniotic fluid
macrophages? Are the macrophages in Rhesus amniotic
fluid due to the same factor which causes an increase
in Hofbauer cells?
One possible source of the macrophages in
anencephalic amniotic fluid is the fetal lesion. Exposure
of highly vascularised tissue, with only a membrane
between the fetal circulation and the amniotic fluid,
might allow blood macrophages to enter the amniotic fluid.
Free communication between the cerebro-spinal fluid (C.S.F.)
and the amniotic fluid might allow macrophages from the
C.S.F. to enter the amniotic fluid. Wollard (1924)
claimed that under the influence of irritants the
mesothelial cells of the arachnoid and pia mater are set
free into the C .S .F . as macrophages. Greenfield and
Carmichael (1925) stated that macrophages were present in
the C.S.F. in cases of sub-arachnoid haemorrhage, tumours
and tuberculous meningitis but " .... have no special
pathological significance". Chester et al., (1971) have
reported the presence of macrophages in C.S.F. from cases
of hydrocephalus.
Two lines of approach to this study of macrophages
in amniotic fluid were made. The first, and most
clinically relevant, was to ascertain whether the
observation made in two cases was applicable in general.
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Is an Increased number of macrophages in amniotic fluid
diagnostic of anencephaly and possibly other open neural
tube defects? The second approach was to study the




Samples of amniotic fluid from normal and abnormal
pregnancies and C.S.F. obtained at autopsy from hydro¬
cephalics were studied for comparison with amniotic
fluid from pregnancies in which the fetus was either
known or suspected of having a gross C.N.S. defect.
The macrophage content of the amniotic fluids was
quantitated. Primary amniotic fluid culture was set
up as outlined in chapter 1. A coverslip was removed
from the Petri dish 20 hours after the culture had been
set up, washed twice in P.B.S., fixed in three changes
of absolute methanol and stained with Giemsa. The
number of cells adhering to the coverslip was counted
in 10 randomly chosen low power (xlOO) fields. The
count was adjusted for the volume of amniotic fluid
which had been used to establish the culture and the
glass adherent cell count was then expressed as the
number/10 low power fields/10 ml. of amniotic fluid.
If this count is multiplied by 6.25 then the result is
the macrophage count/ml. of amniotic fluid - the area
2 2
of a low power field is tT(1) mm and the area of the
2 2
Petri dish is Tf (25) mm hence the area of a low power
field is l/625th of the total area of the Petri dish.
The assumptions made in using this parameter, that the
attached cells are evenly distributed on the substrate,
that the degree of attachment is independent of the
cell innoculum and that all the attached cells are
macrophages, are probably not correct. Nevertheless,
the resultant count is useful for comparing amniotic
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fluids.
Initial erythrophagocytosis experiments were
carried out using sheep red blood cells sensitised with
rabbit haemolysin (Sutherland et al., 1973b, appendix
HI). In further experiments human red blood cells
sensitised with rabbit anti-human red cell serum
according to Habeshaw (1970) were used. Phagocytosis
experiments were carried out by placing the coverslip
containing the macrophages in a 30 mm. Petri dish,
adding one ml. of tissue culture medium (Ham's F10
with 30% fetal calf serum) and one ml. of a 5% suspension
of the red blood cells in serum free Ham's F10 medium.
The culture was incubated for two hours at 37 C in an
atmosphere of 5% C02 in air. The coverslip was then
washed, fixed and stained with Giemsa as outlined above.
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RESULTS
Macrophage content of amniotic fluid.
Throughout this chapter the glass adherent cell
count after 20 hours in culture (number/ 10 low power
fields/ 10 ml. of amniotic fluid) will be used
synonomously with macrophage count, although all the
glass adherent cells are probably not macrophages.
Macrophage counts were carried out on amniotic fluids
from normal and abnormal pregnancies and the data are
given in table IV, appendix II and summarised in
table 5.1 and Fig. 5.1.
Table 5.1. Macrophage counts in amniotic fluids from




























Spina bifida 2 13 and 14 82 and 168
Diabetic 1 38 14
Other 2 18 and 22 445 and 232
♦
Where more than one sample from any pregnancy was
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Fig. 5.1. Macrophage counts of all amniotic fluids
included in this study in relation to gestation. Case 1
and case 2 refer to the two anencephalic amniotic fluids
in Sutherland et al. (1974 , appendix III).
The amniotic fluids in each category will be
considered separately:
Normals: The macrophage counts in the normal amniotic
fluids ranged from O to 41, but in only two samples
were the counts above 25. The macrophage counts did
not appear to change with gestation but this can only
be confidently concluded for the range from 14 to 20 weeks.
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There was no correlation between the total cell
innoculum, which ranged from less than 10,000 cells up
to 1.1 x 10 cells per Petri dish, and the macrophage
counts, There was no correlation between the
a-fetoprotein levels and the macrophage counts.
Rhesus iso-immunised fluids: The macrophage counts in
these fluids ranged from 1 to 276, There appeared to
be a fall in the count with increasing gestational age
although the numbers studied were too small for this to
be significant. The macrophage counts in some of these
' 1 1 1 1—
O O.I Q2 0.3 0.4 0.5
O.D.D. at 450 mji
Fig. 5.2. Relationship between macrophage counts and
O.D.D. at 450 mji for Rhesus iso-immunised amniotic fluids.
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fluids were much higher than in the normals although the
range was very wide. There was no relationship between
the macrophage counts and the O.D.D. at 450 mji (Fig. 5.2).
In the cases where more than one sample of amniotic
fluid was collected from a single pregnancy the
macrophage counts varied considerably.
Hydramnios amniotic fluids: There were only four fluids
from such cases and in these the macrophage counts were
all within the same range as for the normals. There
were no fetal abnormalities in this group.
Anencephalic amniotic fluids: There were 8 fluids from
6 pregnancies in this group. If only the first sample
from each pregnancy was considered, the macrophage
counts ranged from 576 to 6,226 (Fig. 5.3). These
counts were all well above those from the normal fluids
Fig. 5.3. Glass adherent cells from anencephalic
amniotic fluid (273) after 20 hours in culture.
(Giemsa, xlOO).
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Table 5.2. Data on amniotic fluids from the twin
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and do not overlap those from the Rhesus iso-immunised
fluids. In the first case in which more than one
sample was available from an anencephalic pregnancy
(case 2, Sutherland et al., 1973b, appendix III) there
was close agreement between the counts. In the second
such case the findings were ambiguous. This was from
a twin pregnancy in which there was a normal male twin
and an anencephalic female twin. Some data on the
fluids from this pregnancy are shown in table 5.2. The
reasons for the failure to find a high macrophage count
in the second sample from the anencephalic twin are
unknown. The possibility that the samples from the
two sacs were confused is remote but cannot be
completely eliminated. This was the only anencephalic
amniotic fluid in which the macrophage count was within
the same range as that for the normal fluids.
Spina bifida amniotic fluids: There were fluids from
only two pregnancies in this group. They both had
macrophage counts greater than the normals but less
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than the anencephalics. Their macrophage counts were
in the same range as the higher values for the Rhesus
iso-immunised fluids. The first such fluid (367) was
collected primarily for chromosome studies, from a 26-
year-old woman who had a child with Down's syndrome.
The macrophage count was 168 and the a-fetoprotein was
elevated (181 |ig/ml). The pregnancy was terminated
and resulted in a female fetus with spina bifida and
meningomyelocoele. Amniotic fluid obtained at
termination of pregnancy had a macrophage count of 189,
in close agreement with the count from the first
sample. The second pregnancy was to a 39-year-old
woman who had amniocentesis performed for the antenatal
diagnosis of maternal age associated chromosome
anomalies. Amniocentesis at 13 weeks' gestation
yielded fluid with a macrophage count of 82 and an
tt-fetoprotein of 143 pg/ml. The pregnancy was
terminated and resulted in a female fetus with spina
bifida and meningomyelocoele. Amniotic fluid obtained
at termination was grossly bloodstained and had a
macrophage count of 84 and an a-fetoprotein of 118 fig/ml.
Diabetic amniotic fluid: Only one such fluid was
available for study and this had a normal macrophage
count. The fluid was collected at 38 weeks* gestation
for estimation of lecithin/sphingomyelin ratio from a
woman who was a mild diabetic. The placenta showed no
pathological changes (Dr. G.A. Machin).
Other amniotic fluids: Two samples of amniotic fluid
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have been considered apart from all the others. These
both had raised macrophage counts but normal a-feto-
protein levels. There was no evidence of feto-maternal
incompatability or diabetes in either case. The
reasons for the high macrophage count with the normal
a-fetoprotein remain unknown. The pregnancies have
been allowed to continue.
If the estimation of the macrophage count is to be
usefully employed for the screening of amniotic fluid
cultures then removal of a coverslip must be shown not
to prejudice the success of the culture or to increase
the time required to achieve a chromosome result. In
only one case where a coverslip was removed for a
macrophage count did the culture fail to produce either
a chromosome result or a cell strain if this was
required. This was a sample of fluid (376) grossly
contaminated with old blood from a previously
unsuccessful amniocentesis and with fresh blood;
cellular proliferation in culture was not observed.
The mean time to chromosome result for the first 25
normal cultures on which macrophage counts were
performed was 13.0 days. The 20 cultures harvested
in the minimum time prior to this, when macrophage
counts were not being performed, required an average
of 14.5 days for a chromosome result. These two
figures are not strictly comparable since they were
from cultures studied at different periods of time
and there was a tendency for the time required for a




Fig. 5.4. Two morphologically distinguishable types
of macrophage showing erythrophagocytic activity (a)
spindle shaped cell and (b) round cell. (Giemsa, x400).
However they do indicate that carrying out macrophage
counts does not increase the time required for the
chromosome results. Two grossly bloodstained samples
yielded normal macrophage counts, hence this does not
appear to interfere with the reliability of the count.
The nature of the macrophages in amniotic fluid.
All the data discussed above has related to the
glass adherent cells in the amniotic fluid and to
denote all of these as macrophages is probably incorrect.
Morphologically there appears to be two types of cells
which are capable of phagocytosis, a spindle-shaped
cell which can have very long cytoplasmic processes
(Fig. 5.4a) and a rounder type of cell which does not
show cytoplasmic processes (Fig. 5.4b). These two
types are probably the ends of a spectrum of cell
morphology since numerous intermediate forms were also
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Fig. 5.5. Glass adherent cell from spina bifida
amniotic fluid (369) after 48 hours in culture, showing
features of a macrophage.
Note numerous phagosomes and myelin figure.
(Fixation: 2 parts 1% osmic acid and 1 part 2.5%
glutaraldehyde in 0.067 M cacodylate buffer pH 7.4.
Stain: 1% uranyl acetate in 75% ethanol during
dehydration and Reynold's lead citrate on section.
Embedded in Epon 812 resin. Electronmicrograph xl0,000)
present. Initial studies showed that most of these
cells were definitely of fetal origin (Sutherland et al.,
1973b, appendix III). There is no way of determining
the nature of all the glass adherent cells in amniotic
fluid. Ultrastructural studies of some of these cells
from the first case of spina bifida showed features
which indicated that they were macrophages (Fig. 5.5)
although some cells had ultrastructural features
similar to those of the reticular cells (Fig. 5.6)
described by Stuart and Davidson (1971).
Erythrophagocytosis studies on three Rhesus iso-
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Fig. 5.6. Area of cytoplasm of glass adherent cell
from spina bifida amniotic fluid (369) after 48 hours
in culture, showing features of a reticular cell.
Note numerous microfilaments, phagosomes and small
vesicles.
(Preparation as for Fig. 5.5. Electronmicrograph
x20,000)
immunised, two anencephalic and one spina bifida fluid
showed that a proportion of the glass adherent cells
were phagocytes. In the case of the spina bifida
fluid erythrophagocytic activity was demonstrated
after a total of 6 hours in culture (the last two hours
in the presence of tagged red cells). Such studies
are particularly difficult in the case of normal
amniotic fluids because of the very low cell densities
and the need to conserve most of the material for
diagnostic cytogenetic studies. Because of the low
cell densities it was difficult attempting to quantitate
the erythrophagocytosis but the fluids from the cases
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Fig. 5.7. Macrophages from hydrocephalic C.S.F.
showing massive autoerythrophagocytic activity.
(Giemsa, x400).
of CNS defects appeared to have about 60-80% of the
glass adherent cells capable of phagocytosis. In the
case of the Rhesus iso-immunised fluids only about
40-50% of the cells showed phagocytic activity.
In the anencephalic fluids in which the glass
adherent cell density was high there were dividing cells
present after 24-48 hours (ascertained by harvesting for
cytogenetic studies after 6 hours exposure to colchicine).
It was not possible to ascertain whether or not the
dividing cells were macrophages. In those anencephalic
fluids where the cell density was lower, and in some of
the Rhesus iso-immunised fluids with high glass adherent
cell density, metaphases were not seen after 6 hours
exposure to colchicine. In one of the cases of spina
bifida occasional metaphases were seen after exposure to
colchicine overnight, but again it is unknown whether
the dividing cells were macrophages.
Studies on CSF collected from cases of hydrocephalus
at perinatal necropsy showed that macrophages were
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abundant in this material (Fig. 5.7). There were some
differences in the behaviour of these macrophages
compared with those from amniotic fluid. Even when
present at very high density CSF macrophages did not
yield metaphases on exposure to colchicine. Auto-
erythrophagocytosis was extensive in some of the CSF




This study of macrophages in amniotic fluid has
shown that the macrophage count (i.e. the glass adherent
cell count after 20 hours in culture) can be used as an
indicator of gross fetal C.N.S. abnormality without
prejudicing other diagnostic studies. Nelson et al.
(1974) have confirmed the finding of increased
macrophages in anencephalic amniotic fluid and used this
to make an antenatal diagnosis of anencephaly.
Unfortunately there are conditions which interfere and
produce macrophage counts within the spina bifida range.
Hence it is suggested that there are a number of
possible instances in which macrophage counts might be
increased:
1. Open fetal C.N.S. defects in which the C.S.F.
is in free communication with the amniotic fluid. In
such cases the a-fetoprotein level will also be
increased. These cases present no problem for antenatal
diagnosis.
2. Fetal lesions which result in an area of the
fetus which is not covered with skin but with a
membrane, such as exomphalos may produce raised macrophage
levels in the presence of normal a-fetoprotein levels.
There are two cases in the present series which could
come into this group but until more experience is
gained with this technique these cases present an
antenatal diagnostic problem.
3. Rhesus iso-immunisation (and presumably any
other feto-maternal incompatability) can result in a
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moderate increase in the macrophage count. This
increase in amniotic fluid macrophages is associated
with the increase in placental macrophages (Hofbauer
cells) reported in this condition (Fox, 1967). Both
these findings might be due to the increase in fetal
extramedullary haemopoesis which can occur in this
condition (Morison, 1963). If this is the case then
increased amniotic fluid macrophage counts could be
expected where there is maternal diabetes mellitus
since both increased extramedullary haemopoesis
(Morison, 1963) and increased Hofbauer cells (Fox, 1967)
are known to occur in this condition. Only one
diabetic amniotic fluid was available for study and its
normal macrophage count does not impede this argument
since it was from a mild diabetic and there was no
placental pathology.
4. If the argument regarding an increase in
extramedullary haemopoesis is valid then an increase in
amniotic fluid macrophages would be expected in any
other condition in which this was a feature, such as
the chondro-dystrophies (Potter, 1961) and some intra¬
uterine infections (Bain et al., 1956).
Hence the estimation of the amniotic fluid
macrophage count may be a useful indicator of ffctal
diseases other than those involving gross lesions.
Unfortunately interference with this count a
diagnostic test by conditions which are generally
recognised as compatible with normal survival may be a
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problem. However a raised macrophage count can suggest
that all is not well and indicate that further
investigation is required. Sufficient experience has
not yet been gained with cases in which there is a
raised macrophage count in the presence of normal
a-fetoprotein levels and the absence of Rhesus
incompatability or maternal diabetes. The numbers
involved in the present study are too small to indicate
how often this situation may arise. Even on the
present evidence it is considered that a raised
macrophage count without explanation could be grounds
for therapeutic abortion if it is accepted that
termination of a possibly normal pregnancy is preferable
to allowing the birth of an abnormal infant.
The origin of the macrophages in the amniotic fluid
remains speculative. There are a number of possibilities
in both the normal and abnormal cases. It is worth
considering the absolute number of macrophages present.
In an amniotic fluid with a macrophage count of 20
(about the middle of the normal range) there would be
125 macrophages/ml. At, for example, 20 weeks*
gestation the volume of amniotic fluid is about 450 ml.
(Emery, 1970), therefore the total number of macrophages
would be about 60,000. This is not a great number of
cells and with a motile cell such as the macrophage
migration via the lungs, urinary tract and even the
placenta itself could account for these. Even in the
Rhesus iso-immunised cases, where there is no obvious
point of entry of the macrophages into the amniotic fluid
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the numbers encountered were only about 10 times normal,
i.e. 600,000 cells. Hence if the increase in
haemopoesis augmented the number of circulating
macrophages then again simple migration could be
responsible for the increased macrophage count.
In the cases with open C.N.S. lesions the C.S.F.
is a possible source of the macrophages since it can
contain these cells. In anencephaly, and to a lesser
extent in spina bifida, there is a large area of highly
vascularised tissue exposed and there can be little to
impede migration of circulating macrophages into the
amniotic fluid.
The nature of the glass adherent cells remains
unclear. There can be little doubt that a proportion
of these are macrophages in view of the rapidity with
which they become attached to glass, their
erythrophagocytic capacity and their ultrastructure.
Morphologically they are similar to the human peritoneal
macrophages described by Stuart (1967). There is
controversy about the ability of mature macrophages to
divide _in vitro (Jacoby, 1965) although a recent report
(Golde et al., 1974) claimed that mature pulmonary
macrophages could proliferate in culture. Stuart (1967)
described another cell type present in macrophage
cultures, a serosal or reticular cell which was capable
of undergoing division. Some of the cells in the
present study had an ultrastructure similar to that of
these reticular cells (Stuart and Davidson, 1971;
Davidson, personal communication). Further
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characterisation of the glass adherent cell population
in amniotic fluid is required and would probably be best
pursued using histochemical studies and by an
examination of the cell surface receptor sites.
Hence it has been shown that the quantitation of
glass adherent cells in amniotic fluid, whether all of
these cells are macrophages or not, can be a useful
diagnostic aid. The full potential of this finding is
yet to be realised. In laboratories without facilities
for a-fetoprotein determination but with tissue culture
capabilities this can be, and has been (Nelson et al.,
1974) used for the antenatal diagnosis of gross C.N.S.
abnormalities. When there are facilities for
a-fetoprotein studies the macrophage count can provide
an independent parameter on which to base the antenatal
diagnoses of gross C.N.S. abnormalities. Raised
macrophage counts due to other causes are a problem at
present and will remain so until much more information
about these cases is available. It is possible that
raised macrophage counts may be a non-specific indicator
that all is not well with the fetus and suggest that
further investigation is required.
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SUMMARY
The glass adherent cell population of amniotic
fluid has been quantitated. Many of the glass adherent
cells have been shown to be macrophages and the glass
adherent cell count has been referred to as the
macrophage count. Greatly increased macrophage counts
have been shown to occur in anencephaly. A lesser but
definitely increased count occurs in spina bifida and
can occur in Rhesus iso-immunisation. Two cases have
been encountered with increased macrophage counts of
unknown etiology and the pregnancies have been allowed
to continue. It has been shown that amniotic fluid
cultures can be screened by macrophage counts without
prejudicing their success. The potentialities of this
parameter as a non-specific diagnostic test of extra-
medullary fetal haeraopoesis as well as a specific test
for fetal C.N.S. abnormalities is discussed.
Chapter 6
Lysosomal Enzymes in Cultured
Amniotic Fluid Cell Strains
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BACKGROUND
Nadler (1968b) and Fujimoto et al. (1968) showed
that some inborn errors of fetal metabolism could be
identified in cultured amniotic fluid cells. Before
this knowledge can be applied to antenatal diagnosis of
genetic diseases it is essential that the normal
characteristics of any enzyme that may have to be
measured for such diagnosis are known. Indeed Nadler
a
(1968) wrote "Knowledge of normal patterns of enzyme
distribution in cultured amniotic fluid cells is mandatory
if we are to utilize this material in a responsible
manner." It is not sufficient to extrapolate data gained
from the study of cultured skin fibroblast-like cells to
cultured amniotic fluid cells since the biochemistry of
these two types of cell strain are not identical. Even
within amniotic fluid cell strains the biochemistry of the
various cell types is different (Gerbie et al., 1972).
Melancon et al. (1971) showed that "epithelial cells"
from amniotic fluid cell strains had high levels of
histidase whereas "fibroblasts derived from the same
original culture" had no detectable activity of this
enzyme. Conversely cystathionine synthetase is active in
cultured fibroblast-like cells but not in epithelioid
cells from amniotic fluid (Gerbie et al., 1972). This
latter finding is somewhat at variance with that of
Uhlendorf and Mudd (1968) who found that this enzyme has
a much higher activity in cultured amniotic fluid cells
than in cultured skin fibroblast-like cells. Brock (1973)
lists 12 enzymes for which relative activities in these
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Table 6.1. Lysosomal enzymes chosen for study in
cultured amniotic fluid cells and the inborn errors of


























Brock (1972) has tabulated references to the
identification of these diseases except for
8-glucuronidase deficiency which was
described by Sly et al. (1973).
two types of cell strain have been reported.
In view of this need to know more about the character¬
istics of enzymes in cultured amniotic fluid cells a group
of lysosomal enzymes was chosen for study. All except
one of these is involved in an inborn error of metabolism
(Table 6.1). These particular enzymes were chosen because
there are simple and reliable assay methods available for
them and because they are relevant to both post-natal and
antenatal diagnosis.
The first studies on lysosomal enzymes in cultured
amniotic fluid cell strains were by Nadler (1968b).
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Although his paper contained no assay values for acid
phosphatase, a-glucosidase, 13-glucuronidase and
8-galactosidase, he claimed that the levels of these
enzymes in cultured amniotic fluid cells did not vary
with gestation over the period from 10 to 36 weeks. He
also claimed that the activities of these enzymes in
cultured amniotic fluid cells were not different from
those found in (presumably) cultured fibroblast-like cells
from newborns and adults.
There has been no study of the levels of activity of
lysosomal enzymes in normal amniotic fluid cell strains.
The only such data in the literature are in case reports
of antenatal diagnoses which include a few "control" cell
strains in which the relevant enzyme was assayed or from
studies of individual enzymes where the level of the
particular enzyme has been measured in a number of tissues
including cultured amniotic fluid cells. Brock (1973)
has listed 18 enzymes (mostly lysosomal) for which assay
values in cultured amniotic fluid cells have been quoted.
Since the enzymology of cultured amniotic fluid
cells cannot be assumed to be the same as that of
cultured fibroblast-like cells it is necessary for the
specific activities of the enzymes in both of these types
of cell strain to be measured and their relationship
known. The main reasons for this are that in many ante¬
natal diagnoses the only suitable control material
available for the enzyme assay is cultured fibroblast-
like cells. In addition, confirmation of an antenatal
diagnosis may have to be made using such material. This
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problem has been discussed at some length by Kaback and
Leonard (1970) who compared activities of B-galactosidase,
N-acetyl-8-D-glucosaminidase and arylsulphatase A in
cultured amniotic fluid cell strains with that in maternal
and fetal fibroblast-like cell strains. For each enzyme
they found that the activity in fetal fibroblast-like
cell strains was significantly less than that in amniotic
fluid cell strains. They also found that 8-galactosidase
activity was higher in cultured amniotic fluid cells than
in maternal fibroblast-like cell strains and, conversely,
that arylsulphatase A activity was lower in cultured
amniotic fluid cells. The results of Kaback and Leonard
(1970) are not supported by Leroy et al. (1973) who found
Table 6.2. Reported antenatal diagnoses of inborn errors





Tay Sachs Schneck et al. (1970);
O'Brien et al. (1971)
Sandhoff's Desnick et al. (1973)
Lysosomal acid phosphatase
deficiency
Nadler and Egan (1970)
Generalised gangliosidosis Lowden et al. (1973)
Gaucher *s Epstein et al. (1972)
Fabry's Brady et al. (1971)
Pompe *s Nadler and Messina (1969)
Metachromatic Leuko¬
dystrophy
Nadler and Gerbie (1970);
Leroy et al. (1973)
*
Where two references are given either the first
gives inadequate documentation or the second is
a key reference related to the particular disease.
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the same level of activity in amniotic fluid cell strains
and cultured skin fibroblast-like cells.
Another problem in the enzymology of cultured
amniotic fluid cells is that of cell type (see
Sutherland et al,, 1974a, appendix III), Kaback and
Leonard (1972) assayed B-galactosidase, arylsulphatase A
and N-acetyl-8-D-glucosaminidase in cells of epithelioid
and fibroblast-like morphologies and found no differences
between the two groups. Gerbie et al. (1972) did the
same for a number of enzymes and claimed that there were
no differences in the lysosomal enzyme activities of these
cell types. Examination of the data of Gerbie et al.
(1972) suggests that their claim is not true for all the
enzymes. For acid phosphatase there is no overlap of
the quoted ranges of activity in the two cell types.
Antenatal diagnoses of 9 of the inborn errors in
which the enzymes chosen for study are involved have been
reported (Table 6.2). In spite of this there has been
no systematic study of factors associated with tissue
culture, such as passage number, time after subculture,
growth rate of the cells, type of culture medium, amount
of serum supplement to the culture medium or pH of the




The materials used in this study were the cell
strains derived from amniotic fluid cell cultures as
described in chapter 3. The methods of cell
homogenisation and enzyme assay are included in the
section of this work which has been published (see
appendix III) . Two methods of cell homogenisation were
used. The first was used for the majority of the
studies and is outlined in Butterworth et al. (1973a,
appendix III) . The second was used for the later




Most of the results of this study have been
published. The levels of the lysosomal enzymes in
normal cultured amniotic fluid cell strains at the third
passage of culture are given in Butterworth et al.
(1973a , appendix III)• Studies of the variation of the
levels of these enzymes with time in culture are
reported in a series of three papers, Butterworth et al.
(1973b), Sutherland et al. (1974c) and Butterworth et al.
(1974a), all in appendix III. The effects of serum
concentration in the culture medium, the type of culture
medium used and the pH of the culture medium on the
levels of the lysosomal enzymes in cultured amniotic
fluid cells are presented in Butterworth et al. (1974b ,
appendix III). A study of the variations in enzyme
levels in thirteen cell strains derived from one sample
of amniotic fluid using three culture methods (see
chapter 2) are reported in Sutherland et al. (1974b ,
appendix III). The last two studies were carried out
using cell homogenates prepared by the second method of
cell homogenisation (Sutherland et al., 1974b).
The only part of this study which has not been
published is a comparison of the effects of the two
homogenisation methods on the activities of the lysosomal
enzymes and this is shown in table 6.3.
The method of homogenisation did not affect the
specific activities of acid phosphatase, a-galactosidase
or a-mannosidase. The activities of three enzymes,
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Table 6.3. Comparison of the two methods of cell
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a-arabinosidase were lower when the second method of
extraction was used, whereas the activities of
B-galactosidase, B-glucosidase and a-glucosidase were
lower when the first method was employed.
During the course of this study three women at risk
for having children with inborn errors of metabolism
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were studied.
Case 1. Mrs. S.M, had one normal child and one child
which died in the neonatal period and was diagnosed as
suffering from maple syrup-urine-disease. She became
pregnant in October 1971, amniocentesis was performed
at 15 weeks* gestation and amniotic fluid (42) cell
culture established. The culture grew slowly and then
degenerated. Because of failure to reach any decision
about the status of the fetus the pregnancy was
terminated and resulted in a macerated male fetus. No
decision was reached as to whether this fetus was
normal. Mrs. S.M. again became pregnant in September
1972 and amniocentesis was performed at 15 weeks'
gestation. The amniotic fluid (205) culture grew well
and after 4 weeks assays for leucine decarboxylase
(Dr. R.A. Harkness) indicated that normal amounts of
this enzyme were present. The pregnancy continued and
at term a female infant was delivered. Serum and
urine amino acid analyses indicated that this infant
had maple syrup urine disease. Enzyme studies on cord
blood and venous blood showed normal levels of leucine
decarboxylase activity. The infant is surviving with
dietary treatment for its inborn error of metabolism.
Case 2. Mrs. McD. was at risk for producing a child
with Sandhoff's disease, full family studies having been
carried out in this department (Bain et al. 1973). She
became pregnant in April 1973 and amniocentesis was
performed at 14 weeks' gestation. The amniotic fluid
161
(284) was grossly bloodstained and after one week in
culture there was no evidence of cellular proliferation.
A second amniocentesis was performed 6 days after the
first and again the amniotic fluid (286) was bloodstained.
The cells from this sample grew slowly in tissue culture
and five weeks after amniocentesis there was one small
baby bottle of cells available for enzyme assay. Assay
of N-acetyl-B-D-glucosaminidase indicated that this
enzyme was present and the pregnancy was allowed to
continue. Assay values for this enzyme in both samples
of amniotic fluid and the cultured cells are shown in
table 6.4. The infant was subsequently shown to have
normal levels of N-acetyl-13-D-glucosaminidase in its
cord blood leucocytes.
Table 6.4. Results of enzyme studies on which the
antenatal diagnosis in case 2 were based.
Material Specific activity of
N-acetyl-8-D-glucosaminidase
Amniotic fluid 284 3.80a
286 3.06a





a nmole methylumbelliferone/min./ml. of fluid.
b nmole methylumbelliferone/min,/mg. protein.
1, 2 and 3 are normal amniotic fluid cells cultured at
the same time as 286.
"Sib" is a fibroblast-like cell strain from a previously
affected sibling of the fetus.
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Case 3. Mrs. L.C. had two children with a neuro¬
degenerative disorder which had been diagnosed as
metachromatic leukodystrophy on the basis of low levels
of the enzyme arylsulphatase A. An attempt at ante¬
natal diagnosis in another hospital had been inconclusive.
Amniotic fluid (291) from the present pregnancy was
received at 23 weeks' gestation. The culture grew well
and enzyme assays had been completed within 4 weeks.
Arylsulphatase A was present and the pregnancy was
allowed to continue, a healthy female infant was
delivered. The results of the enzyme assays on which
this diagnosis was based are shown in table 6.5. The
infant had normal levels of arylsulphatase A in its
cord blood leucocytes.
Table 6.5. Results of enzyme studies on which the
antenatal diagnosis in case 3 was based.
Material Arylsulphatase A specific activitya





Two separate cultures (I and II) of amniotic fluid cells
were assayed, one normal control amniotic fluid grown
under the same conditions and fibroblast-like cells




The sections of this study which have been
published have all been discussed in the relevant papers
in appendix III. This work showed that there were very
marked fluctuations in the levels of the enzymes studied
at different stages of culture. In spite of
investigation of some of the variables which might have
been responsible for this fluctuation the reasons for it
remain unknown. The relevance of these findings to the
antenatal diagnosis of inborn errors of metabolism by
enzyme assay of cultured amniotic fluid cells is that
this fluctuation could be a source of error. In the
present study no cell strain at any time had such a low
level of enzyme activity that it could have been
suspected of having an enzyme deficiency. The chances
of any of the cell strains studied being heterozygous
for a lysosomal enzyme deficiency are small. In
pregnancies where the fetus is at risk for an inborn
error of metabolism half the amniotic fluid cell strains
could be expected to be heterozygous. If the enzyme
levels in these cell strains, which would be expected to
be about half that of normal cell strains, fluctuate to
the same extent as they do in these latter cell strains
then such fluctuations might lead to the diagnosis of an
enzyme deficiency if only an isolated cell culture was
assayed. No antenatal diagnosis of an inborn error of
metabolism should be established by the assay of the
cells from a single culture bottle of amniotic fluid
cells. The particular cell strain involved should be
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assayed at least twice at different stages of culture
before an enzyme is considered to be absent.
The preparation of cultured cells for enzyme assay
is a problem which almost all workers solve differently.
Even different reports from the one laboratory use
different methods of cell homogenisation even when the
same group of enzymes are being studied. Gerbie et al.
(1972) removed cells from the culture vessel with
trypsin, washed them in isotonic saline and then
suspended them in water. On the other hand Ryan et al.
(1972), essentially the same group of workers, suspended
their cells in 0.25M sucrose, lysed them by 5 cycles of
freeze-thawing then centrifuged at 600g for 10 min to
remove cell debris. It is of some concern that Gerbie
et al. (1972) obtained activities of B-glucosidase 50
times higher, and arylsulphatase about 5 times higher in
cultured amniotic fluid cells than Ryan et al. (1972)
found in fibroblast-like cell strains when using the
same conditions of enzyme assay. Other variations have
included sonication in phosphate buffered saline followed
by centrifugation at 200g (Kaback and Howell, 1970),
freezing in isotonic saline followed by sonication
(Milunsky et al., 1972a), sonicating in water (Kanfer and
Spielvogel, 1972) and suspension in water followed by
mechanical homogenisation (Den Tandt and Schaberg, 1973).
Beutler et al. (1971) used a saline suspension of intact
fibroblasts for enzyme assay and claimed that freeze/
thawing had no effect on enzyme levels.
Ryan et al. (1972) reported that excessive
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centrifugation of homogenates removed B-galactosidase
activity. This report prompted the change in
homogenisation used in the present study. The findings
of Ryan et al. (1972) were confirmed as far as
3-glucosidase activity was concerned in that the enzyme
activity in homogenates centrifuged at the lower speed
were significantly higher than in those centrifuged at
2 5,OOOg.
There are a number of possible explanations for the
effects of the homogenisation methods used in the
present study. When enzyme levels remain constant the
distribution of the enzyme must be the same in the
particulate fraction and the soluble fraction of the
homogenate. When enzyme levels are higher in the
homogenate produced by the second method this may be
because protein removed by the high speed spin does not
contain enzyme, hence the specific activity, expressed
on a protein basis, will be higher. The reasons for
enzyme levels being lower in the homogenate produced by
the second method are that tire enzyme is being
concentrated in the high speed sediment, this could be
for reasons of solubility or because the enzyme has to
be membrane bound to function normally (Ho et al., 1973).
The possibility that the NaCl used in the first method
may increase the solubility of some enzymes or act to
stabilise them cannot be discounted. In addition,
sonication could affect enzyme activity. Some of the
enzymes in the group studied are considered to be
constituent parts of the lysosomal membrane and others
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to be bound to it (Tappel, 1969). For example
8-glucosidase remains firmly bound to the membrane of
rat liver lysosomes when these are ruptured (Beck and
Tappel, 1968). This whole problem of cell homogenisation
requires further study and standardisation if results
from different laboratories are to be comparable.
The three pregnancies monitored for possible inborn
errors of fetal metabolism illustrate several important
points which should be noted. The first case involving
"maple-syrup-urine disease" should never have been
attempted. The basic requirement that the previously
affected individual in the family should have been
diagnosed at the enzyme level was not met. In this
first case it would appear that because this basic
requirement was not fulfilled the antenatal diagnosis
had no chance of being correct other than the fortuitous
one of being right for the wrong reason, since the infant
appears to have normal levels of the enzyme which was
thought to be absent. Others have been more successful
in the antenatal diagnosis of maple-syrup-urine disease.
Nadler and Gerbie (1970) monitored two pregnancies at
risk for this disease and predicted that the fetuses
would be normal. Milunsky (1973) records that seven
pregnancies had been monitored for this condition, one
was terminated after being diagnosed as affected and the
remaining six were unaffected. The only adequately
documented instance of the antenatal diagnosis of this
disease is the case reported by Wendl et al. (1973).
The second case is probably as close to an ideal
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situation as is likely to be encountered in this type of
work. The family had been studied previously in this
department (Bain et al., 1972) and cultured skin
fibroblasts from one of the previously affected members
were available for use as control material for the
enzyme assay. Desnick et al. (1973) have documented
the antenatal diagnosis of Sandhoff's disease.
The third case has a number of unsatisfactory
features. The amniotic fluid was received in mid-
pregnancy after another laboratory had failed in an
antenatal diagnosis attempt. The family had not been
studied enzymatically in this department and the residual
enzyme activity in the affected members of the family was
unknown. Metachromatic leukodystrophy has been subjected
to antenatal diagnosis on a number of occasions;
Milunsky (1973) records 6 pregnancies which have been
monitored for this disease.
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SUMMARY
The normal range of activity of 9 lysosomal enzymes
in cultured amniotic fluid cells was established.
Marked variations in the levels of the enzymes studied
were found to occur throughout the period of culture of
individual cell strains. The serum concentration of
the culture medium, the type of culture medium (Ham's
F10, Eagle's M.E.M.) and the pH of the culture medium
did not affect the levels of the enzymes with the
exception of a small but significant increase in the
activity of B-galactosidase when grown in medium with a
serum concentration of 30% compared with 15%. The
levels of the enzymes in 13 cell strains, at the third
passage of culture, derived from a single sample of
amniotic fluid showed less variation than did the enzymes
in cell strains derived from different samples of fluid.
Nevertheless some enzymes in these 13 cell strains
showed 2 to 3 fold variations in activity. Three
pregnancies in which the fetus was at risk for an inborn
error of metabolism were monitored and a mistake in





The specific site of origin of the cells cultured
from amniotic fluid is unknown. The heterogenous nature
of amniotic fluid cultures suggests that more than one
type of cell is proliferating. Cytological studies on
amniotic fluid have indicated that the cells present
come from various sources. Exfoliated cells from the
amnion, fetal skin, respiratory and urogenital tracts
have all been implicated (see Sutherland and Bain, 1972,
appendix III for references). Even without cytological
evidence it is difficult to imagine other possible sources
of these cells. However, Uhlendorf (1970) has suggested
that some of the cells may have originated from the
chorionic villi.
The only experimental approach to this problem was
made by Jacobson and Barter (1967). They initiated
cultures from amniotic, allantoic and tracheal fluids
and urine from sheep fetuses; only one of the urines
produced a successful culture. They also initiated
cultures from bladder aspirates of four human fetuses and
chorionic and yolk sac fluids from three human fetuses;
none of these cultures were successful.
Early in this work it was found that cells from the
urine of newborn children could be used to initiate
cultures (Sutherland and Bain, 1972, appendix III).
These cultures could be readily used for cytogenetic
studies (Sutherland et al. 1973a, appendix III). Hence
it is feasible that some, although not necessarily all, of
the cells from amniotic fluid which proliferate in culture
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are derived from the fetal urinary tract.
A comparison of cultured urine cells has been made
with cultured amniotic fluid cells at the morphological,
cultural and biochemical levels. Cultured urine cells
may be a more suitable model than cultured skin fibro¬
blasts for biochemical studies which may have to be




Urines were collected into standard sterile urine
collecting bags by the nursing staff. Occasional
samples were collected by suprapubic aspiration, either
when urine cell culture could be justified clinically or
for bacteriological purposes when the excess was
available for cell culture. Urine was collected from
perinatal post-mortems by aspiration from the bladder
after the abdomen had been opened.
The methods used for all phases of the work on
urine cell culture were the same as those used for
comparable studies on amniotic fluid cells.
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RESULTS
The results of the studies on urine cell culture will
be presented in the same sequence as the studies on
amniotic fluid cell culture. Since the success rate in
culturing urine cells was low the first section of these
results will relate to possible factors affecting the
success of urine cell culture. Microbial contamination
of urine samples was a major problem in this work; about
25% of urines collected into urine collecting bags from
newborn infants showed contamination in the first few days
of culture. These samples will not be considered further.
Success in culture is defined as the appearance of
Days Weeks Years
AGE
Fig. 7.1. Histogram showing the relative success rates





Fig. 7.2. Histogram showing the relationship between
gestational age and success in urine cell culture for
fetuses and infants aged one week or less.
proliferating cells in the Petri dish within one month and
data pertaining to those urines successfully cultured are
in table II, appendix II.
The relationship between the age of the individual
from whom the urine was collected and success in culture
is shown in Fig. 7.1. This figure does not include
urines collected from stillborn fetuses at postmortem.
The oldest child from whom urine cells were successfully
cultured was 2 years old, the "youngest" was a fetus of
18 weeks* gestation. During the first few weeks of life,
success in culture appeared to be unrelated to age,
however for older children the chance of success in
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culture was very low.
The relationship between the gestation of stillborn
fetuses and of the infants aged one week or less to
success in culture is shown in Fig. 7.2. One successful
culture from the bladder aspirate of a fetus of 18 weeks *
gestation has been omitted from this figure. The
success of urine culture from fetuses and neonates does
not appear to be related to their gestational age.
The relationship between the cell count of a group
of urines and success in culture is shown in Fig. 7.3.
As in the case of amniotic fluids, urines with very low
cell counts were allocated a value of 1000 cells/ml. The
cell counts appear to have little effect on the success
of the urine culture. Urines with 1000 or less cells/ml.
both succeeded and failed in culture as did urines with
more than 100,000 cells/ml.
If all urines initially contain cells which have the
potential to proliferate in tissue culture, then the
nature of the urine itself could be such as to maintain
or destroy this potential. Two properties of the urine
were investigated in this regard, osmolarity and acidity.
The relationship between osmolarity and success in
culture is shown in Fig. 7.4. Most of the successfully
cultured urines had osmolarities on the hypotonic side of
physiological normal (approximately 300 mosm./Kg.). The
unsuccessful samples were also mainly on the hypotonic
side of normal but some were more hypertonic. These low
values for urine osmolarity are due to most of the samples
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Fig. 7.4. Graphical display of the relationship
between urine osmolarity and success of urine cell
culture.
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Table 7.1. Relationship between degree of acidity and






10 2 3 7
The degree of acidity was rated by the colour change
in the medium when it was mixed with the urine cells.
From table 7,. I it can be seen that all urines which were
rated as very acidic failed to grow, however those rated
as not acidic were not necessarily successful in culture.
The only tentative conclusion is that while hypertonic,
acidic urines are unlikely to be successful in culture
these two factors are not useful predictors of the
outcome of culture when the urine is more neutral and
isotonic.
There were 46 urines which were successful in culture
Table 7.2. Data on the origin of the 46 urines which
were successfully cultured.
Means of
^ Number Age ^ Number Gestational age
collection Range 7 days range (weeks)
old for those < 7
days old
(i) 16 l-23d 15 32 - 40
(ii) 24 SB-35d 22 18 - 40
(iii) 6 ld-2y 2 35 - 38




See Table II, appendix II.
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Fig. 7.5. Karyotype from primary urine cell culture
from a male infant which had been dead for 5 days prior
to postmortem. Note 47,XXY karyotype.
and all further results pertain to these. Some data on
the origin of these 46 urine samples are given in table II,
appendix II and summarised in table 7.2.
Cytogenetic studies were carried out on 29 of the
successfully cultured urines. Three of these urines
had abnormal karyotypes, one (93) was 47,XXY (Fig. 7.5)
and two samples (116 and 130) were from an infant with
Edward's syndrome and karyotype 47,XX,+18/48,XX,+18,+fra
(Fig. 7.6). These two infants had been diagnosed as
chromosomally abnormal before urine cell culture was
attempted. The use of urine cell culture for cytogenetic
studies has been published (Sutherland et al., 1973a,
appendix III).
Since cytogenetic results from urine cell culture
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Fig. 7.6. Karyotype from the third passage of a cell
strain derived from urine collected by suprapubic
aspiration from an infant with Edward's syndrome. The
additional fragment was absent from about 35% of the
cells in this culture.
Table 7.3. Data on eleven primary urine cell cultures



















See table II, appendix II.
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were of little clinical importance only eleven cultures
were harvested for such studies in the minimum time.
These eleven were not a random sample but were from
cultures which were growing well. The data on these
cultures are shown in table 7.3. There is little point
in comparing these times statistically with those for
amniotic fluid cultures. However, it can be seen that
the times required for cytogenetic results from either
type of culture are of the same magnitude.
Of the 46 successful primary urine cell cultures
5 degenerated and could not be subcultured. Hence 41
primary cultures were subcultured and data relating to
these are shown in table 7.4. The time in primary
culture was independent of the means of collection of the
urines. The difference in this parameter between the
Table 7.4. Data relating to the 46 successful primary
urine cell cultures.




(i) 16 26.5 ± 10.49a
16 - 48b
(ii) 24 3 29.8 + 8.05
19 - 50
(iii) 6 2 35.5 ± 13.58
21 - 53
Total 46 5 29.0 + 9.72
16 - 53
a - mean ± standard deviation
b - range
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urines collected via urethra and those collected at post¬
mortem is not significant. The urines collected by
suprapubic aspiration from living children took longer
in primary culture but the numbers involved (only four
cases) are too small for this finding to be significant.
The time in primary culture for the 41 urine cell strains
was not different from that for the two series of amniotic
fluid cell strains (see chapter 3).
The cell strains derived from the primary culture of
urine cells suffered badly in the outbreaks of microbial
and mycoplasma contamination. Only 12 cell strains were
cultured to senescence without encountering such problems
and data on these are shown in table 7.5. Any
conclusions drawn from these data would be greatly
influenced by the exclusion of the majority of the cell
strains. The two cell strains showing the greatest
growth potential (66 was discarded in the 35th passage
and 137 in the 27th) both suffered from mycoplasma
contamination and seven other cell strains which survived
for more than 10 passages had to be discarded because of
contamination. In view of this there is little point
in carrying out statistical comparisons of the behaviour
of these cell strains with that of amniotic fluid cell
strains. Ten of the twelve cell strains were tested
and found not to contain mycoplasma on at least one
occasion, the other two were in culture at a time when
no other cell strains yielded mycoplasma.
Of the 12 cell strains cultured to senescence there
were 6 collected into urine collecting bags, 4 were
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52 18 12 111 9.2
63 42 8 62 7.8
77 35 8 70 8.8
93 26 14 94 6.7
100 18 19 98 5.2
104 33 18 90 5.0
116 53 14 60 4.3
131 30 4 31 7.8
147 25 11 111 10.1
150 31 3 34 11.3
184 35 14 104 7.4
265 34 7 61 8.7
Mean 31.67 11. 00 77.17 7.69
Standard
Deviation
9.75 5. 12 28.16 2.12
collected at post-mortem and 2 by suprapubic aspiration
from living infants. The age range of the infants from
whom the urines were collected was from one day to 23
days, however 7 were one day old and only one was older
than one week. All had normal karyotypes except 116
(Edward's syndrome); there were 7 males and 5 females.
The behaviour of the cell strains was apparently
unrelated to any of these factors.



























4 5 6 7 8 9 10 1
Mean interval between subcultures (Days)
~r ~r -i
12
Fig. 7.7. Relationship between the number of passages
for which urine cell strains could be cultured prior to
death and the mean interval between subcultures.
between the various parameters of cell behaviour. As
in the case of the amniotic fluid cell strains the only
significant finding was a correlation between the number
of passages and the mean interval between subcultures
(Fig. 7.7). This correlation (r = -0.743) is highly
significant (P < .01) and is of the same magnitude as
that found for both series of amniotic fluid cell strains.
Most of the urine cell strains which survived for
more than 4 or 5 passages were stored in the liquid
nitrogen unit. Eight of these were removed from storage
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(iii) (iv)
Fig. 7.8. Proliferating cells in primary urine cell
cultures. (Phase contrast, x 100).
(i) Epithelioid type I cells, note well defined
border of cell colony.
(ii) Epithelioid type III cells, note that there is
no well defined border to the cell colony.
(iii) Epithelioid type II cells, note large size of
the cells, fibrillar nature of the cytoplasm and "loose"
nature of the cell colony.
(iv) Area of fibroblast-like cells.
and put back into culture; none were again cultured to
senescence.
Three of the cell strains in this series (of 12) had
cytogenetic studies performed after the 10th passage and
examination of at least 10 cells revealed no departure
from normal diploidy. A further 5 cell strains outwith
this series had similar cytogenetic examinations and again
no departure from normal diploidy was observed. The two
cell strains in which in vitro chromosome changes,
associated with mycoplasma contamination, occurred have
been described in chapter 3.
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(iii) (iv)
Fig. 7.9. Cells on flying coverslips prepared from
urine cell strains (Stain, Giemsa, x 100).
(i) Epithelioid type III cells from second passage
of culture.
(ii) Epithelioid type III cells with some type II
cells from second passage of culture.
(iii) Epithelioid type II cells from sixth passage of
culture, note variation in size with some binucleate cells.
(iv) Cell strain in 12th passage of culture showing
epithelioid type II and III cells interspaced amongst
fibroblast-like cells.
The morphology of the urine cell strains was
indistinguishable from that of amniotic fluid cell strains
under the light microscope. The only difference was
that macrophages were less frequently seen in primary
cultures. Typical examples of the morphology of
cultured urine cells in primary culture and after serial
cultivation are shown in Figs. 7.8 and 7.9.
Since the early passages were less affected by
contamination (two cell strains were lost after the first
subculture) than the later passages it was possible to
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Table 7.6. Data on 39 cell strains cultured until there
were enough cells for a biochemical assay.
Means of Number Days in Days to
collection 1° culture biochemical result
(i) 14 25.9 ± ll.lla 36.8 ± 10.64
16 - 48b 23 - 56
(ii) 21 29.8 ± 8.05 41.1 ± 10.42
19 - 50 25 - 64
(iii) 4 35.5 ± 13.58 45.0 + 14.31
21 - 53 33 - 63
Total 39 28.9 ± 9.96 39.9 + 10.9
16 - 53 23 - 64
a - mean ± standard deviation
b - range
study the time required to produce enough cells for a
biochemical assay. This is of little clinical relevance
in the post-natal situation, but as a parameter of cell
strain behaviour it can be validly compared with that
for amniotic fluid cell strains. The results of this
study are shown in table 7.6. The differences between
the times taken to achieve a biochemical result for the
three groups of cell strains (according to method of
collection of the urine) are not significant. As in the
case of amniotic fluid cultures (see chapter 3) it can be
seen that about two-thirds of the time required to
produce a biochemical result is due to the time in
primary culture.
The distribution of the times taken to achieve a
biochemical result for the 39 cell strains is shown in
Fig. 7.10. A comparison of these results with those for
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the two similar series of amniotic fluid cell strains is
shown in table 7.7. The differences between the two
series of amniotic fluid cell strains and the urine cell
strains are minimal and not significant.
The levels of 9 lysosomal enzymes in urine cell
strains at the third passage were compared with those in
amniotic fluid cell strains at the same stage of culture
and with connective tissue derived fibroblast-like cell
strains in early passages of culture. The results of








4 5 6 7 8 9 10
Week of culture in which result
was attained
Fig. 7.10. Distribution of the times taken to achieve
a biochemical result from 39 urine cell strains.
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Table 7.7. Comparison of the times taken to achieve a
biochemical result from amniotic fluid and urine cell
cultures.
Amniotic fluid Urine
First year Second year
Mean time to result
(days)
41 .4 37 .2 39 .9
Number successful 56 44 39
Success at 6 weeks 36 (64%) 32 (73%) 26 (67%)
Success at 8 weeks 49 (88%) 40 (91%) 36 (92%)
Table 7.8. Specific activities of 9 lysosomal enzymes
in amniotic fluid, urine and fibroblast-like cell strains.
Enzyme Amniotic fluida Urine (n 9) Fibroblast-

































































a Data from Butterworth et al. (1973a) appendix III.
b mean ± standard deviation; c range;




this table shows that the specific activities of the
enzymes studied are very similar in the urine and amniotic
fluid cell strains. The greatest differences are in the
activities of a-arabinosidase and a-mannosidase and these
are not statistically significant.
Comparison of activities of the enzymes in the three
types of cell strains as shown in table 7.8 indicates
that there are no differences for 8-glucuronidase,
8-glucosidase and a-arabinosidase. The differences
between the activities are not statistically significant
for acid phosphatase or a-galactosidase. The Student's
t-test values for the remaining enzymes are shown in
table 7.9. Hence it can be seen that the activities
of a-mannosidase and 8-galactosidase are lower in urine
and amniotic fluid cell strains than in fibroblast-like
cell strains. The position is less well defined for
N-acetyl-8-D-glucosaminidase and a-glucosidase . In
both cases the enzyme activities are very significantly
lower in amniotic fluid cell strains than in fibroblast-
like cell strains. However, these enzyme levels in
urine cell strains, although virtually identical to
those in the amniotic fluid cell strains, are not
significantly different from those in fibroblast-like
cell strains. This is probably due to the small number
of urine cell strains studied and it is likely that
further studies would indicate that N-acetyl-8-D-
glucosaminidase and a-glucosidase would be less active
in urine cell strains than in fibroblast-like cell
strains.
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Table 7.9. Results of Student's t-tests on the
difference in the activities of 4 enzymes in amniotic










'25 1.443 (N.S.) t55 = 2.613 (P <.01)
3-galactosidase t27 3.118 (P <.01) t59 " 5.078 (P
a-glucosidase t =*27 1.825 (N.S.) t58 = 3.434 (P
a-mannosidase t27 " 3.142 (P C.01) t57 = 3.681 (P
The enzyme levels were measured in one cell strain
at daily intervals after subculture and the results are
shown in table 7.10. Many of the enzymes show great
variation in activity with time after subculture and
these variations do not appear to follow any pattern.
For some enzymes the highest level of activity seen was
two or three times that of the lowest.
*
Table 7.10. Specific activities of nine lysosomal
enzymes in a urine cell strain assayed at varying times
after subculture at the 10th passage.
Enzyme Days after subculture
1 2 3 4 7
N-acetyl-3-D-
glucosaminidase
55.1 50.8 67.3 51.3 45.8
Acid Phosphatase 7.01 6.68 10.7 5.85 9.85
8-galactosidase 2.67 2.51 3.01 1.84 2 .67
8-glucuronidase 2.19 0.91 1.05 0.74 1.19
8-glucosidase 0.84 0.52 0.60 0.37 0.65
a-galactosidase 0.33 0.30 0.43 0.34 0.33
a-arabinosldase 0.43 0.36 0.46 0.35 0.35
a-glucosidase 0.21 0.16 0.19 0.12 0.15




Table 7.11. Specific activities of nine lysosomal
enzymes in one urine cell strain assayed at different
passages.
Enzyme Passage
1 2 3 4 5 7 9
N-acetyl-8-D- 26.1 41.4 27.6 29.9 26.6 42.0 33.0
glucosaminidase
Acid Phosphatase 5.60 4.15 3.78 4.48 3.58 4.77 3.57
3-galactosidase 2.50 2.90 2.13 1.70 1.11 2.03 1.75
8-glucuronidase 0.72 0.68 0.55 0.62 0.38 0.63 0.59
8-glucosidase 0.033 0.067 0.035 0.051 0.046 0.086 0.035
a-galactosldase 0.24 0.39 0.19 0.25 0.23 0.30 0.27
a-arabinosidase 0.50 0.44 0.27 0.26 0.17 0.23 0.26
a-glucosidase 0.23 0.41 0.23 0.21 0.12 0.17 0.25
o-mannosidase 0.59 0.64 0.39 0.45 0.49 0.61 0.53
$
nmole methylumbelliferone/min./mg. protein.
The variations in enzyme activity with increasing
passage number were studied in one urine cell strain. The
results are shown in table 7.11. For most of the enzymes
the highest values are 2 or 3 times the lower ones.
There do not appear to be any patterns in the changing
activities of these enzymes related to passage of culture.
A urine cell strain was established from only one
child with an inborn error of lysosomal enzyme metabolism.
This was a two-year-old child (128) with Tay-Sachs
disease. Enzyme studies (Dr. R.W. Tateson) indicated
that the inborn error of metabolism was indeed reflected
in the urine cell strain. The results of these studies
are shown in table 7.12. The isoenzymes were separated
by DEAE cellulose absorption and in this system Tay-Sachs
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Table 7.12, N-acetyl-B-D-glucosaminidase findings




Normal urine 17.6 13.4 1.3
Tay-Sachs urine 3.5 25.6 0.14




disease is defined as having an N-acetyl-B-D-
glucosaminidase A/B ratio of less than 0.5 whereas a
value between 1 and 2 is considered normal.
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DISCUSSION
The hypothesis that amniotic fluid cells which
proliferate in culture are in part derived from the
fetal urinary tract will be explored.
The rate of urine production by fetuses of
gestational age from 30 to 40 weeks has been directly
measured by an ultrasonic technique (Campbell et al.,
1973; Wladimiroff and Campbell, 1974). At 30 weeks
this was found to have a mean value of 9.6 ml./hour.
Since the fetal kidney functions from the 20th week, and
possibly from as early as the ninth (Emery, 1970) there
is no reason to doubt that fetal urine is being excreted
into the amniotic fluid from the end of the first
trimester until term. Indeed Abramovich (1968) has
estimated that at 11 weeks gestation the fetus produces
1.2 ml./day of urine. The finding of oligohydramnios
in most cases of renal or genito-urinary malformations
which prevent fetal micturition (Bain and Scott, 1960)
suggests that the fetal kidneys may be a major source of
amniotic fluid, especially in the second half of
pregnancy.
It is known that urine from neonates is rich in
cells for the first few days of life (Aas, 1961;
Baccichetti et al., 1971). The cellular content of
amniotic fluid shows a marked increase at about 13 to 17
weeks of gestation (Nelson and Emery, 1970). Hence
shortly after the time at which the fetal kidney is
almost certain to be functioning there is a marked rise
in the cellular content of the amniotic fluid. The
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ability of urine cells to proliferate in tissue culture
has been confirmed (Bolande, personal communication;
Dallaire,1973).
What arguments are there against this hypothesis?
Obviously amniotic fluid in the early weeks of pregnancy,
before the fetal kidney is functioning, cannot come from
this source. The acellular component of the amniotic
fluid is not all of fetal origin as a number of proteins
have been shown to be of maternal origin (see Emery,
1973, for references) although others (e.g. the enzyme
N-acetyl-B-D-glucosaminidase) are certainly fetal. In
early pregnancy the cellular content of amniotic fluid
is low - Wachtel et al. (1969) even claimed that amniotic
fluid prior to 16 weeks gestation was virtually acellular.
In a study of the cytology of amniotic fluid Casadei et
al. (1973) reported the presence of cells from fetal
skin, oral mucosa and amniotic epithelium. They did
not identify cells which they could attribute to the
fetal urinary tract but all the amniotic fluids studied
were of less than 20 weeks gestation. On the other
hand Huisjes (1968) considered that the 'parabasal'
cells of amniotic fluid were from the fetal bladder.
Hence circumstantial evidence suggests that fetal
urine is one possible source of the cells in amniotic
fluid. What of the experimental evidence? The only
recorded experimental approach to this problem was by
Jacobson and Barter (1967). They attempted to culture
urine, yolk sac fluid, chorionic fluid and tracheal
aspirates from human fetuses. Only the tracheal
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aspirates produced cell growth. This does not however
provide evidence as to the nature of the cells in the
aspirate since the fetus carries out respiratory
movements which cause amniotic fluid to travel in and
out of the lungs (Dawes, 1973). Hence tracheal
aspirate is mainly amniotic fluid, although as term
approaches the concentration of total phospholipids,
lecithin and chloride in pharyngeal fluid is
approximately ten times that in the amniotic fluid (Biggs
et al., 1974).
The ability of cells from urine to grow in culture
implicates them as a source of the cells cultivated from
amniotic fluid. Although it was not possible in the
present study to obtain much fetal material, one bladder
aspirate from an 18 week fetus grew well in culture. It
should however be noted that when urine is collected by
aspiration the needle has to pass through tissue and
cellular contamination from this source is always a
possibility, even if a remote one. The fact that urine
collected by suprapubic aspiration can contain large
numbers of cells refutes the claim by Biasini et al.
(1969) that the cells in the urine of neonates come
mainly from the terminal urethra. That urine cells are
not the only ones in amniotic fluid which can proliferate
in culture is demonstrated by the successful culture of
two amniotic fluids of less than 8 weeks gestation
(Jacobson and Barter, 1967), presumably prior to fetal
kidney function and micturition.
One problem associated with urine cell culture which
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requires explanation is that of the very poor success
rates in culture compared with amniotic fluid. Much of
this can probably be attributed to the nature of the
fluid in which these cells occur. Amniotic fluid is
maintained at a constant pH (Cassady and Barnett, 1969)
and the osmolarity is fairly constant although it does
fall towards term (Cassady and Barnett, 1968; Lind et
al., 1969). In other words, cells in amniotic fluid
are in an isotonic medium which shows little variation
in pH. In addition toxic wastes such as uric acid and
creatinine are maintained at low levels until near term
(Jakabovits et al., 1972; Harrison, 1972). On the
other hand cells in urine are in a fluid which varies
greatly in pH and osmolarity and whose concentration of
waste products is higher than in amniotic fluid - such
conditions can do little to maintain cell viability.
Hence the differences in success in culturing cells from
two such fluids is hardly surprising. Indeed the
diminished success rate in culturing cells from amniotic
fluids collected at term (see chapter 2) may well be due
to this increase in waste product concentration in the
amniotic fluid at that time.
When the cells from urine had been successfully
cultured, there were no discernable differences between
these and amniotic fluid cells in either behaviour in
culture or morphology. This morphological similarity,
especially the presence of epithelioid type II cells (see
chapter 4) indicates that these cells do not necessarily
arise from the chorionic villi as suggested by Uhlendorf
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(1970).
The findings from the enzyme studies are of
particular interest. Comparison of these with amniotic
fluid cell strains and connective tissue derived
fibroblast-like cell strains indicates that the urine
cell strains are similar in their lysosomal enzyme
patterns to amniotic fluid cell strains. In the case
of 13-galactos idase and cf-mannosidase urine and amniotic
fluid cell strains have lower activities than do
fibroblasts and the same is probably the case for
a-glucosidase and N-acetyl-B-D-glucosaminidase.
Kaback and Leonard (1970) compared the levels of
three lysosomal enzymes in amniotic fluid cell strains
with cultured maternal and fetal fibroblast-like cells.
Their findings are not strictly comparable with those of
the present study. However they did find that
8-galactosidase and N-acetyl-B-D-glucosaminidase levels
in cultured amniotic fluid cells were higher than those
in fetal fibroblast-like cells. This was also the case
for a comparison with maternal fibroblast-like cells for
B-galactosidase but not for N-acetyl-B-D-glucosaminidase.
In the case of arylsulphatase A, not included in the
present study, the levels in amniotic fluid cell strains
were found to be intermediate between those in maternal
and fetal fibroblast-like cells. Leroy et al. (1973)
published data similar, in part, to that of Kaback and
Leonard (1970). They found no difference in the
activity of the 3 enzymes studied by Kaback and Leonard
(1970) when comparing amniotic fluid cell strains and
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fibroblast-like cells (presumably not of fetal origin).
O'Brien et al. (1972) found that N-acetyl-B-D-
glucosaminidase A activity was higher in cultured amniotic
fluid cells than in cultured skin fibroblast-like cells.
Possible reasons for these different findings from
different laboratories are the lack of standardised
procedures for cell homogenisation (see chapter 6) and
enzyme assay. Kaback and Leonard (1970) used
p-nitrophenol conjugates as substrates rather than the
methylumbelliferone conjugates used in the present study
and by O'Brien et al. (1972).
The findings of marked variations in lysosomal
enzyme levels in urine cell strains with time factors
associated with tissue culture are very similar to those
found in amniotic fluid cell strains (see chapter 6).
This in itself does not indicate that the lysosomal
enzyme biochemistry of urine cell strains is more like
that of amniotic fluid cell strains than that of
fibroblast-like cell strains. Such studies were not
carried out using fibroblast-like cell strains but
lysosomal enzyme levels have been reported to show great
variation in these cell strains (Hultberg et al., 1973).
The enzyme which might have been of greatest use in
demonstrating a similarity between urine and amniotic
fluid cell strains and a difference between these and
fibroblast-like cell strains was histidase. This enzyme
was reported (Melancon et al., 1971) to be present in
epitheloid but not fibroblast-like cells derived from
amniotic fluid. Attempts to assay this enzyme were
199
unfortunately unsuccessful (Dr. J. Butterworth). It was,
however, later reported that histidase was not present In
either skin fibroblast-like cells or cultured amniotic
fluid cells which were epithelial in nature (Ota, 1973).
This report documented difficulties in the enzyme assay
akin to those found in the present study, and its results
suggested that errors could be made such that non-specific
changes in the enzyme reaction mixture could be interpreted
as enzyme activity. The question of whether histidase
activity is present in cultured amniotic fluid cells of
one type and not in another remains open. However, in
view of the report of Ota (1973) and work in the present
study it is probable that this enzyme can not be assayed
in cultured cells using currently available techniques.
Carter (1970) has written "Mistakes can be made if
it is assumed that the enzyme levels in amniotic cells
are necessarily the same as in fibroblast cultures".
This study has shown that such an assumption would be
invalid for some lysosomal enzymes. Kaback and Leonard
(1970) have demonstrated that amniotic fluid cells have
lower activities of arylsulphatase A than do skin
fibroblast-like cells from adults although their
findings are not supported by Leroy et al. (1973). Other
differences between the activities of enzymes in amniotic
fluid cell strains and in fibroblast-like cell strains
have been reported (see Brock, 1973, for references).
In enzyme assays for the antenatal diagnosis of
inborn errors of metabolism, two types of control
material are required. The first is a normal control,
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that is cells which do not have the inborn error of
metabolism in question and hence have normal levels of the
enzyme being assayed. The best such control would be
amniotic fluid cells at the same stage of culture as those
in which the enzyme levels are to be determined. If such
material is not available then urine cells at the same
stage of culture may well be a more suitable alternative
to skin fibroblast-like cells which are another
possibility. The second type of control material
required is cultured cells which are known to have the
inborn error of metabolism in question. Ideally these
would be cultured amniotic fluid cells from a previously
affected case in the same family. This sort of material
will rarely be available hence skin fibroblast-like cells
from a previously affected member of the family are
regarded as the next best control material with skin
fibroblast-like cells from a similarly affected
individual outside the family in question being a possible
third. It is suggested that in view of the similarity
between cultured amniotic fluid and urine cells that the
latter would be preferable as control material to skin
fibroblast-like cells. This may well be of particular
importance where the enzyme levels in a disease state are
not totally absent but present in variable amounts up to
about 10% of normal. Hence it would be desirable to
produce urine cell strains from infants known to have
inborn errors of metabolism and to store these in liquid




The culture of cells from the urine of newborn
infants and fetuses is described. Urine cell culture
was not as successful as amniotic fluid cell culture and
factors such as age and gestation of the urine donor
together with cellular content, osmolarity and acidity
of the urine, which may affect success have been
examined. The behaviour and morphology of cultured
urine cells has been studied and compared with that of
cultured amniotic fluid cells; no differences between
these two types of cells in tissue culture could be
demonstrated. The levels of activity of a group of
lysosomal enzymes in urine cell strains were compared
with those in amniotic fluid and connective tissue derived
fibroblast-like cell strains. There were definite
similarities between urine and amniotic fluid cell
strains and these were different from fibroblast-like
cell strains for B-galactosidase and o-mannosidase.
This was probably also the case for a-glucosidase and
N-acetyl-B-D-glucosaminidase. The inborn error of
metabolism in Tay Sachs disease was expressed in cultured
urine cells. The use of urine cell strains, in
preference to skin fibroblast-like cell strains, as
control material for the antenatal diagnosis of inborn
errors of metabolism is suggested. The hypothesis that
cells which can be cultivated from amniotic fluid are in




When this project was commenced the use of cultured
amniotic fluid cells for the antenatal diagnosis of
chromosome abnormalities was slowly coming into general
use. In spite of this much remained to be learnt
about the cytogenetics of amniotic fluid cultures;
tetraploidy and aneuploidy, with its implications in
the diagnosis of mosaicism, were ill understood. The
antenatal diagnosis of inborn errors of metabolism was
in its infancy, both from the biochemical and tissue
culture aspects. There was virtually no data available
on the culture of amniotic fluid cells for the antenatal
diagnosis of these biochemical defects or on the
behaviour of amniotic fluid cell strains in long-term
serial cultivation. Apart from some studies on cell
viability, from which no conclusions could be drawn,
there had been little systematic study of the behaviour
of primary cultures of amniotic fluid collected
throughout pregnancy. The origin of the cells in
amniotic fluid which proliferate in culture was the
subject of speculation based only on cytological evidence.
At the same time antenatal diagnosis of gross CNS
lesions was not possible since the basic work by Brock
and his colleagues had not been published.
What is the present situation? It is now possible
to perform the antenatal diagnosis of gross CNS defects
by estimation of amniotic fluid a-fetoprotein levels.
The antenatal diagnosis of chromosome abnormalities is
now fairly widespread with many laboratories offering
this service. The biochemistry of many inborn errors
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of metabolism is much better understood, hence the
chances of making errors in these diagnoses should be
diminished. Nevertheless, in most cases this aspect of
antenatal diagnosis must still be regarded as experimental.
Sophisticated microassay techniques have been developed
which should enable the antenatal diagnosis of some
inborn errors of metabolism within the same time as that
required for chromosome abnormalities.
The present study has made significant contributions
to the understanding of the behaviour of amniotic fluid
cells in tissue culture. The success, judged by any
criterion, of primary cultures of amniotic fluid was
unrelated to gestational age or the reason for
collection of the fluid except that fluids collected at
induction of labour at term were difficult to cultivate.
Similarly the time required to culture sufficient cells
for a biochemical assay, and the behaviour of the cell
strains in serial culture were not related to the origin
of the amniotic fluid. Amniotic fluid cells are
relatively easy to grow in tissue culture and variations
in culture methods had little effect with the exception
that the method of Gray et al. (1971) was found to be
less successful than more conventional methods.
The morphology of the cell types which proliferate
in tissue culture was studied and a classification of
the cell types proposed. One cell type, the macrophage,
was found to be present in greatly increased numbers in
anencephalic amniotic fluids. Studies of the macrophages
in such amniotic fluids and those from Rhesus isoimmunised
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and normal pregnancies failed to reveal their origin.
In anencephalic and spina bifida amniotic fluids the
increase in the number of macrophages is probably
associated with the open lesion. Amniotic fluids from
Rhesus isoimmunised pregnancies have a slightly
increased number of macrophages and this may well be
associated with the increase in placental Hofbauer cells
described in this condition. Although the findings of
macrophages must await further studies for their full
significance to be realised, they appear at present to
offer an additional method for the antenatal diagnosis
of gross CNS malformations.
Cytogenetic studies of primary amniotic fluid
cultures have confirmed that technology in this field is
reliable and suitable for screening pregnancies at risk.
Apart from cases with a family history of chromosome
abnormality the major group which should benefit
comprises those women who become pregnant towards the
end of their reproductive life. Although the major
chromosome abnormality to be detected in such cases will
be trisomy 21, other abnormalities will undoubtedly be
detected such as the case of trisomy 18 diagnosed ante-
natally in this study. Some problems in the cytogenetics
of amniotic fluid are discussed, including the inter¬
related problems of aneuploidy, in vitro chromosome change
and the diagnosis of mosaicism. In all cases where fetal
mosaicism has been diagnosed from amniotic fluid cultures,
the diagnosis has not stood the test of extrauterine
verification. Possible explanations of these cases of
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misdiagnosis of mosaicism have included some form of in
vitro chromosome change. In this study JLn vitro
chromosome changes were demonstrated in cell strains but
not in primary cultures. Unfortunately these changes
were associated with mycoplasma contamination and the
question of whether some amniotic fluid cell cultures
can undergo spontaneous in vitro chromosome changes
remains unresolved. Other cytogenetic studies, on cell
strains not contaminated with mycoplasma, indicated that
chromosomal stability, as seen in other human diploid
cell strains, was a feature of amniotic fluid cell
strains.
The finding that cells from the urine of neonates
will proliferate in tissue culture suggested a possible
site of origin for the amniotic fluid cells which
proliferate in tissue culture. Studies of urine cell
strains indicated that they were similar to amniotic
fluid cell strains in all respects studied. Lysosomal
enzyme patterns of the urine cell strains were more
closely resembled by those of amniotic fluid cell strains
than those of connective tissue derived fibroblast-like
cell strains. The hypothesis that the cells which
proliferate in amniotic fluid cultures are derived in
part from the fetal urinary tract has been explored and
evidence has been put forward to suggest that this
hypothesis is correct.
The behaviour of a number of lysosomal enzymes in
cultured amniotic fluid cell strains has been studied.
The range of activity of the ensymes in normal amniotic
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fluid cell strains was established for this laboratory.
It was found that the enzyme activity in these cell
strains showed marked fluctuations when measured at
different stages of tissue culture. In spite of an
extensive study of possible factors which could have
been related to these fluctuations their source remained
undetected. Similar fluctuations in the activity of
lysosomal enzymes in fibroblast-like cell strains have
been reported. The special significance of these
fluctuations in the antenatal diagnosis of inborn errors
of lysosomal enzyme metabolism has been discussed and it
was concluded that the diagnosis of such a condition
should never be based on the results obtained from assay
of the cells from a single culture vessel.
Four pregnancies in which the fetus was at risk for
an inborn error of metabolism were monitored. Two had
favourable outcomes in that normal infants were predicted
and delivered. Two pregnancies, at risk for maple-syrup-
urine disease, from one woman were unsuccessfully monitored.
The first was terminated after failure of the cell cultures
and the second resulted in an affected infant after a
normal infant had been predicted. This case demonstrated
the folly of attempting antenatal diagnosis when the
initial diagnosis on which the procedure is based is not
at the enzyme level. The general problem of culturing
sufficient cells in a reasonable period of time when
monitoring such pregnancies is discussed and the results
from the present study suggest that the chances of
having sufficient cells within 6 weeks of amniotcentesis
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are too low for this procedure to be offered in a
clinical situation. This situation will change when
microassay methods for the enzymes involved in inborn
errors of metabolism are sufficiently developed to
enable enzyme assays on primary cultures. Progress in
this direction has been made by Galjaard et al. (1972,
1973) but their methods are highly specialised and not
widely applicable at present.
In summary, the present study has resulted in a
number of findings and conclusions.
1. Amniotic fluid cells are not difficult to
cultivate ^n vitro.
2. The behaviour of amniotic fluid cells in primary
and long-term culture has been documented.
3. Cytogenetic studies of amniotic fluid cultures
provide a rapid, reliable and, within the constraints
of any method involving cultured cells, straightforward
means of establishing the fetal karyotype.
4. Amniotic fluid from pregnancies in which the
fetus has a gross CNS malformation has an increased
number of macrophages and this finding may form the
basis of a method for the antenatal diagnosis of such
fetuses.
5. The behaviour of a number of lysosomal enzymes
in amniotic fluid has been documented, marked
fluctuations in their activities have been described
and possible reasons for them sought.
6. Cells from the urine of neonates can proliferate
in tissue culture. This finding suggests a possible
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source for some of the amniotic fluid cells which can be
cultured.
It has been stated that "Genetics has the
reputation among some practising clinicians of being
concerned with rare, esoteric and untreatable disease
" (Finn, 1973). If the present study has helped,
even to a very small extent, to dispel such notions
then it has been worthwhile.
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Appendix I
Materials and aethods used for
tissue culture
229
This appendix contains details of the types of
tissue culture vessels used and the methods of cleaning
them. Details of the tissue culture medium and other
solutions used for tissue culture are also included.
Methods used in tissue culture in this study, but not
recorded elsewhere are outlined.
GLASSWARE
The following glass items were used during this
study:
1. Baby feeding bottles, 125 ml capacity,
2
approximately 20 cm growth surface area (Fig. Al.l).
2. Baby feeding bottles, 225 ml capacity,
2
approximately 40 cm growth surface area (Fig. Al.l).
3. Roux flasks, 1 litre capacity, approximately
2
240 cm growth surface area.
4. Centrifuge tubes, 15 ml capacity, conical base.
5. Coverslips 6 x 22 mm, No. 1 (Chance Ltd.).
The culture vessels were all cleaned using the
following procedure:
(a) rinsed in cold water;
(b) placed in hot water to which 1-2% Dri-Decon
(Decon Laboratories Ltd.) had been added;
(c) cleaned on a mechanically rotating bottle
brush;
(d) transferred to "Gallay Labmatic" glassware
washing machine where they were washed in hot water and
rinsed several times with cold water. The last two
rinses were in deionised water.
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Fig. Al.l. Main culture vessels used throughout this
study. Plastic (Nunclon) Petri dish, 50 mm. (left);
baby feeding bottle, 125 ml. capacity (middle); baby
feeding bottle, 250 ml. capacity (right).
(e) dried, capped and then sterilised in hot air
at 160°C for two hours.
Centrifuge tubes were similarly washed and
siliconised monthly with 2% dimethyldichlorosilane in
CC14 ("Repelcote", Hopkins and Williams Ltd.).
Coverslips were boiled in a 5% solution of Dri-Decon
for 10 min., rinsed well in tap water then boiled in two
changes of deionised water. They were stored in
absolute ethanol and when required were removed from the
alcohol, polished between two linen covered blocks,
placed in a glass Petri dish and sterilised in hot air.
DISPOSABLE PLASTICS
Two types of disposable plastic culture vessels were
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used:
1. Nunclon-delta Petri dishes, 50 mm diameter,
13 mm deep with three air vents (Fig. Al.l).
2
2. Nunclon-delta T-flasks, 30 ml capacity 25 cm
growth surface area.
TISSUE CULTURE MEDIA AND SOLUTIONS
The tissue culture medium used for almost all this
work was Ham's F10 (Ham, 1963) which was prepared from
the following components:
(a) Ham's F10 concentrate (lOx) (Flow Laboratories
Ltd.).
(b) Deionised water.
(c) L-glutamine, 200 mM solution prepared from BDH
Chemicals Ltd. reagent.
(d) Fetal (bovine) calf serum (Biocult Laboratories
Ltd.).
(e) Kanamycin sulphate B.P.C. ("Kanasyn", Winthrop
Laboratories) or penicillin-streptomycin ("Crystamycin",
Glaxo Laboratories).
(f) 4.4% NaHCOg solution prepared from "Analar"
analytical reagent.
The medium was prepared using non-sterile deionised
water. As soon as the medium had been prepared, ultra¬
filtration was carried out by passing it through a 142 mm.
diameter Millipore filter with a pore size of 0.22 fi.
The filtered medium was sterility tested by inoculation
into Robertson's cooked meat medium which was plated on
to blood agar after 16 hours incubation.
Other solutions used for tissue culture were:
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(i) Trypsin solution, 0.25% in PBS prepared from
Trypsin 1:250 (Dlfco Laboratories) and sterilised by the
same filtration procedure as used for the tissue culture
medium.
(ii) Phosphate buffered saline (PBS) prepared from
"Oxoid" tablets and sterilised by autoclaving at 15 p.s.i.
for 20 minutes. When the full "Dulbecco A" PBS was
required a Ca/Mg solution was added.
INCUBATION OF PRIMARY AMNIOTIC FLUID CULTURE
Primary cultures were set up in open Petri dishes,
hence incubation in an atmosphere of 5% C02 in air was
required. This was achieved by carrying out incubation
in an anaerobic jar. A rack was constructed, from
Fig. A1.2. Incubation system used for Petri dishes
during this study. Anaerobic jar and rack constructed
from acrylic sheeting.
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acrylic sheeting, to fit inside the jar (Fig. A1.2).
This rack could hold 36 of the Petri dishes used. The
Petri dishes were placed on the rack in the jar, the lid
secured and the gas cocks opened. The jar was then
flushed for about 5 minutes with 5% COg in air, the cocks
closed and the jar placed in an incubator at 37°C. The
only modification of the jar required was the removal of
the catalyst and sealing of the side arm. The anaerobic
jars used were manufactured by Baird and Tatlock to a
modified Mcintosh and Fildes design.
FLYING COVERSLIPS
Flying coverslips were prepared regularly from most
cell strains for morphological studies. The technique
of preparation, staining and fixation is after Paul (1965).
3"
Coverslips (6 x 22 mm) were placed in 6 x -g test tubes.
To each tube was added 1 to 2 ml. of cell suspension. The
tubes were incubated at 5° from horizontal until the cells
on the coverslip became confluent. The fixation and
staining procedure was as follows:
(1) The medium was removed from the tube.
(2) The coverslip was washed twice in PBS (Ca and
Mg enriched).
(3) The coverslip was fixed for 5 min. in two
changes of absolute methanol.
(4) The coverslip was air-dried and transferred to
a staining jar.
(5) The coverslip was stained for 5 min. in Gienisa
(Gurr's "R66") diluted 1 in 10 with buffer pH 7 (Gurr's
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buffer tablets).
(6) The coverslip was rinsed twice in buffer
pH 7.0 and then twice in deionised water, air dried and
mounted on a slide.
COUNTING CELLS IN AMNIOTIC FLUID
Cells were counted in an "improved Neubauer" cell
counting chamber. The total inscribed area of this
chamber contains a volume of 0.9 jil. Hence the cell
count of the amniotic fluid (cells/ml.) is the number of
cells in the inscribed area x 10/9 x 1000. The amniotic
fluid was not diluted but introduced directly into the
chamber. Since the presence of only 1 cell in the
inscribed area would give a cell count of approximately
1100 cells/ml. this must be regarded as the lower limit
of sensitivity of this method. Amniotic fluids with one
or no cells within the inscribed area were given an
arbitrary cell count of 1000 cells/ml. Urine cell
counts were also performed using this method and those
with very low cell counts were also given an arbitrary
count of 1000 cells/ml.
Appendix II
Data on amniotic fluids
and urines studied
236
This appendix contains data on the amniotic fluids
and urines included in this study. The data is set out
in four tables:
Table I contains data pertaining to all the amniotic
fluids used in this study over the two year period
1.12.71 to 30.11.73.
Table II contains data pertaining to the urines
used in the study where proliferating cells were seen
in the primary cultures. The urines for which no growth
was seen in primary culture have been omitted.
Table III contains data on all the pregnancies
monitored diagnostically by antenatal chromosome studies
over the period 1.12.71 to 31.1.74.
Table IV contains data on all amniotic fluids on
which macrophage counts were carried out.
It should be noted that the sample numbers are not
consecutive since other material, not included in this
study, was incorporated within the laboratory numbering
system.
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Table I. Data on all amniotic fluids studied over the
two year period 1 .12. 71 to 30. 11.73,
1 2 3 4 5 6 7 8 9 10 11 12
36 ii 12 23 + * 29 8 34 43
37 ii 12 16 + 22 6 30 37
38 ii 15 49 + * 49 4 63 30 3
40 ii 17 25 + 38 48
42 iv 15 * 0 b
43 ii 15 0 N 0 b
44 i 32 33 + * 33 47 i5
45 i 25 26 + 25 33 16
46 i 35 26 + 34 48 15
47 ii 18 20 + 33 5 43 34 1
48 ii 16 18 + * 26 4 39 19
49 ii 17 22 + * 23 34 16
50 i 23 21 + * 23 5 30 31
55 ii 18 13 + 18 14 29 135
57 i 24 12 + * 29 9 53 83
59 ii 23 51 16 + 35 11 50 76 1
62 ii 22 145 + * 28 12 45 107 k42; 1
63 i 32 15 + * 30 11 47 80 1
64 i 31 N 30 0 hi
69 ii 16 + 29 11 40 77 1
70 ii 22 65 + 26 25 36 f; 1
71 i 22 + * 28 11 49 106 e; 1
72 i 31 + 26 25 36 146 1
73 i 18 + 28 18 36 144 1
74 i 23 + 26 18 42 125 1
75 i 34 + 26 17 39 127 1
238
Table I (cont'd.)
123456789 10 11 12
76 i 30 *
81 i 26 + *
82 i 26 +
83 i 34 +
84 i 34 + ♦
85 i 27 +
86 i 22 26 +
89 i 27 12 + *
90 i 28 14 +
92 i 24 12 +
94 ii 18 3.3 15 + *
108 vi 41 0 N
109 vi 39 19 + *
110 vi 38 + *
111 i 34 26 + *
115 iii 15 10 19 +
118 ii 12 4.5 14 +
119 i 34 14 +
120 i 31 19 +
121 i 34 14 + *
122 ii 16 15 + ♦
123 i 33 21 +
124 ii 11 19 +
127 i 35 19 +
129 ii 16 13.3 14 + *
136 i 19 7 + *
0 hi
4 61 42 k71
22 36 129 k74; 1
22 39 137 1
14 34 90 k76 j 1
23 34 111 1
9 41 108 k73; 1
18 41 110 1
10 25 71 k74 ; 1
15 34 110 k73; 1
20 35 114 1
0 a
11 37 84 1
43 i4
39 gl9; k89
35 f; 128; 1
16 32 89 1
29 32 115 1
11 32 75 1
14 27 82 1
34 gl7
3 74 35 k86; 1
15 46 69 1
17 42 69 k86; 1
0 b



























1 2 3 4 5 6 7 8 9 10 11 12
152 i 24 110 + * 34 13 44 109 1
168 vi 40 75 N 28 2 35 26 1
169 vi 39 1000 0 0 a
171 i 30 13 + * 20 7 31 64 kl36
176 i 20 17 + * 20 35 28 142 1
177 i 36 + * 34 8 60 103
179 i 23 ♦ 23 8 46 115 1
180 i 33 26 + ♦ 0 b; kl36
181 1 30 + * 27 43 i9; kl52
186 ii 22 16 + 20 34 15
189 i 23 95 21 + * 28 9 41 84 kl76
190 i 25 200 + 24 55 36 191 1
191 i 20 45 12 + 43 2 69 25
192 i 32 65 14 + ♦ 43 9 64 78 kl52
195 i 26 158 14 + * 41 8 62 72 kl79; 1
200 iii 35 33 16 + * 30 10 57 115 1
202 i 22 46 6 64 67 1
203 i 26 13 + * 31 11 46 98 kl76
205 iv 15 5 + 26 38 i4
206 i 26 + 55 8 69 71 k202
207 i 30 + 0 d; e
209 i 31 17 + 37 46 h9; kl90
210 i 29 * 36 43 h9; kl76;
213 i 27 12 + 30 46 hlO; kl91
214 i 31 N 0 c
216 Hi 16 14.5 19 + 0 d
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Table I (cont'd.)
123456789 10 11 12
217 lii 16 5
220 iii 14 1 38 +
\
224 i 33 *
225 i 30
226 iii 16 17 14 +
227 iii 19 21 +
231 i 30 +
246 iii 15 1 10 +
247 iii 15 10 15 + *
249 iii 15 4 15 + *
260 i 25 130 + *
261 i 19 85 + *
263 i 24 60 + *
264 ii 16 45 12 + *
266 iii 15 3 14 + ♦
267 vi 40
268 V 19 14 +
269 i 35 N
271 i 24 45 *
273 V 20 20 2 + *
274 iii 14 13 9 +
276 V 16 4 14 + *
277 iii 14 1 10 + *
278 V 19 15 12 +
279 i 30 + *




16 46 32 kl91; 1
0 d
0 d; e; k217
28 h9; 1
23 32 140 1








































123456789 10 11 12
281 V 12 24 + 36 49 gll
283 lii 17 11 + * 25 36 gl4
234 iv 14 1 0 b
285 iii 16 17 + * 21 27 g9
286 iv 14 2 + 30 0 il; k284
287 i 31 132 + * 28 32 gl7; j;k271
288 i 32 * 28 32 g8; j;k261
290 iii 21 7 + * 27 31 gl2
291 iv 23 + 21 26 i4
292 iii 15 16 + * 22 29 ilO;l
293 iii 15 6 18 + * 29 il;g4
294 V 21 + 17 24 i6 ;l
295 vi 22 18 1 + 13 20 g8; k294
298 vi 36 324 1° contamination of all cultures
299 vi 36 85 1° contamination of all cultures
300 iii 18 3 14 + 27 32 14
302 iii 20 81 15 + * 23 27 i6
304 V 34 300 13 + 16 25 i4; j
305 V 34 72 13 + * 19 23 15 ;j;k304
306 vi 29 150 18 25 16
307 V 36 160 21 32 i4;j;k304
308 V 36 50 * 19 28 i6;j;k304
309 i 23 12 + * 20 29 i4
321 iii 15 12 + 19 28 15
322 iii 19 16 + ♦ 28 41 17
323 iii 17 16 + 28 36 15
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Table I (cont*d.)
123456789 10 11 12
324 v 15 11 + 22 30 i8
325 lii 16 14 15 + * 30 42 16
Footnotes to Table I
71 - karyotype 47,XY,t(1;12)(p21;q21)
207 - karyotype 47,XXX
227 - karyotype 47,XX,+18
273 - fetus anencephalus
294 - fetus anencephalus
295 - fetus anencephalus
298 - fetus anencephalus
304 - fetus anencephalus
306 - fetus anencephalus
307 - fetus anencephalus
Key to Table I
Column numbers:
1. Laboratory number allotted to amniotic fluid.
2. Means of or reason for collection of amniotic fluid:
(i) Rhesus iso-immunised pregnancy,
(ii) hysterotomy specimen.
(iii) diagnostic amniocentesis for fetal chromosome
studies.
(iv) diagnostic amniocentesis for possible inborn
error of metabolism.
(v) diagnostic amniocentesis for a-fetoprotein
estimation.
243
(vi) at rupture of membranes for the induction
of labour.
3. Gestation of pregnancy from which amniotic fluid
was collected (weeks).
4. Cell count of amniotic fluid (lOOO cells/ml. of
amniotic fluid).
5. Time required for a cytogenetic result when this
was obtained in the minimum time (days).
6. Cytogenetic studies carried out but not necessarily
on the primary culture or in the minimum time, +;
cytogenetic failure, 0; blank space indicates
cytogenetic studies not attempted.
7. Chromosomal sex of amniotic fluid: *, male;
N, not known; blank space, female.
8. Time from setting up primary culture until sub-
culturing it (days).
9. Number of passages for which cell strain derived
from the amniotic fluid could be subcultured, using
a 1:2 subcultivation ratio, before the cell strain
died.
10. Time required to achieve a biochemical result
(days); biochemical failure, 0.
11. Time as a cell strain (days).
12. Other comments:
(a) Primary culture never showed any signs of
cellular proliferation.
(b) Primary culture degenerated and could not be
subcultured.
(c) Primary culture lost to microbial contamination
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before any assessment of growth or cytogenetic
studies were possible.
(d) Primary culture lost to microbial contamination
after cytogenetic studies had been completed.
(e) Karyotype other than normal, as stated in
footnote.
(f) Jta vitro chromosome changes in cell strain.
(g) Mycoplasma contamination, culture discarded at
passage.
(h) Microbial contamination, culture discarded at
passage.
(i) Cell strain not cultured to senescence, serial
cultivation terminated at passage.
(j) Primary culture not set up until the day after
the amniotic fluid was collected.
(k) Sample from the same pregnancy as (previous
laboratory number).
(1) Cell strain tested for mycoplasma contamination
and reported negative.
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Table II. Data pertaining to all urines in this study
which showed cellular proliferation in tissue
culture.
1 2 3 4 5 6 7 8 9 10 11 12 13
52 i Id 35 17 + * 18 12 30 111 1
53 i Id 32 12 + 15 13 23 f;gi8
54 i 2d 39 17 + * 19 27 15; 1
66 1 Id 37 + 43 55 f; g35
63 i Id 40 + * 42 8 56 62 1
77 i 2d 37 4.5 + * 35 3 46 70
78 i Id 34 130 * 31 hi
80 i Id 38 1 31 hi
93 ii Id 32 15 + * 26 14 35 94 e; 1
100 i Id 33 130 14 + 18 19 30 98 1
104 i 23d 1 + * 33 18 42 90 1
116 iii 6d 38 + 53 14 63 60 e ;f; l
125 ii 4d 37 + * 33 42 gl7
126 iii 8d b; 1
128 iii 2y + * 21 12 33 65
130 ii 35d + 32 41 e;gl5;
kll6
131 iii Id 35 + * 38 4 50 31 1
134 ii S.B 36 + * 50 64 14
135 ii Id 30 14 + 20 27 g8
137 iii 13d 16 + 30 34 g27; 1
144 iii 8d 1 ♦ b, 1
145 ii 2d 36 41 b
147 ii 7d 28 44 + 25 11 42 111 1
148 ii 5d 39 b; 1
150 ii Id 32 + * 31 3 52 34 1
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Table II (cont'd.)
1 2 3 4 5 6 7 8 9 10 11 12 13
154 ii Id 38 * b
163 ii Id 32 + 28 37 hl4 1
164 ii S.B 38 6.5 + 26 37 hl2 1
165 ii 17d * 35 52 hll 1
174 ii Id 34 43 56 i8
184 ii Id 39 + 35 14 60 104 1
212 ii 4d 37 * 40 48 hl5;
222 ii Id 34 ♦ 21 31 h9; 1
265 i 6d 37 2 + * 34 7 43 61
272 ii Id 33 + * 19 25 13
275 ii Id 34 23 34 16
282 ii S.B 18 37 48 g8
296 ii Id 36 ♦ 24 35 i6
297 ii Id 28 23 33 15
303 ii 2d 40 16 + * 27 34 19
310 ii Id 32 17 + * 27 38 14
312 i Id 36 14 + 20 37 18
317 i Id 40 11 + 16 30 18
318 i 7d 34 16 24 16
319 i Id 40 10 + 16 32 15
320 i 7d 34 32 40 14
Footnotes to Table II
93 - karyotype 47,XXY
116 - karyotype 47,XX,+18/48,XX,+18,+fra
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Key to Table II
Column numbers:
1. Laboratory number allotted to urine.
2. Means of collection of urine sample:
(i) Urine collecting bag.
(ii) Aspiration from bladder at post-mortem,
(iii) By suprapubic aspiration from a living child.
3. Age of child, d - days; y - years; S.B. - still¬
born .
4. Gestational age of child (weeks) if postnatal age
is less than one week.
5. Cell count of urine (1000 cells/ml. of urine).
6. Time required for a cytogenetic result from the
primary culture when this was obtained in the
minimum time (days).
7. Cytogenetic studies carried out but not on the
primary culture or in the minimum time, +;
blank space indicates cytogenetic studies not
attempted.
8. Sex of child from whom urine was collected:
* - male; blank space - female.
9. Time from setting up primary culture until sub-
culturing it (days).
10. Number of passages for which cell strain derived
from the urine sample could be subcultured, using a
1:2 subcultivation ratio, before the cell strain
died.
11. Time required to achieve a biochemical result (days);
blank space - no biochemical result.
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12. Time as a cell strain (days).
13. Other comments:
As for Table I. It should be noted that urines
to which comments (a) or (c) would have applied
were not included in Table II.
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Table III. Data on amniotic fluid from pregnancies on
which diagnostic antenatal cytogenetic
studies were carried out.





115 40 15 (i) 19 b 17 17 2/126 (i)
200 41 35 (vi) 16 a 5 5 0/12 (i)
216 41 16 (i) 19 b 1 7 8 1/16 (i)
217 41 16 (i) culture failed, repeated as No. 227
220 23 14 (ii) 38 b 3 3 0/3 (i)
226 19 16 (iii) 14 b 1 10 11 0/19 (i)
227 41 19 (i) 20 c 1 8 9 2/22 (i)
246 39 15 (i) 10 b 15 15 0/39 (ii)
247 41 15 (iii) 15 a 1 7 8 2/30 (i)
249 45 16 (i) 15 a 2 16 18 0/68 (i)
266 19 15 (ii) 14 a 2 17 19 4/173 (i)
274 41 14 (i) 9 b 1 19 20 3/107 (i)
277 20 14 (ii) 10 a 12 12 1/47 (i)
283 31 17 (ii) 11 a 1 19 18 1/56 (i)
285 43 16 (i) 17 a 15 20 4/51 (i)
290 26 21 (ii) 7 a 2 16 18 1/27 (i)
292 29 15 (iv) 16 a 1 14 15 3/63 (i)
293 25 15 (v) 18 a 9 9 3/17 (ii)
300 41 18 (i) 14 b 1 12 13 2/32
302 45 20 (i) 15 a 2 17 2 21 1/26
321 34 15 (iii) 12 b 2 18 20 24/200
322 40 19 (i) 16 a 14 14 1/40
323 41 17 (i) 16 b 2 11 13 4/28
325 35 16 (i) 15 a 4 16 20 4/2OO
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Table III (cont'd.)





328 40 16 (i) 15 a 17 17 8/100
330 40 14 (i) 8 b 2 10 12 1/41
332 44 19 (i) 13 b 10 10 0/150
340 41 18 (i) 13 b 2 18 20 12/120
341 43 18 (i) 12 a 1 19 20 23/200
342 42 15 (i) 15 a 12 12 3/45
343 41 14 (i) 12 a 10 10 4/30
344 40 16 (i) 10 a 1 14 15 1/29
345 39 14 (11) 13 a 20 20 22/200
Footnotes to Table III
115 - one cell (-G,+C)
227 - karyotype 47,XY,+18, one cell -D
249 - one cell -C, one cell -G
266 - one cell -C, one cell -F
233 - one cell (-G,-C)
290 - one cell -G, one cell -C
302 - one cell -C, one cell -E, one cell +F, one
cell +C
321 - one cell -E, one cell (-F,-G)
323 - one cell -G, one cell -C
325 - one cell -E, one cell -16, one cell -G, one
cell (-D, -C, +ace), one cell Dr.
330 - one cell -C, one cell (-G,-F,+C)
340 - one cell -C, one cell -E
341 - one cell -D
344 - one cell -G
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Key to Table III
Column numbers:
1. Laboratory number.
2. Maternal age (years).
3. Gestation of pregnancy (weeks).
4. Reason for amniocentesis:
(i) Advanced maternal age.
(ii) Previous child with Down's syndrome,
(iii) Family history of Down's syndrome,
(iv) Parental chromosome translocation
heterozygosity.
(v) Mother was carrier of an X-linked disease,
(vl) Other reasons.
5. Time required to achieve chromosome result (days).
6. Karyotype (a) normal male karyotype
(b) normal female karyotype
(c) other (see footnote to Table).
7. Cytogenetic data:
(a) number of cells with 45 chromosomes
(b) number of cells with 46 chromosomes
(c) number of cells with 47 chromosomes
(d) total number of cells examined.
8. Ratio of polyploid cells/total number of cells
examined for ploidy.
9. Outcome of pregnancy:
(i) As predicted.
(ii) As predicted, pregnancy terminated.
Blank - pregnancy continuing.
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Table IV, Data on amniotic fluids on which macrophage
counts were performed.
1 2 3 4 5 6 7 8 9 10
273 iv 21 8 20 238 6226 2 iv
294 iv 17 8 254 1540 iv
295 V 18 20 18 250 1640 1 iv
298 V 36 10 324 6.4 660 iv
299 ii 36 25 85 4 iii
300 iii 18 15 3 10.6 10 14 i
302 iii 20 8 81 6.7 0 15 i
304 vi 33 18 300 26 590 13 iv
305 vi 33 12 71 1 6 13 i
306 V 29 20 150 44 630 iv
307 vi 35 10 160 21 10 iv
308 vi 35 10 50 3.5 10 i
309 i 23 5 0.16 102 12 ii
321 iii 15 18 7.7 6 12 i
322 iii 19 8 17.5 7 16 i
323 iii 17 6 12.2 2 16 i
324 iv 15 10 16.0 13 11 i
325 iii 16 7 14 19.2 12 15 i
326 ii 29 10 410 0.3 17 iii
327 iv 15 5 680 576 iv
328 iii 16 6 16.7 10 15 i
329 ii 21 8 5.0 4 15 i
330 iii 14 12 1 25.6 10 8 i
332 iii 19 2.5 37 31.1 20 13 i
333 iv 18 20 10.0 6 12 i
334 i 23 7 130 0.11 276 ii
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Table IV (cont'd.)
1 2 3 4 5 6 7 8 9 10
335 i 32 7 125 0.02 43 ii
336 iv 16 10 13.4 20 18 i
337 ii 20 17 65 5.1 11 14 iii
339 iv 14 10 7 18.8 41 8 i
340 iii 18 10 76 2.8 10 13 i
341 iii 18 8 5 16.8 8 12 i
342 iii 15 4.5 30 13.4 25 15 i
343 iii 14 8 30 16.3 25 12 i
344 iii 16 8 8 16.3 20 10 i
345 iii 14 6 13 22.6 9 13 i
347 iii 16 12 30 13.8 8 10 i
348 iii 18 10 35 19.2 2 13 i
349 iii 16 8 16 17.3 16 12 i
351 ii 34 10 100 0.8 1 iii
353 i 33 5 0.04 1 ii
354 i 27 2.5 0.36 52 ii
355 i 32 8 330 0.05 28 ii
356 i 28 9 175 0.14 16 ii
357 vi 38 6 57 1 i
358 i 19 8 60 0.07 259 ii
359 i 35 7 10 4.0 0.05 14 ii
360 vi 38 4 57 14 vi
362 iv 18 7 52 6.0 445 16 vii
363 iv 15 10 1 25.4 3 14 i
364 iv 17 10 3 22 .0 19 13 i
365 iv 17 12 13 7.7 1 13 i
366 iv 16 10 15 12.0 14 15 i
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Table IV (cont'd.)
1 2 3 4 5 6 7 8 9 10
367 iii 14 8 3 181 168 V
368 iv 20 10 110 4.8 20 10 i
369 V 16 7.5 11 173 189 V
370 iii 13 5 1 143 82 V
371 iv 21 7 5 16.6 4 i
372 i 31 4 0.32 33 ii
373 iii 22 3.5 30 4.8 232 8 vii
374 iv 16 4 15 13.5 15 10 i
375 iv 18 10 35 13.5 40 10 i
376 iv 19 8 21.2 15 i
377 iii 16 5 4 23.4 2 14 i
378 iii 14 5 1 17.1 2 12 i
380 i 34 5 68 0.45 24 ii
381 V 15 1 118 84
382 iv 16 10 10 14.0 0 14 i
383 iii 16 1 20.2 16 13 i
384 iv 16 8 8 23.4 21 8 i
385 iv 18 5 18 12.7 12 12 i
Footnotes to Table IV
294, 295 - from the same pregnancy.
304, 305, 307, 308 - from twin pregnancy (see table 5.2).
333 - grossly bloodstained sample.
334, 335 - from the same pregnancy.
354, 372, 380 - from the same pregnancy.
367, 369 - from the same pregnancy.
370, 381 - from the same pregnancy.
376 - grossly bloodstained sample, failed to grow in culture.
381 - grossly bloodstained sample.
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Key to Table IV
Column numbers:
1. Laboratory number allotted to amniotic fluid.
2. Reasons for collection of amniotic fluid:
(i) Rhesus iso-immunised pregnancy,
(ii) Hydramnios of unknown etiology,
(iii) Diagnostic antenatal chromosome studies,
(iv) a-fetoprotein estimation.
(v) At termination of pregnancy (including
induction of labour at term).
(vi) Estimation of lecithin/sphingomyelin ratio.
3. Gestation (weeks) of pregnancy from which amniotic
fluid was collected.
4. Volume (ml.) of amniotic fluid used to establish
culture on which macrophage count was estimated.
5. Cell count (1000 cells/ml.) of amniotic fluid.
6. o-fetoprotein level (pg/ml) in amniotic fluid.
7. Optical density difference at 450 mp of amniotic
fluid.
8. Macrophage count (glass adherent cells/ 10 low
power fields/ 10 ml. of amniotic fluid).
9. Time to cytogenetic result (days) when this was
achieved in the minimum time.
10. Category of amniotic fluid (table 5.1 and Fig. 5.1)
(i) Normal. (vi) Diabetic,
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The development of methods of diagnosing genetic disorders in the early fetus via
amniocentesis are discussed. The role that this technique can play in genetic counselling
is emphasised and it is stressed that this service should be offered to all couples who have
a high risk of producing children with a disease that can be diagnosed in utero. It is also
suggested that the screening of fetuses at moderate to low risk would be an economically
viable public health measure which could significantly reduce the incidence of mongolism
in the community.
One of the difficulties facing the genetic
tunsellor is that he can usually only give
ospective parents an indication of the risk
volved in having an affected child. If this
;k is high then the parents may choose to
tve no children and request termination of
ty pregnancies which may arise. This can
eate ethical problems which were summarised
■ Pitt (1969) when he said "that to perform
. abortion for a one in four risk of abnor-
ality is to run a three in four chance of losing
normal infant". In cases where the risk is as
gh as one in four, many parents would not be
epared to take the chance of having, what
tuld be to the majority in this situation,
other affected child. When the risks are lower,
y of the order of 5%, then decisions regarding
rther children and those of terminating
egnancy become more difficult. Such pro¬
ems could be largely overcome if any fetal
normality could be accurately determined
rly enough for therapeutic abortion of
ected fetuses. This would allow parents
th a high risk of having an affected child
have a normal family and should go much
the way to solving the problem outlined
Pitt.
The problem of attempting to find out
tether a pregnancy will result in an affected
ild has received increasing attention in the
t few years. The main method of this
Mr.) Cytogeneticist, Department of Pathology, Royal
lospital for Sick Children, Edinburgh EH9 1LF, Scotland
Address for Reprints).
fetal diagnosis is by a study of the amniotic
fluid. In a procedure known as amniocentesis
a sample of about 10 ml. of this fluid can be
fairly readily obtained by puncture of the
uterus from early in the second trimester on¬
wards. The fluid so obtained is a clear amber
colour and it contains a number of cells which
are almost certainly of fetal origin (Votta et al.,
1968) although their exact source is uncertain.
A full discussion of the techniques used to
obtain amniotic fluid is beyond the scope of
this paper. Early workers tried the trans¬
vaginal approach and had a high incidence of
fetal complications. Riis and Fuchs (1966)
had three spontaneous abortions and one still¬
birth out of eleven cases using this method.
The transabdominal approach (see Thiede,
1968 for details of this technique) seems to
carry little risk. Gerbie et al. (1971) reported
no complications, either fetal or maternal, after
256 such procedures and knew of 170 others
which had been performed without complica¬
tion. Ferguson-Smith et al. (1971) have had
no complications in 30 cases and now use
ultrasonography to locate the placental site
and to exclude multiple pregnancy which is a
contra-indication to amniocentesis.
A sample of amniotic fluid provides three
avenues for study, the composition of the fluid
itself, the cells present in the fluid and the
culture of these cells.
Amniotic Fluid
There is controversy regarding the origin of
amniotic fluid in early pregnancy (Emery,
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1970). However, there is little doubt that
fetal urine contributes to the fluid and that
this contribution becomes more significant as
gestation proceeds. The total volume of
amniotic fluid increases throughout pregnancy
from 50 ml. at 12 weeks to 150 ml. at 15
weeks and 450 ml. at 20 weeks (Emery, 1970).
As amniotic fluid is composed partly of fetal
urine it would be reasonable to assume that
it could be put through the series of tests
which are normally applied to urine when
screening for metabolic disorders. However,
it will not be until normal values for all
relevant components (as a function of gesta¬
tional age) have been determined that the
validity of this approach will be known. At
present it is not known how the ability of the
fetal kidney to secrete various metabolites
varies with gestation and, possibly, with the
diet of the mother. Nadler et al. (1970) re¬
ported a case of Pompe's disease in which the
enzyme normally absent, a-1,4-glucosidase,
was present in the amniotic fluid but not in
the cells cultured from it; some enzymes in
amniotic fluid may be maternal in origin.
Matalon et al. (1970) reported that Hurler's
syndrome could be diagnosed by the presence
of excessive amounts of heparatin sulphate in
the amniotic fluid at 14 weeks, Brock et al.
(1971) failed to confirm this and missed
diagnosing a case using similar criteria; genetic
heterogeneity of this disease may explain this
apparent contradiction. Jeffcoate et al. (1965)
have diagnosed the adrenogenital syndrome by
demonstrating grossly elevated levels of 17-
ketosteroids and pregnanetriol in the amniotic
fluid shortly before birth. As the source of
these steroids is presumably the fetal urine and
as the fetal adrenal cortex functions by the
fourteenth week, the possibility of diagnosing
this syndrome early enough for termination
of the pregnancy arises. However, Merkatz
et al. (1969) were unable to diagnose this
syndrome in early pregnancy using these
criteria, in fact, the steroid levels were only
suggestive of the diagnosis at term.
To date, amniotic fluid studies have been
generally equivocal and much more data on
the composition of this fluid in normal and
diseased states will be necessary before con¬
fident diagnosis of genetic disorders can be
made early in pregnancy. When the production
of an abnormal metabolite is not present at
birth but depends on diet (e.g. phenylketonuria)
it is difficult to see how the condition could be
diagnosed from the amniotic fluid.
Amniotic Fluid Cell Studies
At present the information which can
obtained from the cells without tissue cultu
is limited to sex chromatin determination, t
ABO blood groups and, recently, electri
microscopy studies.
Sex Chromatin
In 1956, several workers independent
found that fetal sex could accurately be dete
mined by X-chromatin studies on the ce
present in amniotic fluid. This technique h
been extended, and probably increased
reliability, since the discovery of the quinacri
fluorescence pattern of the Y chromosome
interphase nuclei (Pearson et al., 1970) w
extended to amniotic fluid cells (Rook et t
1971). By combining these methods it shot
be possible to accurately determine the s
chromosome complement in all cases.
The determination of X-chromatin
amniotic fluid cells was first used by Riis a
Fuchs (1960) in the management of the pn
nancies of two women who were carriers
the gene for haemophilia. The technique
however, applicable to all cases where an
linked gene is responsible for a disease wh:'
cannot be specifically diagnosed. When
woman carries such a gene, half her sc
would be affected but all her daughters woi
be normal. By terminating the pregnane
where the fetus is a male the parents concern
can have a family of normal girls. This di
not completely solve the problem of f
(1969) although it reduces the chance
losing a normal infant from three in four
one in two and has been used by numerc
genetic counsellors to manage pregnane
involving X-linked conditions (e.g., Gerbie
al. 1971) where male fetuses have been abo
ed. Edwards (1970) has suggested that fe
sex determination could be used as the basis
aborting the female fetuses fathered by rr
who carry X-linked diseases (e.g. Haemophil
as this "... could allow the reduction of si
diseases to the level maintained by mutatii
the virtual elimination of familial cases, a
progress in therapy without the prospect of
creasing the incidence of disease."
Blood Groups
The determination of the fetal ABO blc
groups is possible using cells from the amnic
fluid as early as 11 weeks gestation (Sachs
al., 1956). However, attempts to demonstr
the Rh groups have been unsuccessful (Sc
et al., 1969). Such information is of little
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genetic counselling at present but may be-
le useful when genetic maps of the auto-
les have been constructed, especially if it
omes possible to determine other blood
ups from these cells. In cases of close
age where the probability of recombination
>mall, it may be easier to determine the
cd group than to assay for its closely
:ed disease-producing gene. So far, the only
i close linkage known is that of the ABO
is to the gene for nail-patella syndrome, and
sibly the MNS blocd group locus to that for
rotylosis (Renwick, 1969).
cfross Microscopy Studies
lie ultrastructure of normal amniotic fluid
^ has been studied by Hoyes (1968) who
id two recognisable cell types. Bartman
71) studied cultured amniotic fluid cells
found only one cell type similar to fibre-
Is cultured from other sources. Hug et al.
70) found that amniotic fluid cells obtained
ing the 36th week of gestation from a
nan carrying a child subsequently shown to
e Pompe's disease, had abnormal lysosomes
suggested that it may be possible to diag-
3 this disease early in pregnancy by electron
roscopy of uncultured amniotic fluid cells.
siiotic Fluid Cell Culture Studies
'his aspect of fetal diagnosis will probably
ve to be by far the most important. Two
id fields of study are opened up by culturing
cells present in the amniotic fluid, viz.,
igenetics and biochemistry. Although much
k has been done on the methodology of
uring these cells, the optimum conditions
s probably not yet been found. Hence,
time required to produce results is longer
l ideal especially when a result may indicate
lination of a pregnancy; to produce a
/otype requires two to three weeks and a
:hemical result may take significantly longer.
flieniical Studies
lavidson (1970) lists about 30 different cell
notypes which can be distinguished in
ures of fibroblasts grown from skin biopsy,
ris (1970) estimates that these represent
ut one-third of the metabolic disorders in
:h the biochemical defect is known. This
wledge cannot be directly applied to fetal
;nosis until it has been established that the
; cultured from amniotic fluid cells similarly
consistently express the same biochemical
lotypes as those grown from skin. It would
lecessary to establish this for each enzyme
ither property separately and any variations
during gestation would need to be known. For
these reasons work on fetal diagnosis of bio¬
chemical disorders is proceeding slowly; each
disorder requires a separate technique for diag¬
nosis and each technique will require highly
skilled staff, separate reagents and often
expensive laboratory equipment. At present,
biochemical techniques can only be applied to
individual families who have already produced
an affected child, the detection of heterozygotes
in the population is not feasible unless the
detection is reasonably simple and the gene
frequency in the population is high, e.g.,
screening for carriers of Tay-Sachs disease in
some Jewish populations where their frequency
is as high as 1 in 30.
Biochemical studies on cultured cells involve
three main types of approach, autoradiography,
histochemistry and the assaying of enzyme
levels on cell homogenates. These are all
sophisticated methods which are prone to
technical difficulties. The procedures are also
lengthy, autoradiography usually requiring at
least a week to prepare after sufficient cells
have been grown. However Fujimoto et al.
(1968) reported the autoradiographic diagnosis
of a female fetus heterozygous for the Lesch-
Nyhan syndrome 22 days after amniocentesis.
The main histochemical technique is the stain¬
ing for metachromatic granules in the cyto¬
plasm using toluidine blue. These granules
have been demonstrated in a number of condit¬
ions including the polysaccharidoses and cystic
fibrosis of the pancreas. It is, however, difficult
to distinguish homozygotes from heterozygotes
and the metachromasia may not develop until
after two to three months in cell culture
(Fratantoni et al., 1969), in fact this technique
should not be used for diagnostic purposes
at its present stage of development. The assay¬
ing of enzyme levels in cultured cell homo¬
genates generally requires a large number of
cells which may take several weeks to produce.
However, specific enzyme deficiencies in
cultured cells have been demonstrated for
galactosemia, metachromatic leukodystrophy,
lysosomal acid phosphatase deficiency and
Pompe's disease (Nadler and Gerbie, 1971),
in each case making intrauterine diagnosis
possible. Regan et al., (1971) have diagnosed
xeroderma pigmentosum, an autosomal reces¬
sive disease in which there is a lack of
functional ultraviolet endonuclease, from
cultured amniotic fluid cells. Their technique
which was able to clearly distinguish normals
from homozygotes and from heterozygotes was
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based on shifts in the DNA sedimentation
constants after the cells had repaired ultra¬
violet induced lesions in the presence of 5-
bromodeoxyuridine and then been subjected to
further irradiation.
Cytogenetic Studies
Shortly after Klinger first grew amniotic
fluid cells in tissue culture, two small series of
cultures reported by Steele and Breg (1966)
and by Thiede et al. (1966) confirmed that
the cells would grow in culture and that they
could be used for chromosome analysis, thus
making available a technique for the antenatal
diagnosis of chromosome abnormalities. The
bringing of this technique to perfection and its
widespread application has been slow and is
far from complete at present. It is, however,
better developed than the majority of bio¬
chemical techniques, largely because the
methods used are few, well established and
largely within the competence of established
cytogenetic units. Nevertheless, only one large
series of cases of chromosome analysis as a
result of amniocentesis has been reported, that
of Gerbie et al. (1971) who successfully karyo¬
typed 238 out of 250 samples of amniotic
fluid. Such remarkable success has not been
widespread, Nelson and Emery (1970) were
successful in culturing only 49 out of 90
samples; although Ferguson-Smith et al. (197
were successful in 29 out of 30 cases referi
for genetic counselling (repeat amniocente
was, however, required in five cases) th
managed to obtain karyotypes in only 17
24 samples obtained at hysterotomy.
The results of successful amniocentesis p
formed for genetic counselling purposes wh
required chromosome analysis are summari;
in Table 1. The results reveal some surpris
The finding of three pregnancies with Dow
syndrome amongst 85 where the mother f
had a previous regular mongol is, as Fergusc
Smith et al. (1971) point out, much higl
than the generally accepted recurrence risk
this syndrome. Also the 5 abnormal fetu
(three cases of Down's syndrome, one
Klinefelter's syndrome and one XYY ma
found in 130 women with advanced age at
time of pregnancy (older than 40 years
most cases) is more than expected. Advanc
maternal age is a factor in the production
both Down's and Klinefelter's syndromes 1
the risk figures are generally believed to
less than found here.
Whilst the theoretical expected risk of p
ducing unbalanced offspring from Robertson
translocations involving non-homologc
chromosomes is 33%, it has been found
practice to be in the region of 4-9% depend
TABLE 1
Cases in Which Fetal Chromosome Analysis via Amniocentesis
Counselling

























Previous child with regular
mongolism 5(1) 67(2) 13 85(3;
Previous child with other
chromosome abnormality 1 1
Parent with balanced
translocation 1(1) 2(1) 41(10) 1(1) 4 49(13
Maternal mosaic for mongolism 1 1
Increased maternal age 1 6(1) 119(4) 4 130(5)
Family history of mongolism 1 3 4
Exposure to mutagens 2 6 1 9
Total 4(1) 2(1) 18(2) 227(16) 1(1) 27 279(2
+ Three mongols, one XXY and one XYY male
Figures in parentheses indicate number of abnormal fetuses diagnosed and, except for two cases of Na
and Gerbie, also indicate that these fetuses were therapeutically aborted.
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the sex of the carrier parent and the exact
romosomes involved (Hamerton, 1970). The
asons for the finding of 13 out of 49 affected
uses from balanced translocation carriers,
■parently in aggreement with the theoretical
;ure, is not known. Apart from the small
imber of cases, a possible reason for the
iding of an apparent excess of abnormal
tuses in all the groups studied could be
at these findings in mid-pregnancy should
it be directly compared with expected fre-
lencies of chromosome abnormalities in
eborn neonates. With two exceptions, all
e chromosomally abnormal fetuses were
erapeutically aborted. It is possible that
me of these would have spontaneously
iorted had they continued, this could have
duced the incidence of neonates with
romosome abnormalities amongst these
oups closer to the expected levels. This is,
iwever, unlikely because most chromosomally
normal abortuses are lost during the
st trimester, and amongst mid-trimester
ontaneous abortuses there are only about
7o with chromosome abnormalities (Carr,
'70).
Hence it can be seen that antenatal chromo-
me analysis is an effective means of pre¬
ying the chromosomal status of the fetus and,
followed by abortion of affected fetuses, can
luce the incidence of chromosomal disorders
birth. Unfortunately, misdiagnosis has
curred and a normal fetus has been aborted
at least one occasion (Kohn and Robinson,
'70), however, no child with an unknown
romosome abnormality has been born after
iniocentesis although in the series of Gerbie
al. (1971) two fetuses diagnosed as female
amniocentesis were in fact males with
irmal karyotypes. The reason for this error
is probably an overgrowth of contaminant
iternal cells.
iture Prospects
When any relatively safe technique which
n prevent or improve the prognosis of a
;ease is discovered the question of screening
ipulations at risk arises. Amniocentesis is
ch a technique, and it is worth considering
lether it could be usefully employed as a
"eening test for disorders which can be diag-
sed in utero, either with a view to terminat-
l the affected pregnancies or initiating
:atment of the fetus or the subsequent neo-
te. The decision regarding termination or
utment or neither will depend on the particu-
■ disease, the attitudes of parents, doctors and
the law. In a liberal atmosphere fetuses with
treatable disorders (e.g. phenylketonuria if it
becomes detectable at this stage) would prob¬
ably be terminated as would those with any
sex chromosome abnormality and perhaps even
those with balanced autosomal rearrangements,
the termination of this last group is however
difficult to justify on genetic grounds (Hamer¬
ton, 1970). In a more restrictive climate,
probably only those with severely debilitating
and unbeatable disorders would be terminated.
Littlefield (1970) suggested that amniocente¬
sis was appropriate for four distinct groups of
women ranging from those with high risks of
producing abnormal fetuses to those with a low
to moderate risk. 1 would suggest that in the
'nigh risk cases amniocentesis is not only
appropriate but its offer should be an essential
part of genetic advice (where facilities are
available) in the following instances:
1. Either parent carries a chromosomal re¬
arrangement or has a chromosome abnor¬
mality, e.g. where the mother is XXX or the
father XYY.
2. The parents are known to be carriers of
autosomal recessive genes for any disease diag-
nosable in utero. These would normally have
been ascertained via a previously affected child.
3. When one parent carries an autosomal
dominant condition which can be diagnosed
in utero.
4. When the mother is known to be the carrier
of an X-linked condition, even when the
specific condition cannot be diagnosed.
Where facilities are available amniocentesis
is being offered in most of these cases at
present and it can be expected that in the
near future most major centres will have at
least one unit capable of providing antenatal
diagnostic services for such cases.
Apart from cytogenetic abnormalities,
screening for other disorders is not feasible at
present. This is because each requires a
separate technique and even with considerable
selection the incidence of fetuses with any
single disorder is very low. The most common
would probably be Tay Sachs disease with an
incidence of about one per thousand in some
Jewish populations but even here it is pre¬
ferable to screen prospective parents for
heterozygosity.
Apart from the high risk groups outlined
above, there are two other groups which are
probably worth screening for chromosome
abnormalities. These are:
(a) Women who have produced a child with
a chromosome abnormality.
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(b) Women who become pregnant towards the
end of their reproductive life when the chances
of producing children with chromosome abnor¬
malities is increased.
In general women in these categories are not
being offered amniocentesis for several reasons.
These include the inability of present cyto¬
genetic units to handle the numbers which
would be involved and reluctance on the part
of obstetricians to perform a new procedure
when its risks and benefits may not be fully
understood and who are worried about the
problem of technical failure to produce a
result, necessitating repeat amniocentesis. The
first problem can be overcome fairly easily
because when the costs involved are compared
to the resulting benefits, the saving to the com¬
munity is great, hence government support for
the establishment of adequate cytogenetic
facilities should be forthcoming. The compli¬
cations of amniocentesis, both fetal and mater¬
nal have been discussed and although present
data suggests that this is a procedure which
involves very low risks, more information is
required from large series before this can be
fullv confirmed. The problem of failure will
probably diminish as more experience is gained
by laboratories in amniotic fluid cell culture.
If such a screening programme were applied
to Australia, what could we expect? The
mothers who had produced a previous child
with a known chromosome abnormality would
constitute only a small group and could prob-
ablv be handled without expansion of existing
facilities: this group will not be considered
further. If 40 years was taken as an age above
(and including) which women would be
screened then in Australia in 1967 there would
have been about 5,400 out of 230,000 mothers
included fSutherland, 1970). The chromosome
abnormalities which this group would have
been responsible for are estimated in table 2.
TABLE 2
Chromosome Abnormalities which would have been
produced by 5,400 women 40 years or older in
Australia in 1967
Abnormality No. of Cases
Down's syndrome (47,G + ) 65
Edward's syndrome (47.E+) 3
Patau's syndrome (47.D+) 3
Klinefelter's syndrome (47,XXY) 15
Trinle-X female (47.XXX) 5
"YY-mnles" (47,XYY) 5
Other abnormalities 10
The cost to the community of these abno
malities in human terms cannot be calculate*
it is sufficient to say that they will result
considerable anguish to the families concerne
It is, however, easier to calculate the cost
financial terms, especially for the cases *
Down's syndrome which constitute the mo
significant group. If each case required I
years institutionalisation at a cost of $2000 p*
year, this amounts to $2,600,000. It is mo
difficult to estimate the costs to the communi
of the other abnormalities which would 1
found. The Edward's and Patau's syndron
cases could not be expected to live for mo
than six months but would require hospit
care for most of the time till death. It
difficult to estimate the costs to the communi
of the cases with sex chromosome abnormal
ties. The XXY and XXX individuals do ha1
a tendency towards mental deficiency, b
havioural disturbance and subsequent instib
tionalisation (Bartholomew and Sutherlan
1971). They can develop normally except ft
sterility in the case of XXY, however tl
proportion of each which develops normally
not accurately known. The XYY males prese
even more of a problem, Australian experieni
(Sutherland et al., 1972) suggests that th«
have a tendency towards institutionalisatic
but this is denied in Britain (Jacobs et a
1971). This is a problem which still requin
much nrnre study.
I would estimate that to screen these womc
over 40 years would cost about $500,000 p<
annum (this allows for a centre in each state
Hence the spending of about half a millic
dollars would save about three millio:
Although these cost estimates are extreme
approximate they are of the correct order <
magnitude, hence there would be about
tenfold/fivefold return on money spent on th
type of preventative medicine. The problem <
'"discounting" is beyond the scope of this revie
but it will tend to reduce the magnitude of tl
return on money spent on such populatic
screening. However if the age above whic
pregnant women were screened was lowered \
35 years then it has been estimated (W.H.C
1972) that "the cost of such a programn
would be substantially less than half that <
institutional care for the trisomic population
If further experience with the technique <
amniocentesis confirms that the risks involve
are almost negligible, or at least significant
less than the chance of having a child with
chromosome abnormality, then screening cou
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extended to younger women, e.g. those in
: 35-39 age group. Carter (1970) stated
it in Britain, women of 35 and over produce
out half the mongols, yet comprise only
out 10% of the pregnant populuation.
I can only conclude by wholeheartedly
•eeing with Ferguson-Smith et al. (1971)
en they say "... it is important that
niocentesis should not be undertaken . . .
trivial purposes such as choosing the sex
offspring".
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Culture of Cells from the Urine
of Newborn Children
The increasing importance of amniocentesis for the diagnosis
of disease in utero has focused attention on the cells obtained
by this procedure. Culture of amniotic fluid cells is becoming
an established procedure for the identification of foetuses with
chromosomal and metabolic abnormalities. Cytogenetic and
biochemical studies of these cells in culture and morphological
studies of the uncultured cells have shown that they are of
foetal origin1-3. However, the exact origin of the cells which
grow remains speculative and several possibilities have been
suggested including exfoliated cells from the amnion or from
foetal skin2,3 and also from the foetal respiratory4 and uro¬
genital3,4 tracts. Since foetal urine undoubtedly contributes to
the amniotic fluid as gestation progresses5 it seemed reasonable
to assume that some of the cells cultured from amniotic fluid
could be derived from the foeta! urinary tract.
Fig. 1 Cells cultured from (a) urine and (b) amniotic fluid as
seen 24 h after the third subculture (stain toluidine blue, x 100).
Samples of urine were collected in sterile bags from four
infants less than two days old. For tissue culture, the urine
samples were then treated as amniotic fluids; they were centri-
fuged at 1,000 r.p.m. for 10 min, the supernatant decanted, the
cells resuspended in tissue culture medium and then transferred
to Petri dishes containing cover slips. Ham's F10 TCM
containing streptomycin and penicillin with the addition of
30% foetal calf serum was used. Cultures were incubated at
37° C in an atmosphere of 5% C02 in air. Although one
culture showed contamination within 24 h, the remaining three
were successfully maintained and proliferating cells were first
observed at 6, 9 and 10 days respectively. Sufficient cells were
present to allow harvesting for chromosome studies at 12 days
in the first case and at 17 days for the other two. These culture
times are similar to those being obtained at the present time in
this laboratory for amniotic fluid cell cultures.
Using light microscopy the cultured urine cells appear mor¬
phologically similar to those cultured from amniotic fluid
(Fig. 1); but further characterization of these two types of cell
strain is required. Cell cultures have now been set up using
urines from a total of eight infants aged less than 2 days and of
gestational ages ranging from 31 to 40 weeks. Seven of these
cultures have produced primary cell strains, one of which has
now reached the seventh pass. A small number of cultures
from older children have failed to grow. The only previous
attempt to culture cells from urine is that of Jacobson and
Barter4 who set up cultures from sheep urines and bladder
aspirates from four human foetuses; however, only one of the
former was successful.
The culture of cells from neonatal urine, embodying sim¬
plicity in collection and in culture technique, could provide a
non-traumatizing procedure for cytogenetic investigations
when studies on tissue other than blood are required. More¬
over, the most potentially useful application of this technique
may be the production of primary cell strains for use in the
investigation of inborn errors of metabolism at a biochemical
and molecular level.
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Letter to the Editor
reprinted from THE LANCET, February 24, 1973, p. 423
ANTENATAL SCREENING FOR DOWN'S
SYNDROME
Sir,—Dr Stein and others (Feb. 10, p. 305) have analysed
the feasibility of a screening programme for the prevention
of Down's syndrome for New York City. They have shown
that such a programme is desirable because of the increasing
prevalence of Down's syndrome due to the increasing
lifespan of affected individuals.
We agree with these authors that there is no justification
in delaying the decision to undertake a diagnostic screening
programme for Down's syndrome. If such a scheme can
be shown to be feasible in New York City, we can see no
reason why it should not be feasible in the United Kingdom
and made readily available through the National Health
Service.
The technique of amniotic-cell culture is well established,
and for the antenatal diagnosis of Down's syndrome the
success-rate is high and will probably be increased as
more experience is gained. The nucleus of laboratory
facilities and skill are generally available in the United
Kingdom and phase i of the programme suggested by
Stein et al. could probably be undertaken with only
minimum expansion of existing services, since only about
2% of the pregnant population would be involved.1 An
additional benefit of such a scheme would be the prevention
of other chromosome abnormalities, many of which also
increase with maternal age and most of which have some
associated morbidity.2
Whether we could agree with stages in and iv of the
scheme proposed by Stein et al. is doubtful at present, as
the cost of these stages would be high in relation to the
benefits obtained, and the exposure of fetuses, which have
only a very low risk of cytogenetic abnormality, to the
small but finite hazards of amniocentesis may not be
justified.
Only one small series of diagnostic amniocenteses in
early pregnancy has been published in this country so far.3
Does this reflect the general unpopularity of views such as
those of Stein et al. and similar ones put forward by
others ? 1
Surely it is time for the evaluation in both economic
terms and human considerations of a screening programme
for the prevention of Down's syndrome in the United
Kingdom. If such a programme was limited to stages I
and n of Stein et al., it would pay for itself more than
twice over,4 and unless good reasons are found for not
doing so, should be started forthwith.
2
Department of Pathology,
Royal Hospital for Sick
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YSOSOMAL ENZYMES OF CULTURED AMNIOTIC FLUID CELLS
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immary
1. The levels of some lysosomal enzymes in a minimum of 38 amniotic fluid
11 strains cultured to the third passage were as follows (mean i standard deviation):
V-acetyL/S-d-glucosaminidase 52.1 ± 16.70, acid phosphatase 7.73 ± 2.82, /?-
lactosidase 4.59 i 1.97, /^-glucuronidase 1.30 4; 0.52, /5-glucosidase 0.072 + 0.030,
galactosidase 0.42 i °-i5, a-arabinosidase 0.53 4: 0.25, a-glucosidase 0.38 ^ 0.18
d a-mannosidase 0.65 i 0.30 nmole 4-methylumbelliferone/min/mg protein.
2. No correlation was observed between the levels of these enzymes and gesta-
>nal age.
3. The levels of these enzymes in uncultured cells tended to be lower than in
e corresponding cultured cells. Occasionally, very low levels of certain of the en-
mes were found in uncultured cells, although normal levels were found in the
rresponding cultured cells.
troduction
Amniocentesis combined with biochemical analysis of the amniotic fluid or cells
increasingly being utilized for the antenatal diagnosis of genetic disease. The uses
1 possibilities of this procedure have been reviewed1-3. Great caution must be exer-
ed if amniotic fluid or amniotic fluid cells are used directly for enzyme analysis2. A
■re reliable indication of the presence of enzyme activity in the foetus is obtained
m cultured amniotic fluid cells4. However, the variation in the activity of lysosomal
;ymes of cultured amniotic fluid cells has not previously been investigated in detail
1 is presented here.
terials and methods
Amniotic fluid samples were obtained from hysterotomy specimens and by
niocentesis on rhesus isoimmunised women with no history of inborn errors of
tabolism involving lysosomal enzymes. Primary cultures of cells from these fluids
e established6 and subsequently subcultured, using 0.25% trypsin in phosphate-
fered saline to remove the cells from the Petri dish, into a glass culture bottle with
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a growth surface area of approximately 20 cm2. The cells were then similarly subcu
tured into and maintained in bottles twice this size. Ham's Fio tissue culture mediui
(Flow Lab. Ltd.) supplemented with 30% foetal calf serum (Bio-Cult Lab. Ltd.) wa
used; antibiotics incorporated were kanamycin (100 ^wg/ml) or penicillin (60/y,g/ml) an
streptomycin (100 /xg/ml) in combination. Culture bottles were flushed with 5% CC
in air prior to stoppering.
The cells were harvested on reaching confluency after the third subculture
Trypsin (0.25%) in phosphate-buffered saline was used to remove the cells from tl
glass. After washing in phosphate-buffered saline and centrifuging at 600 x g for 5 mi
at 50 the cells were taken up in 4 ml of ice-cold 100 mM sodium chloride and sonicate
for 15 sec at maximum power using a "Soniprobe" (Dawes Instruments). The hom<
genates were centrifuged at 25000 xg for 10 min at 50 and stored at —65°.
The methods of enzyme estimation were those of Butterworth et al.e with tv
modifications:
/^-glucuronidase—1 mM conjugate, 0.1 M acetate buffer pH 4.0, 30 min
a-glucosidase—2 mM conjugate, 0.2 M phosphate/citrate buffer pH 4.5, 60 mi
RESULTS
The results obtained for the enzymes assayed in a series of cultured amniot
fluid cells are presented in Figs. 1 and 2. Table I gives the mean, standard deviatic
and range for each enzyme. The levels of the enzymes differed greatly, varying fro
52.1 i 16.7 nmole/min/mg protein for A7-acetyl-/3-i>-glucosaminiaase to 0.072
0.030 nmole/min/mg protein for /3-glucosidase. Each of the enzymes showed
fairly narrow range of values except for a few cell strains showing unusually hi/
150—
E
= 100- 100- 100- 20- !
1-5- '
50- J; 50- 50- 10-
s.
05-
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Fig. 1. Specific activities (nmole 4-methylumbelliferone/min/mg protein) of lV-acetyl-/?-D-glu
saminidase, acid phosphatase, /J-galactosidase, //-glucuronidase in amniotic fluid cells after 1
third passage of culture.
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. 2. Specific activities (nmole 4-methylumbelliferone/min/mg protein) of /3-glucosidase, a-
actosidase, a-arabinosidase, a-glucosidase and a-mannosidase in amniotic fluid cells after the
rd passage of culture.
■els of enzyme activity. Consequently 95% confidence limits based on a normal
tribution produce lower limits for the enzyme specific activities which are well
ow those actually measured. Hence Table I gives the upper and lower values
nge) actually measured. The correlation coefficients (r) for the enzyme specific
ivities with gestational age are given in Table I from which it can be seen that none
the enzymes exhibits any relationship with this factor.
In Table II a comparison is made between the levels of the enzymes assayed
uncultured and cultured amniotic fluid cells derived from three amniotic fluid
nples. One feature, with five exceptions, is the lower level of these enzymes in the
BLE I
OSOMAL ENZYMES OF CULTURED AMNIOTIC FLUID CELLS
ryme Number Enzyme specific activity1 Correlation coefficient
of cell Mean Standard Range (r) of enzyme activity
strains Deviation with gestational age6
Vcetyl-/3-D- 39 52.10 16.70 28.70-91.85 — 0.196
lucosaminidase
d phosphatase 38 7-73 2.82 4.34-12.69 0.198
alactosidase 41 4-59 1.97 2.37-10.69 -OI35
lucuronidase 38 1.30 0.52 0.62-2.02 0.284
lucosidase 39 0.072 0.030 0.03—0.17 -0.083
alactosidase 38 0.42 0.15 0.22-0.78 — 0.158
rabinosidase 40 °-53 0.25 0.22—1.30 — 0.081
lucosidase 40 0.38 0.18 0.17-0.97 0.218
annosidase 39 0.65 0.30 0.28—1.27 — 0.093
uole 4-Methylumbelliferone/min/mg protein.
> 0.325 P(r = o) < 0.05 df 35.
298 BUTTERWORTH st t
TABLE II
SPECIFIC ACTIVITY6 OF LYSOSOMAL ENZYMES OF UNCULTURED AND CULTURED AMNIOTIC FLUID CEL
Enzyme Sampleb
LJncul- Cultured Uncul- Cultured Uncul- Cultures
tured1 turedz tured3
iST-Acetyl-/?-D- 8.28 52-37 23.18 47.26 4.46 31.40
glucosaminidase
Acid phosphatase 7.20 7-55 17-59 7-63 3.26 4.84
^-Galactosidase 0.10 436 0.30 3-91 0.25 4.19
^-Glucuronidase 2.20 0.94 2.94 1-34 °-73 1.02
/9-Glucosidase 0.012 0.089 0.028 0.122 O.OI2 0035
a-Galactosidase 0.023 °-37 0.075 o-35 O.OI8 0.32
a-Arabinosidase 0.008 °-43 0.040 o-43 O.O4O 0.60
a-Glucosidase 0.05 0.42 °-57 0.30 0.45 0.25
a-Mannosidase 0.25 o.55 0.28 0.62 0.20 0.50
6 nmole 4-Methylumbelliferone/min/mg protein.
b Gestational age: Sample 1: 23 weeks; 2: 21 weeks; 3: 16 weeks.
uncultured compared with the cultured cells. The low level in uncultured cells of soi
of these enzymes, such as /f-galactosidase, a-galactosidase and a-arabinosida.se, wot
make it very difficult to assert that an absence of enzyme in this material was d=
to a possible inborn error of metabolism. The need for great caution in the use
uncultured amniotic fluid cells for antenatal diagnosis is clearly demonstrated
sample 1. In this sample, the levels of a-glucosidase and a-arabinosidase were ve
low in the uncultured cells, but were normal in the corresponding cultured cells.
DISCUSSION
Nadler7 suggested that the activity of glucose-6-phosphate dehydrogenase
cultured amniotic fluid cells may show a correlation with gestational age and remarl
that there was no such correlation for acid phosphatase, /^-glucuronidase and a-glu
sidase. Indeed, in the present study, this latter group of enzymes, together with
other lysosomal enzymes assayed, did not show a correlation with gestational a
A similar lack of correlation for some lysosomal enzymes has been reported in unc
tured amniotic fluid cells8.
The results presented here form part of an investigation of factors affect
the levels of lysosomal enzyme activity in cultured amniotic fluid cells. The th
passage was the earliest at which it was possible to obtain sufficient cells for
enzyme assays and still maintain all of the cell strains. The enzyme levels in the tl
passage can, however, be taken as representative of at least the first five passag
The use of cells from the third passage results in some delay after amniocentesis bef
the enzymes can be estimated. This delay varied from 4-10 weeks, although 7
of the cell strains could be assayed before 6 weeks. This time-lapse could be a prob)—
in relation to antenatal diagnosis. However, even by using the first passage a m:
mum of only 2 weeks could be saved.
The relative merits of uncultured and cultured amniotic fluid cells for the 1
chemical studies involved in antenatal diagnosis of inborn errors of metabolism
not yet resolved. The assay of uncultured cells, if feasible, would avoid the un<
tainty of culture and permit early diagnosis10. Indeed Tay-Sachs' disease11
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ompe's disease12 have been diagnosed in utero. However, the reliability of using un-
rltured cells for diagnosing these diseases has been seriously questioned13-16. Nadler
ad Gerbie2 have emphasised the need for great caution in the direct assay of uncul-
lred amniotic fluid cells due to the possibility of maternal blood cell contamination,
lzyme instability and inadequate numbers of viable cells. They suggested that the
lzyme of interest should be related to another control enzyme in order to minimise
ly such problems. However, our results indicate that this could be hazardous as it is
issible for uncultured cells to have some enzymes virtually absent and others nor-
al, whilst the corresponding cultured cells have all their enzyme activities in the
mtrol range. In contrast, no enzyme level in cultured cells from the whole series of
irmal amniotic fluid samples was low enough to suggest that a particular enzyme
is absent. However, the suggestion of Nadler and Gerbie2 should be applied when
ing cultured amniotic fluid cells for antenatal diagnosis of inborn errors of metabolism
volving lysosomal enzymes in order to check that the culture and assay conditions
ve not produced uniformly low enzyme levels.
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Metaphase Chromosomes from Neonatal Urine
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Summary. Tissue culture of the cells present in the urine of neonates has been demonstrated
to be a suitable means of obtaining metaphase chromosomes whenever cytogenetic studies
are required on cells other than blood lymphocytes. The advantages of this type of cell culture
compared with the use of fibroblast culture from skin biopsy are discussed.
Zusammenfassung. Es konnte gezeigt werden, daB Gewebekulturen von Zellen aus dem
Urin Neugeborener sich zur Gewinnung von Metaphasenchromosomen eignen, wenn cyto-
genetische Untersuchungen nicht allein an Blutlymphocyten durchgefiihrt werden sollen.
Es werden die Vorteile diskutiert, die diese Art der Zellkultur gegeniiber der Fibroblasten-
kultur aus Hautbiopsien bietet.
Mitotic metaphase preparations for chromosome analyses in the neonate are
usually obtained from blood lymphocyte cultures but if further studies are indi¬
cated then fibroblasts cultured from a skin biopsy are most commonly used. Skin
fibroblast culture has the disadvantage that results are not obtained for many
weeks, skin biopsy is a traumatising procedure and is consequently not readily
repeatable. It is now possible to culture cells from the urine of the neonate (Suther¬
land and Bain, 1972) and these can be used for cytogenetic studies.
Materials and Methods
Urine is collected into standard sterile urine collecting bags and transported to the labo¬
ratory. The urine is centrifuged at 1000 r.p.m. for 10 min and the supernatant removed.
The pellet of cells is resuspended in tissue culture medium and pipetted into a 50 mm plastic
(Nunclon) petri dish containing 4 or 5 glass coverslips (6x22 mm). Duplicate cultures are set
up, the cells from approximately 5 ml of urine being used for each. The tissue culture medium
is Ham's F10 with 30% fetal calf serum added. Antibiotics incorporated in the medium are
kanamvcin, or penicillin and streptomycin in combination. The cultures are incubated at 37°C
in an atmosphere of 5% CO, in air and left relatively undisturbed for 1 week after which time
half the medium is replaced thrice weekly. The cultures are examined regularly for signs of
cell proliferation (almost always first seen on one of the coverslips) which are usually observed
after a period of 7 to 14 days.
When an area of proliferating cells appear large enough for harvesting, the medium is fully
changed and incubation continued for a further 16 hrs. The coverslip, on which the cells to
be harvested are attached, is then removed to a separate petri dish or suitable tube and
covered in fresh medium to which Colcemid at a final concentration of 1 pg/ml has been added.
Incubation is continued for a further 5—6 hrs after which time the medium is aspirated from
the tube and replaced by warm (37°C) 0.075 M KC1. Hypotonic treatment is terminated after
5 min by the addition of an equal volume of fixative (1 part acetic acid to 3 parts methanol)





v •$ •*# i i •» •
t * % i •»»»•%••
•
^ •
£ #• ^ - ^ <8. _
% % 5 ^ v^-# ^ % A *
* .«•#% •'!» 1 *
» i * * • t «,* m + • * W ■•
* • % # f • " %•r. -■
*0 *%« • • # s?f-i
Fig. 1. Primary culture of urine cells harvested for cytogenetic studies after 12 days in culture
and 5 hrs exposure to colcemid. (Stain Giemsa, x 125)
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Fig. 2. Banded karyotype prepared using the method of Grace and Bain (1972) from a primary
urine cell strain in the 13th passage
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to the KC1. Half the KCl/fixative mixture is removed after 1 min and replaced by fixative.
This step is repeated twice following which the coverslip is put through two changes of
fixative, each of about 5 min. The coverslip is allowed to dry in air at room temperature,
stained with Giemsa and mounted on a slide.
By allowing the cells remaining in the original petri dish to proliferate they can be sub-
cultured to produce a primary cell strain suitable for further cytogenetic studies.
Results
A number of neonates have now been karyotyped successfully by tissue culture
of urine. High mitotic activity is present in primary cultures harvested by this
method (Fig. 1) and preparations suitable for fluorescent and banding studies have
been obtained (Fig. 2).
Discussion
The technique of culturing urine cells for the purpose of cytogenetic study
should prove a valuable addition to the techniques already in widespread use. It
-has several advantages over skin biopsy in that no trauma is involved in collect¬
ing the urine and repeat specimens can be readily obtained if contamination or
Dther problems arise. The method is simple and should be within the capability of
my laboratory involved in tissue culture. Results are obtained in 2—3 weeks,
sooner than is usually possible in the case of skin biopsy and much less technical
vork is involved.
The main difficulty encountered is in the collection of the urine samples. Care
hould be taken as the urine may be contaminated by organisms which will
nultiply in the culture medium in spite of the antibiotics used. This problem could
>e overcome by collecting the urine via suprapubic bladder aspiration, a procedure
ortainly less traumatic than skin biopsy.
In the absence of microbial contamination the proportion of successful cultures
las been high and would appear to be independent of the gestational age of the
>aby but the success rate almost certainly decreases as post-natal age increases,
'ossible factors which may influence the ability of the cells present in urine to
>roliferate in tissue culture are being investigated.
We are grateful to the staff of the Paediatric Special Care Unit of the Simpson Memorial
laternity Pavilion, especially Dr. F. Cockburn and Sisters B. Elliott and J. Shaw for collecting
le urine specimens.
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SUMMARY
A number of factors which may correlate with the
levels of a-glucosidase and 6-glucosidase in cultured
amniotic fluid cells have been investigated. Fluct¬
uations in enzyme activity occurred as passage numbers
increased. Whereas a-glucosidase showed a consistent¬
ly lower activity in the earlier passages compared to
the later ones, the results for 6-glucosidase were
equivocal. Both enzymes showed an increase in activity
correlated with the time taken by the cells to reach
confluency in the third passage. When replicate
cultures were assayed daily after subculture, neither
enzyme showed any change correlated with time. When
cultures were grown in parallel in Ham's F10 and
Eagle's M.E.M. tissue culture media, the activity of
both enzymes was unaffected. Cell strains cultured
from serial samples of amniotic fluid from the same
woman had differing enzyme levels unrelated to gestat¬
ional age.
A number of diseases have been shown to be due to a defic¬
iency in the activity of a lysosomal enzyme (1,2,3,4). These
enzymes are normally present in cultured amniotic fluid cells
(5,6,7) and it has been found that an enzyme deficiency in the
foetus is reflected in these cells (8,9,10). Although studies
have been undertaken on the fluctuations in the activity of
lysosomal enzymes in cultured fibroblasts (11-18), very little
attention (11,19) has been paid to the variations in lysosomal
enzymes in cultured amniotic fluid cells. With the rapidly
expanding demand for antenatal diagnosis of inborn errors of
lysosomal enzyme metabolism, a greater knowledge of the variations
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in the levels of these enzymes in cultured amniotic fluid cells
is necessary. Hence an investigation of some of the conditions
of cell culture that may affect the levels of a-glucosidase and
S-glucosidase was undertaken.
METHODS
Amniotic fluid samples were obtained from hysterotomy
specimens and by amniocentesis on Rhesus iso-immunised women
who had no history of inborn errors of metabolism involving lyso¬
somal enzymes. Primary cell cultures were set up (20) then
subcultured, harvested, homogenized (7), and the lysosomal enzymes
assayed using 4-methylumbelliferone conjugates (7,21).
The reproducibility of the combined culture and enzyme assay
techniques was tested by establishing twelve replicate cultures
of one cell strain at two different passages. The twelve repli¬
cates were harvested when they had simultaneously reached con-
fluency and then assayed for enzyme activity. To study enzyme
activity with respect to passage, six cell strains were subcultur¬
ed for up to fifteen passages and the enzyme levels assayed at
intervals. All the cell strains were assayed at the third
passage and the time interval between subculture and harvest
(confluency) noted. The variation in enzyme level within a
passage was followed by establishing a series of replicate cul¬
tures which were harvested for enzyme assay at daily intervals
for up to seven days. The effect of culture medium on enzyme
activity was followed by performing enzyme assays on six cell
strains cultured in parallel for three passages in Ham's F10
and Eagle's M.E.M. tissue culture media (supplemented with 30%
foetal calf serum).
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RESULTS
The reproducibility of the combined culture and assay system
for each enzyme is presented in Table I. The variation of the
total experimental procedure (coefficient of variance) was less
than 10% for both enzymes. The variation in the levels of the
enzymes with passage is given for six cell strains in Figs. 1
and 2. The coefficient of variance of the mean enzyme levels
TABLE I
Reproducibility of Culture and Assay System
Enzyme Mean* Standard Coefficient
Deviation of Variance (%)
a-GLUCOSIDASE 0.41a 0.035 8.5
0.81b 0.027 3.3
8-GLUCOSIDASE 0.154a 0.012 7.8
0.053b 0.005 9.3
* Enzyme activity in nmoles 4-methylumbelliferone/
min./mg. protein for twelve replicates,
a - Assay tenth passage; b - Assay twentieth
passage.
for the different cell strains was 8.9 - 42.6% for a-glucosidase
and 32.9 - 65.0% for B-glucosidase. These values are much
greater than for the experimental procedure and indicate that
there are changes occurring in the enzyme levels in any one cell
strain as culture progresses.
Marked variations in the levels of both enzymes occurred
with passage. In the case of a-glucosidase there was a rise in
activity as culture progressed. This was shown by the lower
activity (P < 0.005) of this enzyme in the first five passages










The activity of a-glucosidase in serial passages
of six strains of cultured amniotic fluid cells.
compared with the next ten. In addition the mean activity in the
third passage was lower (P < 0.01) than that in the tenth passage
of ten strains studied. For 8-glucosidase cell strains 1 and 6
showed a positive correlation (P < 0.05) and strains 3,4 and 5 a
similar negative one with passage number. Although the levels of
this enzyme were also lower in the first five passages (P < 0.05)
than in the next ten, the comparison of activities at the third
and tenth passages showed no difference.
The relationship of the enzyme activity in cell strains
at the third passage to the time at which confluency (harvest) was
reached is given in Fig. 3. Both a-glucosidase (r = 0.48) and
B-glucosidase (r = 0.63) showed a significant positive correlation
with this factor. The correlation was still significant even if
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FIG. 2
The activity of B-glucosidase in serial passages
of six strains of cultured amniotic fluid cells.
FIG. 3
Relationship of the activity of a-glucosidase
and B-glucosidase in cultured amniotic fluid
cells with time to reach confluency (harvest).
All days Without 9-12 days.
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the few cell strains requiring 10-12 days to reach confluency were
not considered.
The fluctuations in the levels of the two enzymes were not
related to the time after subculture and no consistent change was
associated with the point at which confluency was reached (Fig. 4).
TIME AFTER SUBCULTJRE TIME AFTER SUBCULTURE
lOAttl (D4VS|
FIG. 4
The activity of a-glucosidase and B-glucosidase
in six strains of amniotic fluid cells in
relation to time since subculture.
t Confluency; Strain 1 not confluent by 7 days.
Analysis of variance of the mean enzyme levels over three
passages for each cell strain in the two culture media was perform¬
ed. No significant difference was found for either a-glucosidase
(F = 2.1, Fq 0g (1,5) = 6.61) or B-glucosidase (F = 1.0).
Cell strains were grown from serial samples of amniotic fluid
obtained from several Rhesus iso-immunised women and the levels of
the enzymes, at the third passage, are given in Table II. The
activity of the two enzymes showed considerable variability within
each series, but this did not seem to be related to the gestation¬
al age.
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TABLE II
Enzyme Levels* in Cell Strains at the Third Passage
Cultured from Serial Samples of Amniotic Fluid




18 0. 30 0.059
22 0.47 0.057
1 24 o CO CO 0. 048
33 0. 58 0. 081
35 0. 24 0. 025
23 0. 38 0. 064
2 26 0.44 0.072
28 0.20 0.069
3
22 0. 57 0. 167
26 0. 67 0. 117
4
27 0. 63 0. 050
34 0. 31 0. 049
* Enzyme activity - nmoles 4-Methylumbelliferone/
min./mg. protein.
DISCUSSION
Several studies have been undertaken of the influence of
culture conditions on the levels of lysosomal enzymes in fibro-
blast-like cells (11-18). However, very little work of this
nature has been reported using cultured amniotic fluid cells (11).
This may well be due to the supposed difficulty in obtaining cell
strains from amniotic fluid (22,23). However, in our laboratory
it has been possible to culture the majority of the amniotic fluid
cell strains to the tenth passage with some still growing well at
the twentieth (24).
The fluctuations observed in the levels of the two enzymes
720 a-^-Glucosidases In Human Amniotic Fluid Cells Vol. 13, No. 6
studied with passage has not been previously reported for
amniotic fluid cells, although it has been noted for fibroblasts
(25). The increase in the level of a-glucosidase with passage
observed in this study probably reflects the decrease in the
ratio of the epithelioid to fibroblast-like cells which occurs
with time in culture (22). The situation with regard to
B-glucosidase is equivocal. Since the activity of B-glucosidase,
unlike a-glucosidase, can show opposite trends in different cell
strains, it seems very unlikely that these trends can be related
to changes in cell type. This interpretation is supported by
the data of Gerbie et aT. (19) on the activity of these two
enzymes in epithelioid and fibroblast-like cultured amniotic
fluid cells.
The positive correlation between the levels of both enzymes
and time to harvest (confluency) is an unexpected result and may
reflect the proportion of dividing to resting cells in cultures
growing at different rates. The lack of any relationship between
the enzyme activities and time after subculture is perhaps not
surprising as such a relationship has only been demonstrated using
homogeneous cell populations (13,16,17,18).
A significantly lower level of B-glucosidase has been found
in fibroblasts grown in Ham's F10 compared with Eagle's M.E.M.
(11,17). Beutler et al. (11) claimed that this enzyme was also
lower in activity in amniotic fluid cells grown in an enriched
medium. In the present study, however, the high concentration
of serum supplement used may have tended to obscure any real
difference in enzyme activity attributable to the chemically
defined components of the medium.
There has been no previous report on the levels of lysosomal
enzymes in cells cultured from amniotic fluid obtained from the
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same women at different stages of pregnancy. The apparent lack
of a correlation of enzyme activity with the gestational age of
the amniotic fluid agrees with results obtained using samples from
different women (7).
The marked variations due to conditions of culture which
occur in the levels of a-glucosidase and B-glucosidase do not pre¬
clude the antenatal diagnosis of Pompe's or Gaucher's disease, but
they would render the detection of heterozygotes very difficult.
A complete understanding of the causes of these variations will
require further investigation.
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Letter to the Editor
reprinted from THE LANCET, November 10, 1973, pp. 1098-1099
AMNIOTIC-FLUID MACROPHAGES AND
ANENCEPHALY
Sir,—Fetal macrophages have never been described in
amniotic-fluid-cell culture. Elevated levels of a-fetoprotein
in amniotic fluid are correlated with malformations of the
fetal c.n.s., especially anencephaly.10-15 The following two
cases indicate that amniotic fluid from anencephalic preg¬
nancies, diagnosed on raised a-fetoprotein levels, contains
fetal macrophages.
Case 1.—This patient, aged 26, para 2 + 1, agreed to amnio¬
centesis for amniotic-fluid a-fetoprotein estimation because her
third pregnancy had resulted in an anencephalic stillbirth and
her serum a-fetoprotein was raised.16 At 21 weeks' gestation,
amniocentesis produced about 20 ml. of slightly bloodstained
amniotic fluid. The fluid was centrifuged and the cell pellet put
into tissue-culture for chromosome studies.17 The following day
the cultures were noted to contain many macrophages, and a
cytogenetic result was obtained within 48 hours of amniocentesis.
Examination of 35 metaphases revealed only male cells. The a-
fetoprotein level of the amniotic fluid was 238 ixg. per ml. The
pregnancy was terminated and resulted in an anencephalic male
fetus.
Case 2.—This patient, aged 23, para 1 + 1, requested amniotic-
fluid a-fetoprotein estimation because her first pregnancy had
resulted in a spontaneous abortion at 10 weeks and her second in
an anencephalic fetus at 36 weeks. Amniocentesis at 17 weeks'
gestation produced 20 ml. of clear amniotic fluid. As in case 1,
on the day following amniocentesis the culture was noted to
contain considerable numbers of macrophages. The a-fetoprotein
level of the amniotic fluid was 254 ixg. per ml. Although ultra¬
sonography on two separate occasions revealed no fetal mal¬
formation, the pregnancy was terminated by intra-amniotic
prostaglandin and resulted in an anencephalic male fetus.
Amniotic fluid obtained at termination had an a-fetoprotein
level of 250 ixg. per ml. The cells from this second sample of
amniotic fluid were placed in tissue-culture, and again macro¬
phages were present. A cytogenetic result was obtained within
24 hours; examination of 22 metaphases revealed only male cells.
On the second day of culture the macrophages showed phagocytic
activity towards sensitised sheep red cells; after 2 hours' incu¬
bation at 37 °C about 70% of the macrophages had ingested red
cells. Quinacrine-fluorescence studies of such macrophages
indicated that about 80% of those which had ingested sheep red
cells showed fluorescent Y-bodies.
These two cases provide evidence that fetal macrophages
were present in amniotic fluid from anencephalic preg¬
nancies. The fetal origin of the macrophages was demon¬
strated by their male karyotype. There was no evidence of
2
maternal macrophages, although in such circumstances a
small number of these may not have been detected. The
presence of maternal macrophages has been suggested as
the explanation for the finding of female cells in amniotic
fluid from male fetuses,18 but this possibility has never been
confirmed. The origin of the macrophages remains
speculative, but they are most probably associated with the
exposure of highly vascularised meningeal and cerebral
tissue.
The findings reported here have important implications
for the antenatal diagnosis of C.N.s. malformations. Any
laboratory finding macrophages in amniotic-fluid cultures
should investigate the possibility that the fluid may have
come from a pregnancy in which the fetus has a gross
c.n.s. malformation. Furthermore, if this finding of
macrophages in anencephalic amniotic fluid is confirmed
and extended to other c.n.s. malformations, then an
additional indicator to a-fetoprotein levels will be available
on which to base antenatal diagnoses. This may be especially
helpful if a-fetoprotein levels are equivocal, or, as in the
second case reported, ultrasonography fails to detect any
malformation.
We are grateful to Dr J. A. Habeshaw for his help in demon¬
strating the phagocytic activity of the macrophages and to Dr
A. D. Bain for his helpful criticism during the preparation of this
report.
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Summary. The cells from 62 amniotic fluids have been cultured to the stage at which
biochemical studies could have been undertaken. Although all cultures showed initial signs
of cellular proliferation in only 90% of these were sufficient cells obtained for biochemical
assay. If a time limit of 6 weeks was to be imposed, only 58% of the cultures could have been
regarded as successful. The problems involved in culturing amniotic fluid cells for the antenatal
diagnosis of inborn errors of metabolism are discussed.
Zusammenjassung. Von 62 Amnionfltissigkeits-Proben wurden die Zellen bis zu einem
Stadium kultiviert, in dem biochemische Untersuchungen moglich wurden. Obwohl alle Kul-
turen anfiinglich Zeichen einer Zellproliferation zeigten, wurden nur in 90% geniigend Zellen
fur biochemische Untersuchungen gewonnen. Unter Annahme einer Zeitbegrenzung von
6 Wochen konnten sogar nur 58% aller Kulturen als erfolgreich betrachtet werden. Die Pro-
bleme bei der Kultivierung von Amnionzellen fur die pranatale Diagnose angeborener Stoff-
wechselstorungen werden diskutiert.
Cultured amniotic fluid cells are almost always required when the antenatal
diagnosis of an inborn error of metabolism is to be made. Except where histo-
chemical techniques are available, this usually means many more cells are required
than for cytogenetic studies. Gerbie et al. (1971) successfully karyotyped 95% of
250 amniotic fluids and other groups have reported similar high success rates.
Little comparable data exists for success in culturing amniotic fluid cells to the
stage where biochemical assays are possible. The time is usually limited to between
6 and 8 weeks for the culture of sufficient cells if a pregnancy may be terminated
on the result. Hence it is valuable to report the experience in culturing cells from
all the amniotic fluids received in this laboratory over a 1-year period.
Materials and Methods
Amniotic fluids were obtained from hysterotomy specimens and by amniocentesis of
—Rhesus iso-immunised women. The 62 amniotic fluids were taken from 47 women. When more
than one sample was collected from any woman it was always from the same pregnancy.
This study includes all such amniotic fluids received in this laboratory over the year ending
Moveruber 1972.
The methods used for primary culture have been previously described (Sutherland et al.,
1973). The primary culture vessel was a 50 mm Nunclon plastic petri dish whiclt'contained
'our or five 6 x 22 mm glass coverslips. In the majority of cases one or two of these coverslips
vere removed from the culture for cytogenetic studies (Sutherland et al., 1973). The primary
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cultures were subcult-ured according to Butterworth et a,I. (1973) into a glass culture bottle
with a growth surface area of 20 cm2. On reaching confluency the cell strains were further
subcultured into a glass culture bottle with a growth surface area of 40 em2. When the cell
strains reached confluency after this second subculture the time since the amniotic fluid had
been collected was noted and this was regarded as the time required to produce enough
cells for a biochemical assay. Cell homogenates prepared from this quantity of cells contain
y2—1 mg of protein and are adequate for a number of biochemical assays (Butterworth et al.,
1973).
Results
The results are summarized in Table 1 and Fig. 1. There were 62 amniotic
fluids, 21 from hysterotomy specimens and 41 from Rhesus iso-immunised women.
All cultures showed cell proliferation as observed under the inverted microscope.
Table 1. Data on the origin and cultural behaviour of the amniotic fluids in this series
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Fig. 1. Distribution of times taken to achieve sufficient cells for biochemical study
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Table 2. Times required for biochemical and cytogenetic results from serial samples of amniotic
fluid collected from three pregnancies
Preg¬ Gesta¬ Time to bio¬ Time to cyto¬
nancy tion chemical result genetic result
(days) (days)
1 23 42 N
26 36 N
28 25 12
0 24 44 N
30 43 18
32 64 14





a This cell strain degenerated after the third subculture.
N = Cytogenetic preparations not made in the minimum time.
There were two cytogenetic failures due to degeneration of the primary culture
before a chromosome result could be obtained. Four other cultures were successful
cytogenetically but failed from the biochemical point of view, one degenerated
in primary culture after a chromosome result had been obtained, two were lost
to microbial contamination after the first subculture and one degenerated after
the first subculture. Hence, if there was no limit on the time taken to produce
enough cells for biochemical assay, the success rate was 56 out of 62. If a time
limit of 8 weeks was to be imposed then the success rate would fall to 49 out of
62 and if the time limit was to be reduced to 6 weeks then the success rate would
fall to 36 out of 62 or 58%.
There is no correlation between gestational age and time to a biochemical
result, either for the whole series or within the Rhesus or hysterotomy groups.
Similarly, the mean time to such a result for specimens of less than 20 weeks
gestation is not different from the time required by those of 20 weeks or more.
All except 11 primary cultures had at least one coverslip harvested for cyto¬
genetic studies. It might be expected that removal of some of the earliest pro¬
liferating cells would increase the time required for biochemical success. This was
not so as the time to result was not significantly different for the two groups.
The collection of serial samples of fluid from women with Rhesus iso-immuni-
sation problems affords the opportunity of studying the behaviour of these serial
samples in tissue culture. Three women contributed three or more samples and
data on these are shown in Table 2. The times taken to reach a biochemical result
within each series are no more related to each other than to the series as a whole.
Although there appears to be some relationship between the times taken to achieve
cytogenetic and biochemical results, a quick cytogenetic result does not neces¬
sarily mean that a quick biochemical result will follow.
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Discussion
Commenting on tissue culture aspects of antenatal diagnosis, Brock (1973) has
said "... that success to the biochemist is more elusive than success to the cyto-
geneticist". The main problem is one of time. Only 4 out of 62 amniotic fluids
failed to reach a biochemical result because of their inability to proliferate suf¬
ficiently. Two were lost to microbial contamination; this should not happen
and highlights the need for meticulous technique. In practice, if more than
6 to 8 weeks were required to produce enough cells any antenatal diagnosis for
the purpose of terminating affected pregnancies would have to lie regarded as a
failure.
There is little data in the literature on this problem. Most authors discussing
amniotic fluid cell culture have claimed the successful repeated subculture of
primary cultures but the proportion in which this is achieved is usually not stated.
The ability of these cells to proliferate sufficiently has been questioned by Little-
field (1971). Nadler and Gerbie (1970) were only able to subculture 75% of 155
successfully cultivated amniotic fluid cell strains more than three times. The most
useful study in this regard is that reported by Uhlendorf (1970) who managed
to achieve "massive cultures" from 77% of 114 amniotic fluid samples. 4—11
weeks were required to produce two 32 oz. prescription bottle monolayers, several
subcultures being necessary. The time range was very similar to that in the present
study although a higher number of cells were taken as the end point. In many
cases "fairly large amounts" of amniotic fluid were used to initiate cultures
whereas in the present series the volumes of fluid used were always less than
20 ml and often less than 10 ml.
The results from the serial samples taken during individual pregnancies indicate
that each sample of fluid can behave differently. If as Uhlendorf (1970) has stated,
there are less than 10 colony forming cells per millilitre of amniotic fluid, fluc¬
tuations in the number in any given sample of, say, 5 ml could be considerable. It
is perhaps significant that although the cellular content of amniotic fluid increases
throughout pregnancy (Nelson and Emery, 1970) the time required for a bio¬
chemical result is not related to gestation.
One problem not apparent in antenatal cytogenetic diagnosis is the degener¬
ation of primary cultures. If an amniotic fluid culture for cytogenetic purposes
is not proliferating after 7 to 10 days, amniocentesis can usually be repeated and
another sample of fluid cultured. Most reported series of cytogenetic antenatal
assessments contain a proportion of such instances. If, however, the primary
culture grows well initially and then degenerates, it is usually too late to repeat
amniocentesis and start again. A similar situation arises if degeneration takes
place after the first or second subculture. A means of overcoming this problem,
and of producing a quicker result in all cases, may be in the application of histo-
chemical techniques. Uhlendorf (1970) described the use of histochemistry for
the antenatal diagnosis of GM1-gangliosidosis by staining cells for ^S-galactosidase
activity. Hill and Puck (1973) have devised an autoradiographic method for the
detection of galactosaemia which utilizes less than 1000 cultured cells. Such
techniques could be carried out on primary cultures and perhaps produce a bio¬
chemical result in the same time as required for a cytogenetic result.
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Nadler and Gerbie (1970) have stated . . the major limiting factor appears
to be the difficulty in obtaining an adequate number of cells for biochemical
analysis". Unless this problem can be overcome the chances of success in this type
of antenatal diagnosis will remain low enough to give doubts as to its clinical
application. Unless the techniques for the culture of amniotic fluid cells can be
improved then efforts should be made towards developing histochemical tech¬
niques and micro assay methods for the enzymes involved in inborn errors of
metabolism.
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The antenatal diagnosis of trisomy 18
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The antenatal diagnosis of a fetus with trisomy 18 in a 41-year-old woman is reported. The
pregnancy was terminated and the diagnosis confirmed cytogenetically and morphologically. The
pathological findings in the fetus are discussed.
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The antenatal screening of mothers of ad¬
vanced age for fetal chromosome abnormal¬
ities has been advocated by a number of
authors. Although the main reason for this
screening is the prevention of Down's syn¬
drome (e.g., Stein et al. 1973), other chro¬
mosome abnormalities will inevitably be
detected. We wish to report the antenatal
diagnosis of a fetus with trisomy 18 in a
41-year-old mother and the subsequent
pathological findings in the abortus.
Case Report
Pregnancy History
The pregnancy was the fifth pregnancy of
a 41-year-old woman but the first with her
second husband. In her first marriage two
uncomplicated pregnancies were followed
by two spontaneous abortions at 9 and 13
weeks.
She was first seen at 12 weeks of preg¬
nancy when she expressed anxiety about the
possibility of having a mongol child be¬
cause of her age. In view of this anxiety
amniocentesis was performed at 16 weeks'
gestation when 8 ml of amniotic fluid was
withdrawn. This fluid was unsatisfactory in
culture (see below); consequently the amnio¬
centesis was repeated at 19 weeks' gestation
when 15 ml of fluid was withdrawn. At this
time the uterus was found to be smaller
than expected for the gestation. Negative
Kleihauer counts were obtained after each
amniocentesis and the fetal heart, monitored
by Sonicaid, was unaffected. From this
second sample of amniotic fluid the fetus
was shown to have trisomy 18. Lower seg¬
ment hysterotomy through a small Pfannen-
stiel incision was performed at 23 completed
weeks of gestation and the conceptus re¬
moved intact. At this time the uterus was
again noted to be small, as was the placenta.
Post-operative recovery was uneventful. The
mother is contemplating another pregnancy
on the understanding that amniocentesis
will again be performed.
Cytogenetic Findings
The first amniotic fluid sample contained
very few cells and showed poor growth in
culture. After 2 weeks there were only a few
This work was supported in part by the Scottish Advisory Committee on Medical Research and
the Secretary of State for Scotland.
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icattered proliferating cells, growing too
lowly for chromosome studies. The cells
>btained from the second sample did grow
md after 20 days in culture a fetal karyo-
ype of 47,XX,+18 was established.
The pregnancy was terminated by hys-
erotomy and cultures from fetal heart
ilood, skin and fascia all confirmed the
ntenatal diagnosis of trisomy 18 (see Table
)■
'athological Findings
"he fetus (Fig. 1) had a crown-rump length
f 18.5 cm and a crown-heel length of 27
m. There were multiple external abnor-
lalities. The ears were low set with under-
eveloped helices which were adherent to
le scalp. There was a small preauricular
tin tag on the right, and two subcutaneous
ndules in the left preauricular area. There
as micrognathia but no cleft lip and the
date appeared normal. Both hands showed
;xion deformities of the fingers and the
dmar creases were atypical. Both feet had
rocker-bottom appearance and the first
es were shorter than the second. There
is only a single umbilical artery.
Internally there also were multiple mal-
rmations. There was complete esophageal
esia with a tracheo-esophageal fistula,
le heart showed a high interventricular
)tal defect. There was a complete horse-
)e kidney. A Meckel's diverticulum was
:sent with a small nodule of whitish tissue
Fig. 1. The fetus at necropsy. Note low set ears,
micrognathia, flexion deformities of the fingers and
the horse-shoe kidney.
at its tip; histologically this proved to be
pancreatic tissue without islet cells. The only
abnormality of the brain was an anterior





is amniotic fluid 9 47,XX,+ 18
heart blood 30 47,XX,+-18
fibroblasts (a) skin 15 47,XX,+ 18
(b) fascia 15 47,XX,+ 18
ler blood 30 46,XX
er blood 30 46,XY
Discussion
The case illustrates two main points. The
first is the value of antenatal diagnosis of
fetal abnormality when this can be followed
by abortion. The second is that chromosome
abnormalities other than mongolism will be
encountered when fetal karyotyping is per¬
formed on women of advanced age (Suther¬
land 1972). The prevention of children with
these other chromosome abnormalities is an
GORDON, SUTHERLAND, BAULD, AND BAIN
added benefit in any attempt to reduce the
incidence of Down's syndrome (Stein et al.
1973).
The amniocenteses were apparently with¬
out any ill effect. There were no maternal
complications, the sac was intact at hys¬
terotomy and the fetus showed no evidence
of injury.
There are only two previously reported
instances of the antenatal diagnosis of tri¬
somy 18. The first, diagnosed at 31 weeks'
gestation, proceeded to term and resulted in
a stillbirth with the features of Edwards'
syndrome (Milunsky et al. 1972). The sec¬
ond (Hsu et al. 1973) was a case similar to
the present one, diagnosed in a 40-year-old
woman and aborted at 20 weeks' gestation.
The pathological findings in the fetus are
typical of those seen in neonates and older
children with this syndrome (Taylor 1968).
It is of interest that this fetus and the one
described by Hsu et al. (1973) both had a
Meckel's diverticulum with a small nodule
at its tip. In the present case this proved to
be heterotopic pancreatic tissue. One of the
cases described by Taylor (1968) also had
heterotopic pancreatic tissue but apparently
not in association with a diverticulum.
The fetus had a crown-rump length which
corresponded to only 20 weeks' gestation
and the placenta was small. The finding of
a small placenta in this syndrome has been
recorded by Hecht (1963) and by Hsu et a
(1973). The study of fetuses such as thi
may help to determine the time of onset c
the retardation in growth and developmer
usually associated with chromosome abnoi
mality.
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Observations on human amniotic fluid cell strains
in serial culture
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Department of Pathology, Royal Hospital for Sick Children and University of Edinburgh, Edinburgh EH9 1LF
Summary. Observations made on 31 amniotic fluid cell strains serially cul¬
tured until senescent are recorded. The cell strains had an average life in culture of
13-9 passages (range 3-29). The source of the amniotic fluid from which the cul¬
tures were initiated did not influence the behaviour of the cell strains. The be¬
haviour of the cell strains was unrelated to the growth characteristics of the primary
cultures from which they were derived. Cell strains derived from serial samples of
amniotic fluid from three women were compared and their characteristics were no
more related to each other than to the group as a whole. The cell types found in
amniotic fluid are described. The karyology of 12 of the cell strains was moni¬
tored and no significant changes from normal diploidy were seen. Possible reasons
for the highly variable and unpredictable behaviour of amniotic fluid cell strains are
discussed.
Cultured amniotic fluid cells are now in wide¬
spread use for the antenatal diagnosis of chromo¬
some disorders and inborn errors of metabolism
(Emery, 1970; Sutherland, 1972; Emery, 1973;
Milunsky, 1973). An accurate knowledge of the
behaviour of normal cultured amniotic fluid cell
strains is therefore essential for their use in genetic
studies. However, little appears to be known
about the characteristics of these cells in tissue cul¬
ture. It has been stated (Melancon, Lee, and
Nadler, 1971) that there are at least two morpho¬
logically distinguishable cell types in amniotic fluid
cell cultures—an epithelial type which cannot be
subcultured more than two to five times and a
fibroblast-like cell which can be cultured for more
than 30 passages. On the other hand, Littlefield
(1971) has said that '. . . 6 to 8 weeks of rapid cul¬
ture can approach the limit of the growth potential
of amniotic fluid cells . . .'. This report records
observations made during the long-term culture of
31 amniotic fluid cell strains.
Materials and Methods
Amniotic fluids were obtained from hysterotomy
specimens (HS), by amniocentesis on Rhesus iso-
immunized women (RhS) and by artificial rupture of
Received 5 November 1973.
membranes (ARM) for the induction of labour. The
primary cultures were set up as previously described
(Sutherland and Bain, 1972) and subculturcd according
to the method of Butterworth et al (1973). The cell
strains- were maintained in 250-ml glass vessels with a
growth surface area of 40 cm2 and regularly subcul¬
tured on reaching confluency, using a 1:2 subculture
ratio. Throughout this study, all cell strains were cul¬
tured in Ham's F10 tissue culture medium supple¬
mented with 30 % fetal calf serum and with the anti¬
biotics kanamycin, or penicillin and streptomycin in
combination. The methods used for cytogenetic studies
on primary cultures have been described (Sutherland,
Grace, and Bain, 1973b). Once cell strains became
established, chromosome preparations were made using
'standard methods. Cell strains were stored in 10 ,
dimethyl sulphoxide in culture medium in the vapour
phase of a liquid nitrogen unit.
Results
The 31 cell strains were derived from amniotic
fluid samples taken from 25 women, ie, one woman
contributed four samples, another three, and another
two at different stages of pregnancy. The gesta¬
tional ages, means of collection, and chromosomal
sexes of the amniotic fluids are shown in Table I.
All had normal karyotypes with the exception of two
samples from one pregnancy which had a karyotype
46,XY,t(l; 12)(p21 ;q21).
Sutherland, Bauld, and Bain
TABLE I
GESTATIONAL AGES, ORIGINS AND CHROMOSOMAL
SEX OF THE: il AMNIOTIC FLUIDS WHICH
YIELDED CELL STRAINS











ARM (n = 1) 39 1 1
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THE DISTRIBUTION OF THE NUMBER OF PASSAGES
FOR WHICH THE 31 AMNIOTIC FLUID CELL
STRAINS COULD BE CULTURED UNTIL DEATH
No. of passages 0-4 5-8 9-12 1 13-16 17-20 ] 21-24 >25
No. of cell strains 3 3 8
1 7 5 3 2
to which a cell strain could be cultured or the mean
interval between subcultures. Similarly, the num¬
ber of passages was not correlated with the time in
primary cu lture. There was, however, a signifi¬
cant (p<001) correlation (r= —0-550) between
mean subculture interval and the number of pas¬
sages (Fig. 1).
All cell strains which survived more than five or
six passages were stored in the liquid nitrogen unit.
Thirteen strains have been retrieved and then cul¬
tured to senescence. The mean number of passages
before death of the 13 strains was 14 5 (range 5-25)
and after storage the mean was 13-4 (range 5-24).
Most of the retrieved cell strains died within ± 3
passages of the corresponding strain which had not
been stored. The greatest difference was one strain
which survived for 17 passages before storage and
for only 12 passages after being stored at the fourth
passage.
When more than one amniotic fluid sample was
collected at different stages from a single pregnancy
it was possible to compare the cell strains derived
from these samples. Some data relating to three
such groups of cell strains are shown in Table IV.
Some data on the cell strains are shown in Table
II. The differences between the HS and RhS are
not significant for any of these parameters. The
number of passages is the number of times a cell
strain could be subcultured, using a 1:2 subcultiva-
tion ratio, before the cell strain died. Death of a
cell strain was defined as the point at which it would
no longer grow to confluency after subculture. The
time as a cell strain was the interval between sub-
culturing the primary culture and the death of the
cell strain. The mean interval between subcul¬
tures was the time as a cell strain divided by the
number of passages till death, and was a crude esti¬
mator of the overall rate of growth of a cell strain.
The distribution of the number of passages is shown
in Table III.
The data were examined to see if any of the para¬
meters of the amniotic fluid were related to the be¬
haviour of the cell strain in culture. There was no
correlation between gestational age and the follow¬
















Mean interval between subcultures (Days]
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Fig. 1. Relationship between the number of passages for which cell
strains could be cultured before death and mean interval between
passages. (r= -0-550.)
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TABLE IV
DATA ON 9 AMNIOTIC FLUID CELL STRAINS COLLECTED FROM THREE
PREGNANCIES
Chromosomal Gestation Days in No. of Days as Mean Interval
Group Sex (weeks) 1 Culture Passages Cell Strain between
. Subcultures
1* Male 22 28 11 106 9 7
26 41 4 42 10 5
2 Female 18 28 18 144 7-8
22 24 8 108 12 0
21 20 15 110 7-3
35 36 17 69 41
3 Female 23 26 18 125 6-9
26 26 22 129 5 9
28 19 10 71 7-1
* This group has a constitutional chromosome abnormality (see text).
The cell strains in each group do not show uniform
behaviour, they vary as greatly as cell strains derived
from different pregnancies. This may indicate that
the genetic make-up of the cells is not responsible
for the variable behaviour of the cell strains.
The cell morphology was monitored throughout
the period of culture by direct observation under the
inverted microscope and by the examination of
Giemsa-stained monolayers grown on flying cover-
slips. There were five readily recognizable cell
types.
1. Macrophages (Fig. 2). These were visible
the day after primary cultures had been set . j up.
; These appear to divide in culture but cannot be
subcultured. They degenerate and are overgrown by
other cell types. iVery: few macrophages are seen in
amniotic fluid cell culture except when the amniotic
fluid comes from an anencephalic pregnancy when
they are present in considerable numbers (Suther¬
land, Brock, and Scrimgeour, 1973a).
2. Epithelioid Type I Cells (Fig. 3) which
grow in 'islands' in primary culture. These cells
can apparently be subcultured but lose their ten¬
dency to grow in 'islands' after subculture.
Fig. 3. Epithelioid type I cells after 18 days in primary culture.
(Phase contrast, x 200.)
-m
Fig. 2. Macrophages from anencephalic amniotic fluid after 20
hours in culture. (Giemsa stain, * 200.)
Fig. 4. Fpithelioid type II cells after 23 days in primary culture.
There are tibroblast-like cells growing between the epithelioid cells.
Note one binucleate epithelioid cell and the fibrillar nature of the
cytoplasm. (Phase contrast. v 200.)
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3. Epithelioid Type II Cells (Fig. 4). These
are very large cells with much cytoplasm and some¬
times with more than one nucleus. Under phase
contrast the cytoplasm of these cells has a fibrillar
appearance. These cells can be subcultured at
least 20 times. Almost all primary cultures of
amniotic fluid contain these cells.
4. Epithelioid Type III Cells (Fig. 5) which
morphologically resemble type I except that they do
not grow in islands in primary cultures. In their
growth patterns these cells show some of the features
of the next cell type. These cells can be readily
subcultured.
Fig. 5. Epithelioid type III cells in the twenty second passage of
culture. (Giemsa stain, x 200.)
5. Fibroblast-like Cells (Fig. 6) which can be-
readily subcultured. These are morphologically
indistinguishable from fibroblast-like cells cultured
from human embryonic lung or skin biopsy.
Most cell strains were a mixture of cell types
throughout their life in culture. However, in some
cases one type or the other predominated. In this
Fig. 6. Fibroblast-like cells in the fourth passage of culture.
(Giemsa stain, x 2o0.)
series there was a tendency for the more fibroblastic
cultures to live longer however, some died after less
than 10 passages whereas strains in which epi¬
thelioid cells predominated lived for more than 20
passages.
The karyology of 12 of the cell strains was moni¬
tored to w ithin at least three passages before cell
death. At least 10 metaphases per cell strain were
examined at this stage and no departure from nor¬
mal diploid complements were seen, except for that
present in two of the cell strains as a constitutional
abnormality.
All except five cell strains were tested for myco¬
plasma contamination on at least one occasion near
the end of their life in culture. All cell strains
tested were reported free of mycoplasmas.
Discussion
It is apparent that amniotic fluid cell strains have
a highly variable yet finite life-span in culture. In
the series reported here senescent strains and ac¬
tively proliferating strains were in culture at the
same time, receiving the same culture medium and
being kept under apparently identical conditions.
This would suggest that culture factors were not re¬
sponsible for the variation. The longest surviving
cell strain in this series survived 29 subcultures.
This, however, is not the upper limit of life of an
amniotic fluid cell strain; Melancon et al (1971)
have reported that some can be cultured for more
than 30 passages, and other cell strains since this
series was completed have survived more than 50
passages.
The reasons for the variability in the life of-the cell
strains remain unclear. In all cases they are de¬
rived from fetal tissue and as the survival in culture
was not correlated with gestational age, it is unlikely
that the variable age of the cells which initiate the
primary culture is the reason. Martin, Sprague,
and Epstein (1970) have shown that the life span of
.fibroblast-like cells in tissue culture depends on the
tissue used to establish the culture. Skin-derived
fibroblasts survived longer than those derived from
muscle, testis, or bone marrow spicules. Although
the tissue of origin of the cells in amniotic fluid is
uncertain they probably come from more than one
source (Sutherland and Bain, 1972). Some of the
variability seen could possibly be due to different
samples of amniotic fluid having different propor¬
tions of cells from each possible source, each with a
different survival potential in tissue culture.
As there are only a relatively small number of
points of outgrowth in the primary culture the num¬
ber of cell doublings would be much higher than the
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number of passages would imply. This may well
be the reason why amniotic fluid cell strains appear
to have a shorter life in culture than cell strains
grown from other fetal tissues. However, if this
was the reason for the variation in the length of life
in culture, a correlation between number of passages
till death and time in primary culture would be ex¬
pected, this was not found. The fact that the life in
culture is finite is not surprising as Hayfiick (1965)
has shown that human diploid cells have a limited
life span of 50+ 10 passages when grown from fetal
tissue.
The finding that the faster growing cell strains
live longer is unexpected. This has not been pre¬
viously reported for human diploid cell strains and
the reasons for it remain unknown. Hay (1970) has
in fact reported the exact opposite effect for chick
embryo fibroblasts.
The variability in life-span of the amniotic fluid
cell strains is very like that described by Swim and
Parker (1957) for fibroblast-like cell strains. These
workers found that the number of times they could
subculture cell strains grown from neonatal fore¬
skins ranged from 10 to 34 with a mean of 24. Cell
strains grown from other tissues, including human
embryonic lung, survived from two to 32 subcul¬
tures. They attributed this variability to inade¬
quate tissue culture medium. Perhaps the same
explanation may apply to the amniotic fluid cell
strains. Using medium similar to that used in the
present series but with only 15% fetal calf serum
supplement, Nadler and Gerbie (1970) were able
to subculture only 75% of 155 successful primary
amniotic fluid cell cultures more than three times.
Sutherland and Bain (1973) found that 90% of 62
primary cultures could be subcultured to yield cell
strains which could be maintained for at least two
subcultures.
The findings in the groups of cell strains grown
from serial samples of amniotic fluid are not sur¬
prising. As none of the properties studied are re¬
lated to gestation there is no reason why these cell
strains should show cither constant features or any
trends within the groups. It would be of interest
to culture a nuthber of cell strains from a single
amniotic fluid sample and to see if they showed the
same degree of variation as seen in these groups.
Melancon et al (1971) suggested that cell type
may influence length of life in culture. If cell type
did affect life in culture then the number of pas¬
sages till death would be expected to show a multi¬
modal distribution. In this series the distribution
of the number of passages is fairly evenly around the
mean.
The variety of cell types present in amniotic fluid
has received little attention. Gerbie et al (1972)
have said that amniotic fluid cell strains are com¬
posed of two major cell types, epithelial-like cells
and fibroblast-like cells. Melancon et al (1971)
have commented that the epithelial-like cells are
difficult to subculture and can be maintained for
only two to five passages. It is recognized that
medium composition can alter cell morphology (eg,
Griffiths, 1973). In this regard it should be noted
that for this series the medium was prepared in
large batches and that the various cell types not only
co-existed in the same culture vessel but cell strains
of predominantly different morphologies were being
cultured concurrently. The only comprehensive
report of the various cell types is that of Uhlendorf
(1970). He has described fibroblast-like cells and
epithelial-like cells corresponding to types II and
III of this report. The 'small fusiform cells' which
he describes probably correspond to the type I epi¬
thelioid cells of this report. When the islands in
which these cell?) grow become large, the cells in the
centre of the island become crowded and take on an
appearance very similar to that shown in Uhlen-
dorf's Fig. 2. In addition, Uhlendorf described a
cell type not recognized in the present series (Fig.
5 in Uhlendorf, 1970).
It is clear that amniotic fluid cell strains are com¬
posed of a number of different cell types and that
some, if not all, of these can persist as long as the cell
strain survives. If the various tissue culture media
in general use and the variety of conditions under
which these cells can be cultured had the effect of
selecting against any particular cell type then this
could explain the apparent differences reported in
the behaviour of amniotic fluid cell strains. The
very act of subculturing may in fact be such a selec¬
tive mechanism as the fibroblast-like cells are more
readily removed from the growth surface than epi¬
thelial-like ones. Melancon et al (1971) have indeed
used this feature to select cell strains of different
^ morphology.
The findings of normal karyology in the cell
strains monitored until senescence is not surprising.
The types of chromosome changes which have been
described in senescent human diploid fibroblast-like
cells (Saksela and Moorhead, 1963) would not have
been demonstrated due to the small number of cells
examined but any major departure from euploidy
would have been detected. No cell lines or cell
strains other than those derived from amniotic
fluid or urine (Sutherland and Bain, 1972) were
handled in the laboratory during the time this work
was in progress.
The main question posed by this work is why
cannot all amniotic fluid cell strains be maintained
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for the same length of time as cell strains derived
from other fetal tissues/ One reason is probably the
low cell number used to initiate cultures but this is
only part of the answer. The reasons for the vari¬
ability in life expectancy of these cell strains remain
speculative. The factors which prevent these cul¬
tures from having a prolonged existence should be
identified. The loss of valuable amniotic fluid cell
strains at an early passage is a hindrance to building
up adequate controls for the antenatal diagnosis of
genetic disease using cultured amniotic fluid cells.
We are grateful to Professor A. E. H. Emery for help¬
ful criticisms during the preparation of this report, and
to Dr S. Stewart for the Mycoplasma testing. This
work was supported in part by the Scottish Advisory
Committee on Medical Research and the Secretary of
State for Scotland.
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Summary
c
Fifteen primary amniotic fluid cultures were established from a single
sample of amniotic fluid. Three different methods were used to set up these
cultures which yielded 13 cell strains. Nine lysosomal enzymes (acid phospha¬
tase, ^-glucuronidase, (i-galactosidase, a-galactosidase, a-glucosidase, o-man-
nosidase, a-arahinosidase, A'-acetyh/i-D-glueosaminidase and arylsulphatase A)
were assayed in these 13 cell strains. The coefficients of variation of these
enzyme levels were loss than the coefficients for enzyme levels in cell strains
grown from different samples of amniotic fluid but greater than those for the
combined culture and assay system used. No assay values were found which
could have suggested a possible enzyme deficiency disease.
Introduction
Lysosomal enzymes are involved in a number of inborn errors of metabo¬
lism. many of which can now be diagnosed antenatally [11. The activities of
these enzymes fluctuate in amniotic fluid cell strains [2—4] and fibroblast-like
cell strains |5.6] assayed at different stages of culture. Multiple fibroblast-like
cell strains grown from a single skin biopsy have been shown to have consider¬
able variation in the activity of five lysosomal enzymes [7]. This variation was
so great as to suggest that a lysosomal enzyme deficiency disease might have
been wrongly diagnosed. The possibility that a similar situation may exist for
cell strains cultured from a single sample of amniotic fluid has been investi¬
gated.
Materials and Methods
Amniotic fluid was collected from a pregnancy of 18 weeks gestation,
terminated because of severe maternal pre-eclamptie toxaemia. The fluid was
divided into 15 aliquots of 5 ml and one primary culture was established from
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TABLE I
TIMES IN CULTURE FOR THE 3 METHODS OF ESTABLISHING CULTURES
Behaviour of the 15 amniotic fluid cultures (a—o) with time in primary culture and time from the first
subculture until the cells in the third and sixth passages were harvested for enzyme assays
Method of primary Days in Days until Days until
culture and cell primary 3rd passage 6th passage






, • V; —
c 38 46 60
d 36 53 78
e 36 51 82
II f 25 37 51
g 28 39 58
h 25 39 58
i 22 37 53
j 22 37 51
III k 22 39 56
1 23 37 58
m 22 '39 60
n 22 39 58
o 22 37 58
*
Cell strain died in the first passage.
**
Primary culture degenerated and could not be subcultured.
The assay values of the nine lysosomal enzymes measured at the third and
sixth passages are shown in Table II. To compare the variations in enzyme level
in the two passages and to establish their relationship with the variations found
in a series of amniotic fluid cell strains cultured from different samples of
amniotic fluid [10], the coefficients of variation were calculated and are shown
in Table ill. For this calculation the values for the three cell strains derived
from primary cultures established using Method I were excluded because of
their different behaviour in tissue culture. The coefficients of variation of the
combined assay and culture system, determined by assays on replicate cultures
as previously described [2], are also included in Table III.
The coefficients of variation for each enzyme in the third and sixth pas¬
sages are similar in magnitude for-all enzymes except a-mannosidase and u-
arabinosidase. The coefficients for all the enzyme levels in the third and sixth
passages are smaller than those found for the control series of- cell strains
cultured from different samples of amniotic fluid and greater than those for the
combined culture and assay system.
Discussion
Cultured amniotic fluid cells are the most reliable material for enzyme
assay on which antenatal diagnoses of inborn errors of lysosomal enzyme me¬
tabolism are to be based [1,13,14]. It is thus essential that the two principle
techniques involved in such diagnoses, tissue culture and enzyme assay, must
combine to produce reliable and reproducible results. The establishment of a












































































































































































































































































TABLEIII COEFFICIENTFVARIATIONVALUESOB AINED Mean,standardd viationcoefficientfvariationf rhelysosomale zymesthirdandsixthpassagesofcultureandthcoefficientfvariationfcon rolseriesofc llstrainsculturedfromdiffer ntsamplesofa nioticu dandforthecombineda sayaculturesystem.N.D=otone. CellstrainsAcidj3-j3-a-a-a-a-A'-Acetyl-jJ-D-Arylsui-phosphatase-Glucuronidase-Galactosidase-Galactosidase-Gluco idase-M nnosidase-Ar bino idase-glucosaminidaseph t e Thirdpassage Mean5-191.127. 50.087.4441.062.2044.51.93S-D-0.630.281.270.0580.1250.1290.49.580.416Coefficientof12.15.217.69.938.112.23.82.51.5variation Sixthpassage' Mean5.730.886.500.586.0.4160.767. 539.82.16S.D.0.820.210.700.0540. 91.203. 244.950. 13Coefficientof14.423.710.89.5121.926.54.62.419.1variation Control (thirdpassage) Coefficientof36.540.042.835.747.446.147.232.1N.D.variation Combinedsyst m Coefficient7.44,55.23.38.56.5.27.1N.D.ofvariation
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number of primary cultures from a single large sample of amniotic fluid and
enzyme assay on the cell strains subsequently produced allows both laboratory
procedures to be tested simultaneously.
Much of the delay in achieving sufficient cells for a biochemical assay is
taken up by the time in primary culture. Ilence three methods of primary
culture were tested. The first method used has been claimed to produce such
rapid growth of primary cultures that sufficient cells for cytogenetic studies
could be obtained in an average of seven days [8]. No other published method
of primary culture lias reported such rapid cell growth. The second method
used has been employed to study the delay due to tissue culture in the antena¬
tal diagnosis of inborn errors of metabolism [15]. The third method involved a
modification of the culture maintenance schedule of the second, similar to that
of other published methods [16,17 ). The results show that the first method
was inferior to the other two for this sample of amniotic fluid. In addition, t he
variation in the enzyme levels in the three cell strains eventually derived from
the primary cultures set up using the first method was greater than that seen in
the 10 strains derived from the other primary cultures.
There are two main features of this variation in enzyme levels in a series of
cell strains derived from one sample of amniotic fluid. The first is that this
variation is considerably less than that found in a series of cell strains derived
from different amniotic fluid samples. There are several reasons for this other
than the common origin of the cell strains; they were all in tissue culture at the
same time, receiving the same batch of culture medium and fetal calf serum and
all the enzymes were assayed at the same time. In spite of these constant
conditions of tissue culture and enzyme assay the highest value of some en¬
zymes was more than twice the lowest. Such variation would cast doubt upon
heterozygote identification based on enzyme assay of a single sample of cul¬
tured cells. Some cell strains even retained widely different enzyme levels in
both passages as, for example, the a-glucosidase level in strain n which was
approximately twice that in strain o in both passages assayed. If the cell strains
derived from cultures established by method I are considered then this varia¬
tion is even more marked. Strain d had g-galaetosidase and arylsulphatase A
levels which were much greater than in the other cell strains although the rest
of the enzymes in this culture were within the range for the other cell strains.
The second main feature of the results is their relationship to the only
comparable study [7], in which cultured fibroblast-like cells were used. Great
variations were found in the levels of several lysosomal enzymes in multiple
fibroblast-like cell strains grown from a single human foreskin. For jl-galac-
tosidase, there was more than a 3-fold difference between the highest and
lowest values whereas in the present study this difference was relatively small.
The two series agree on the finding for iV-aeetyl-|3-D-glucosaminidase which
showed little variation and for ^'-glucuronidase in which there was a 2.5-fold
difference between the highest and lowest assay values. The results of the
present study for arylsulphatase A are not comparable with those quoted by
Milunsky et al. [7] as their substrate and experimental conditions were not.
specific for arylsulphatase A [ 18,19].
The results of this study on cell strains derived from one sample of am¬
niotic fluid are in agreement with previous findings [10] on cell strains derived
217
from different amniotic fluids. Enzyme assay of normal amniotic fluid cell
strains should not produce values suggestive of an enzyme deficiency disease.
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Lysosomal Enzyme Levels in Human
Amniotic Fluid Cells in Tissue Culture
IS. a-gaSactosidase, p-galactosidase and ot-arabinosidase
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Changes in the activities of a-galactosidase, /J-galactosidase and a-arabinosidase in amni¬
otic fluid cells vvitfi time in culture were studied. Marked fluctuations in all three en¬
zymes occurred with passage. In certain cell strains, /?-galactosidase showed a marked
rise in activity correlated with passage. The activity of all three enzymes, in amniotic
fluid cells at the third passage, was correlated with the total time taken to reach con-
fluency. There was no consistent pattern of enzyme activity associated with the time
after subculture. Enzyme levels in cell strains deived from serial samples of amniotic
fluid from several women showed large differences in activity unrelated to gestational
age.
Received 12 December 1973, accepted for publication 7 January 1974
The number of diseases resulting from a
known deficiency of a lysosomal enzyme
has increased rapidly in recent years. With
the demonstration that these deficiencies
can be detected in cultured amniotic fluid
cells, antenatal diagnosis for inborn errors
of lysosomal metabolism has become prac¬
ticable (Brady 1973, Nadler 1970, 1972,
Prescott et al. 1972). However, little atten¬
tion has been paid to possible fluctuations
in the levels of lysosomal enzymes in cultu¬
red normal amniotic fluid cells (Beutler et
al. 1971, Butterworth et al. 1973a, b, Ger-
bie et al. 1972). The effect of culture time
on the activity of lysosomal enzymes in
normal amniotic fluid cell strains has, there¬
fore, been investigated. The results for «-ga-
lactosidase, /J-galactosidase and o-arabino-
sidase are presented as part of this study.
Methods
Amniotic fluid samples were obtained from
hysterotomy specimens and by amniocen¬
tesis of Rhesus iso-immunised women who
had no history of inborn errors of lysoso¬
mal metabolism. Primary cell cultures were
set up (Sutherland et al. 1973), then subcul-
lured, harvested and homogenized (Butter¬
worth et al. 1973a), and the lysosomal en¬
zymes «-galactosidase, /?-galactosidase and
«-arabinosidase assayed using 4-methylum-
bellifcrone glycosides (Buttcrworth et al.
1972). Protein concentration was assayed
(Miller 1959) using bovine serum albumin
as standard.
The reproducibility of the combined cul¬
ture and enzyme assay methods was tested
by establishing 12 replicate cultures of one
This work was supported by the Advisory Committee on Medical Research for Scotland.
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cell strain at two different passages. The
12 replicates were harvested when they had
simultaneously reached confluency, and
then assayed for enzyme activity. To study
enzyme activity with respect to passage,
six cell strains were subcultured for up to
15 passages and the enzyme levels assayed
at intervals. All the cell strains were as¬
sayed at the third passage, and the time
interval between subculture and harvest
(confluency) noted. The variation in enzyme
level within a single passage was followed
by establishing a series of replicate cultures,
which were harvested for enzyme assay at
daily intervals for up to 7 days.
Results
The reproducibility of the combined culture
and assay system for each enzyme is pre¬
sented in Table 1. The variation of the to¬
tal experimental procedure (coefficient of
variation) was below 6.0% for all the en¬
zymes. The variation in the levels of the
three enzymes with passage is given for
six cell strains in Figs. 1-3. The coefficient
of variation of the mean enzyme levels for
the different cell strains was 20-33% for
a-galactosidase, 27-68% for /J-galactosidase
Table 1
Reproducibility of culture and assay system
Coefficient























* Enzyme activity in nmol 4-methylumbelliferone min-'
mg-1 protein for 12 replicates
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Fig. 1. The activity of «-galactosidase in serial passa¬
ges of six strains of cultured amniotic fluid cells.
and 18-39% for a-arabinosidase. Thus, all
three enzymes showed much greater fluctu¬
ations with passage than could be attributed
to experimental error alone.
A comparison of the enzyme levels in the
first five passages with those in the next
10 for these six cell strains showed that
/(-galactosidase activity was lower (P <<
0.005) in the earlier passages. However,
the mean activity of /?-galactosidase in the
third and tenth passages of these six strains,
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Fig. 2. The activity of /?-galactosidase in serial pas¬
sages of six strains of cultured amniotic fluid cells.
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Fig. 4. Relationship of the activity of «-galactosidase
in cultured amniotic fluid cells with time to reach
confluency (harvest).
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Fig. 6. Relationship of the activity of «-arabinosidase
in cultured amniotic fluid cells with time to reach
confluency (harvest).
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Fig. 3. The activity of «-arabinosidase in serial pas¬
sages of six strains of cultured amniotic fluid cells.
nificantly different. In these 12 strains the
activities of «-galactosidase and «-arabino-
sidase at the third and tenth passages did
not differ significantly. The contradictory
results for /I-galactosidase could be accoun¬
ted for by three of the six strains examined
in detail (strains 4-6, Fig. 2), which showed
13-GALACTOSIDASE-ARABINOSIDASE
1 1 1 1 1 1
SO 2 A 6 8 10 12
TIME TO HARVEST (Days)
Fig. 5. Relationship of the activity of /?-galactosidase
in cultured amniotic fluid cells with time to reach
confluency (harvest).
a marked rise in activity with passage not
apparent in the other strains.
The relationship of the enzyme activity
in cell strains at the third passage to the
oC-GALACTOSIOASE
4
Enzyme levels* in cell strains at the .third
passage cultured from serial samples of
amniotic fluid obtained from four women.
time at which coufluency (harvest) was
reached is given in Figs. 4-6. A significant
correlation between these two parameters
was found for a-galactosidase (r = 0.42),
/j-galactc.sidase (r = 0.64) and a-arabino-
sidase (r = 0.61). However, if the few cell
strains requiring 10-12 days to reach con-
fluency were not considered, only the cor¬
relation for «-arabinosidase (r = 0.37) was
still significant.
Table 2
£ 12 3 15 6 7
TIME AFTER SUBCULTURE (DaysI
Fig. 7. The activity of ./.-galactosidase in six strains
cf amniotic fluid cells in relation to time since sub¬
culture.
^Ccnfluency; Strain 1 not confluent by 7 days
^ i i r— 1 1 j
1 2 3 /, 5 5 7
TIME AFTER SUBCULTURE ( Days)
Fig. 9. The activity of t-arabinosidase in six strains
of amniotic fluid cells in relation to time since sub¬
culture.
$Confluency; Strain 1 not confluent by 7 days
o< - GA LACTOSIDASE c* -ARABINOSIDASE
f3 - GALACTOSIDASE
TIME AFTER SUBCULTURE (Days)
Fig. 8. The activity of /?-galactosidase in six strains
of amniotic fluid cells in relation to time since sub¬
culture.











18 0.30 2.87 0.47
22 0.59 4.51 0.74
1 24 0.78 5.01 0.88
33 0.30 9.55 0.66
35 0.44 5.48 0.38
23 0.35 2.87 0.48
2 26 0.33 4.63 0.38
28 0.29 4.96 0.22
22 0.65 10.76 1.11
26 0.37 7.85 0.74
27 0.32 3,17 0.53
34 0.35 2.67 0.31
* Enzyme activity - nmol 4-methylumbelliferone min-1
mg-1 protein
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The fluctuations in the levels of the
three enzymes in relation to time after
subculture are given in Figs. 7-9. No con¬
sistent change was associated with the time
after subculture. There was also no consis¬
tent change in enzyme activity after the
time at which the cells became confluent.
Cell strains were grown from serial sam¬
ples of amniotic fluid obtained from several
Rhesus iso-immunised women and the lev¬
els of the enzymes, at the third passage,
are given in Table 2. The activity of all
three enzymes showed considerable varia¬
tion within each series, that did not relate
to gestational age. *
Discussion
The activities of «-galactosidase, /?-galacto-
sidase and «-arabinosidase in normal amni¬
otic fluid cells have been shown to vary
with the time in tissue culture. The signi¬
ficance to the results will be considered
in relation to similar studies on other lyso¬
somal enzymes in the following paper (But-
terworth et al. 1974).
References
Beutler, G. H„ W. Kuhl, F. Trinidad. R. Tep-
litz & H. L. Nadler (1971). /i-glucosidase
activity in fibroblasts from homozygotes and
heterozygotes for Gaucher's disease. Amer.
J. hum. Genet. 23. 62—66.
Brady, R. O. (1973). The abnormal biochem¬
istry of inherited disorders of lipid metabo¬
lism. Feci. Proc. 32, 1660-1667.
Butterworth, J., F. Scott, W. M. McCrae &
A. D. Bain (1972). Lysosomal enzymes of
cultured fibroblasts of Cystic Fibrosis pa¬
tients. Clin, chini. Acta 40, 139-142.
Butterworth, J., G. R. Sutherland, D. M.
Broadhead & A. D. Bain (1973a). Lysosomal
enzymes of cultured amniotic fluid cells.
Clin. chim. Acta 44, 295-299.
Butterworth, ]., G. R. Sutherland, D. M.
Broadhead & A. D. Bain (1973b). Lysosomal
enzyme levels in human amniotic fluid cells
in tissue culture. I. a-glucosidase and /?-g!u-
cosidase. Life Sci. 13, 713-722.
Butterworth, J., G. R. Sutherland, D. M.
Broadhead & A. D. Bain (1974). Lysosomal
enzyme levels in human amniotic fluid cells
in tissue culture. III. ^-glucuronidase, N-
acetyl-/?-D-glucosaminidase, a-mannosidase
and acid phosphatase. Clin Genet.
Gerbie, A., S. B. Melancon, C. Ryan & H. L.
Nadler (1972). Cultivated epithelial-like cells
and fibroblasts from amniotic fluid: Their
relationship to enzymatic and cytologic ana¬
lysis. Amer. J. Obstet. Gynec. 114, 314-320.
Miller, G. L. (1959). Protein determination for
large numbers of samples. Analyt. Client. 31,
964.
Nadler, H. L. (1970). Newer procedures in the
preconceptional, prenatal and early postnatal
diagnosis of birth defects. Birth Defects:
Original Article series VI, 26-33.
Nadler, H. L. (1972). Tissue culture and ante¬
natal detection of molecular diseases. Bio-
chimie 54, 677-681.
Prescott, G. H„ R. E. Magenis & N. R. M.
Buist (1972). Amniocentesis for antenatal
diagnosis. Postgrad. Med. 51, 212-217.
Sutherland, G. R., E. Grace & A. D. Bain
(1973). Metaphase chromosomes from neo¬
natal urine. Hum. Genet. 17. 273-275.
Address:
J. Butterworth Ph. D.
Department of Pathology
Royal Hospital for Sick Children
Edinburgh EH9 1LF
Scotland
Clinical Genetics 1974: 5:
Lysosomal enzyme levels In human
amniotic fluid cells in tissue culture
III, (5-glucuronidase, N-acetyl-p-D-glucosaminidase,
a-mannosidase and acid phosphatase
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Fluctuations in the levels of /(-glucuronidase, N-acetyl-/?-D-glucosaminidase, a-mannosi¬
dase and acid phosphatase in amniotic fluid cells with time in culture were studied. The
four enzymes fluctuated markedly with passage; no consistent trends were apparent. The
activity of a-mannosidase in amniotic fluid cell strains at the third passage was corre¬
lated with the lime taken to reach conflttency. There was no consistent pattern of
enzyme activity associated with the time after subculture. Enzyme levels in cell strains
derived from serial samples of amniotic fluid from several women showed large diffe¬
rences in activity unrelated to gestational age. The significance of the findings are
discussed in relation to antenatal diagnosis of inborn errors of lysosomal metabolism.
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Previous reports (Butterworth et al. 1973a,
Sutherland ct al. 1974) have shown that the
levels of five lysosomal enzymes (a-gluco-
sidase, /J-glucosidase, a-galactosidase. ft-ga-
lactosidase, «-arabinosidase) in amniotic
fluid cells fluctuate with time in tissue cul¬
ture. Similar studies httve been carried out
on four other lysosomal enzymes (//-glucu¬
ronidase, N-acetyl-/?-D-glucosaminidase,
a-mannosidase, acid phosphatase), all of
which are involved in inborn errors of
metabolism.
Methods
The amniotic fluid cell strains were cul¬
tured under the experimental conditions
described in previous papers (Butterworth
ct al. 1973a, Sutherland et al. 1974). The
cells were harvested and the enzymes //-glu¬
curonidase, N-acetyl-//-D-glucosaminidase,
a-mannosidase and acid phosphatase as¬
sayed using 4-methylumbelliferone conju¬
gates as substrates (Butterworth et al. 1972,
1973b).
Results
The reproducibility of the combined cul¬
ture and assay system for each enzyme is
presented in Table 1. The variation of the
total experimental procedure (coefficient of
variation) was below 7.5% for all four
enzymes. The variations in the levels of
This work was supported by the Advisory Committee on Medical Research for Scotland.
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Table 1
Reproducibility of culture and assay system
Coefficient
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Fig. 1. The activity of ^-glucuronidase in serial pas¬
sages of six strains of cultured amniotic fluid cells.
100 0-1
50 0-
N - ACETYL -13 -D - GLUCOSAMINIDASE
* Enzyme activity in nmol 4-methylumbelliferone min-'
mg-' protein for 12 replicates
a - assay tenth passage; b - assay twentieth passage
the four enzymes with passage is given for
six cell strains in Figs. 1-4. The coefficient
of variation of the mean enzyme levels for
the different cell strains was 27-38% for
^-glucuronidase, 16-38% for N-acetyU/l-D-
glucosaminidase, 23-52% for u-mannosi-
dase and 18-45% for acid phosphatase. All
four enzymes, therefore, showed fluctua¬
tions with passage greater than could be
expected from experimental error. None
u 2 A 6 B 10 12 1A
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Fig. 2. The activity of N-acetyl-/?-D-glucosaminidase
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Fig. 3. The activity of n-mannosidase in serial passa¬
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Fig. 4. The activity of acid phosphatase in serial
passages of six strains of cultured amniotic fluid
cells.
3
of these fluctuations in enzyme levels sho¬
wed a consistent pattern of activity related
to passage, as judged by previously descri¬
bed criteria (Butterworth et al. 1973a.
Sutherland et al. 1974).
The results were examined to determine
whether the enzyme levels of the cell strains
at the third passage were related to the time
at which confluency (harvest) was reached.
The only significant correlation (r = 0.58)
was for «-mannosidase (Fig. 5). This was
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Fig. 5. Relationship of the activity of a-mannosidase
in cultured amniotic fluid cells with time to reach
confluency (harvest).
Ail days — — Without days 10-12
cell strains requiring 10-12 days to reach
confluency were not included.
Figs. 6-9 show the fluctuations in the
levels of the four enzymes related to the
time after subculture for six amniotic fluid
ceil strains. No consistent pattern of en¬
zyme activity related to this parameter was
noted. Moreover, no consistent increase in
enzyme activity was noted after the cell
strains had become confluent.
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Fig. 6. The activity of /?-9'ucuronidase in serial
strains of amniotic fluid cells in relation to time
since subculture.




















1 2 3 A 5 6 7
TIME AFTER SUBCULTURE I Days)
Fig. 7. The activity of N-acetyl-/?-D-glucosaminidase
in serial strains of amniotic fluid cells in relation
to time since subculture.
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Fig. 8. The activity of M-rnannosidase in serial strains
of amniotic fluid cells in relation to time since sub¬
culture.
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Fig. 9. The activity of acid phosphatase in serial
strains of amniotic fluid ceils in relation to time
since subculture.
^Confluency; Strain 1 not confluent by 7 days
serial samples of amniotic fluid obtained
from four Rhesus iso-immunised women.
The levels of the four enzymes in the third
passage of these cell strains are given in
Table 2. Within each series the activity of
the four enzymes showed considerable vari¬
ability, unrelated to gestational age.
Discussion
The known number of inborn errors of
metabolism due to a lysosomal enzyme
deficiency has increased rapidly in the last
few years (Rrady 1973, Milunsky 1973.
Nadler 1972). Post-natal diagnosis of these
diseases is made by enzyme assay using
leukocytes and cultured fibroblasts. The
properties and variations in activity of lyso¬
somal enzymes in these cell types have been
reported (Hultberg et al. 1973, Milunsky et
al. 1972, Ryan et al. 1972).
With the demonstration that lysosomal
enzymes are present in cultured amniotic
fluid cells (Kaback & Cooke 1970), and
that an enzyme deficiency in the fetus is
reflected in these cells (Padeh & Navon
1971, Salafsky & Nadler I97l), antenatal
diagnosis of inborn errors of lysosomal
metabolism became possible. Indeed, there
are now several reports (Rrady et al. 1971,
Desnick et al. 1973, Kaback et al 1973,
O'Rrien el al. 1971, van der Hagen et al.
1973) of the successful antenatal diagnosis
of such enzyme deficiency diseases. This
very success has had the result of increas¬
ing the demand for antenatal diagnosis.
However, whilst there are many reports
concerning lysosomal enzyme deficiencies
in cultured amniotic fluid cells (Milunsky
19731, much less attention has been paid
to fluctuations of these enzymes in cells
cultured from normal amniotic fluids
(Rcutler et al. 1971, Rutterworth et al.
1973a, 1973b. Gerhie et al. 19721. A study
of the activities of nine lysosomal enzymes
in cultured amniotic fluid cells has been
5
Table 2
Enzyme levels* in cell strains at the third passage cultured from serial










18 0.60 44.4 0.28 6.35
22 0.83 64.0 0.87 12.69
1 24 0.76 57.3 0.95 11.69
33 0.63 61.3 0.81 10.05
35 0.75 32.2 0.42 4.41
23 0.43 68.5 0.52 7.15
2 26 1.09 76.3 0.37 5.90
28 0.42 34.4 0.41 11.52
22 0.98 91.9 0.88 9.15
26 0.90 62.1 0.96 10.52
27 0.66 66.3 1.08 6.85
34 0.64 39.4 0.59 9.67
* Enzyme activity - nmol 4-methylumbelliferone min-1 mg-1 protein
undertaken. The findings for five lysosomal
enzymes have been reported (Butterworth
et al. 1973a, Sutherland et al. 1974) and
these will be considered together with the
present results.
The levels of all the lysosomal enzymes
investigated showed marked fluctuations
with passage in amniotic fluid cell strains,
a finding in agreement with the results of
Milunsky et al. (1972) for cultured skin
fibroblasts. Some amniotic fluid cell strains
showed a significant pattern of increase in
specific activity with passage for certain
enzymes such as /Tglucosidase and /f-galac-
tosidase, but only for «-glucosidase was
this increase consistent. This contrasts with
the general rise in lysosomal enzyme acti¬
vity with passage noted in cultured fibro¬
blasts by Hultberg et al. (1973). The ratio
of epithelioid to fibroblast-like cells in
amniotic fluid cell culture has been repor¬
ted (Melancon et al. 1971) to change with
passage. As the lysosomal enzyme levels
differ between these cell types (Gerbie et
al. 1972), it is possible that the patterns
of change observed in the present studies
reflect this change in cell type.
In cultured fibroblasts, acid phosphatase
(Christofalo & Kritchevsky 1969), N-acetyl-
/TD-glucosaminidase (Okada et al. 1971)
and //-glucuronidase (DeMars 1964, Teroy
& DeMars 1967, Russell et al. 1971) levels
have been shown to be related to the time
after subculture. No such relationship was
consistently found for the lysosomal enzy¬
mes in cultured amniotic fluid cells. Simi¬
larly, the rise in the level of N-acetyl-/?-D-
glucosaminidase (Okada et al. 1971) and
//-glucosidase (Ryan et al. 1972) activity in
cultured fibroblasts after confluency was
not apparent in cultured amniotic fluid
cells. However, a positive correlation was
noted between the activities of some of the
enzymes in amniotic fluid cells and the
time taken to reach confluency. This ap¬
parent relationship may reflect a difference
between the cell types found in slowly and
rap'dly growing cell strains. The lack of a
correlation between gestational age and the
level of the lysosomal enzymes in cells
6
cultured from serial samples of amniotic
fluid is consistent with previous findings
using only one sample from any pregnancy
(Butterworth et al. 1973b).
Hence, cells cultured from amniotic fluid
of any gestational age will provide suitable
control material for antenatal diagnosis of
a disease involving any of these lysosomal
enzymes. Similarly, cells at any stage of
culture up to at least the fifteenth passage
can be used as control material. One pos¬
sible exception is a-glucosidase, where cells
in later passages may have higher enzyme
levels. The possibility still remains, how¬
ever, that an error in diagnosis could arise
due to a change in the isoenzyme pattern
with gestational age or time in culture.
These possibilities clearly need to be taken
into consideration when making an anten¬
atal diagnosis of a disease where only one
isoenzyme is deficient.
The marked variations in the activity of
(he nine lysosomal enzymes described in
this series of studies clearly have implica¬
tions with regard to antenatal diagnosis of
inborn errors of lysosomal metabolism. The
fluctuations of enzyme activity in amniotic
fluid cell strains with culture time, and even
in cells cultured from serial samples of
amniotic fluid from the same woman, re¬
sult in a wide range of normal values which
would make identification of hetcrozygotes
extremely difficult. When undertaking an¬
tenatal diagnosis of recessively inherited
diseases, half the fetuses encountered will
be heterozygotes. If the variation in enzyme
activity is as large for these heterozygotes
as for the normals, then in those diseases
in which the enzyme deficiency is only
partial, the heterozygote could well be mis¬
taken for an affected homozygote.
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Summary
1. Possible changes in lysosomal enzyme activity of cultured amniotic
fluid cells with serum concentration, type of medium and the pH of the me¬
dium were studied.
2. Apart from a small, but significant, decrease in the activity of d-galac-
tosidase, none of the enzymes changed with increasing serum concentration.
3. No significant changes in enzyme activity were found between cells
cultured in Ham's FIO and Eagle's MEM medium.
4. Lysosomal enzyme levels were unaffected by culturing cells for up to 9
days at-pH 7.0, 7.4 and 7.9.
Introduction
As cultured amniotic fluid cells are now being used in the antenatal diag¬
nosis of inborn errors of lysosomal enzyme metabolism, a better understanding
of the reasons for the fluctuations observed in the levels of lysosomal enzymes
in normal cultured amniotic fluid cells [1—4] is clearly required. It is also
important to determine whether the different normal levels of enzyme activity
obtained by different laboratories [5] could be attributed to variations in cell
culture. Hence the effects of serum concentrations, type of tissue culture me¬
dium (Ham's FIO, Eagles's MEM) and the pH of the medium on the levels of
some lysosomal enzymes in cultured normal amniotic fluid cells were investi¬
gated.
* To whom correspondence should be addressed.
Methods
Cell strains were initiated [6], subcultured and maintained [1] as previ¬
ously described.
To study the effects of fetal calf serum concentration in the culture
medium on lysosomal enzyme activity, 3 lots of culture medium (Ham's FIO)
were prepared with fetal calf serum concentrations of 15, 20 and 30%. The
Ham's FIO (Flow Lab. Ltd) and fetal calf serum (Biocult Labs. Ltd) came from
single batches: this condition was adhered to for all the culture experiments. A
cell strain which had been maintained in medium with a 30% fetal calf serum
concentration was used to seed 12 replicate culture bottles. 4 cultures were
maintained at each serum concentration until harvested at confluency for en¬
zyme assay. This procedure was carried out for 3 cell strains.
The effect of using two commercially available culture media, Ham's FIO
(Flow Labs. Ltd) and Eagle's MEM (Wellcome Ltd) on the enzyme levels was
compared. Both media were supplemented with 15% fetal calf serum. 6 cell
strains which had been maintained in Ham's FIO were used for this experiment.
Duplicate cultures which had been maintained in these two media for two
passages were harvested at confluency for enzyme assay.
The effect of the pH of the medium on the enzyme levels was studied
using Ham's FIO culture medium supplemented with 15% fetal calf serum and
buffered with tricine [7]. Solutions of M tricine were prepared and the pH
adjusted with 6 N NaOH so that when added to medium to give a final concen¬
tration of 50 mM, pH values of 7.0, 7.4 and 7.9 were obtained. In an initial
experiment 12 replicate cultures were grown to confluency in Ham's FIO with
15% fetal calf serum and a bicarbonate buffer system. At this point 4 bottles
were maintained in medium buffered at each of the three pH values and the
cells harvested for enzyme assay 24 h later. Since this initial experiment indi¬
cated that pH did not affect the enzyme levels, another experiment was de¬
signed to determine whether growing the cells in media at different pH values'
from the time of seeding would affect the. enzyme levels. 15 replicate cultures
were prepared and medium at each pH was added to 5 bottle?. To minimize pH
changes the culture medium was changed every day. One culture at each pH
was harvested for enzyme assay on days 1, 3, 5, 7 and 9 after the cultures had
been set up. The experiment was carried out on two cell strains simultaneously,
one an amniotic fluid derived fibroblast-like cell strain and the other, a similar¬
ly derived cell strain of mixed epithelioid type II and III cells [8].
The preparation of cell homogenates, protein estimation and the assay of
the lysosomal enzymes were carried out as previously described [9].
Results
The levels of the lysosomal enzymes in three strains of amniotic fluid cells
cultured with 15, 20 and 30% fetal calf serum supplement in the medium are
given in Table I. Analysis of variance of the results indicated that there was a
small, but significant, decrease in the activity of |3-galactosidase (P < 0.05) from
15 to 30% serum levels. None of the other comparisons of enzyme activity
were significantly different. There was a significantly higher level of protein
(P < 0.05) for cell strains cultured in 30% compared to 15% serum.































































































































































































LYSOSOMAL ENZYME ACTIVITIES OF AMNIOTIC FLUID CELLS CULTURED USING HAM'S FIO
AND EAGLE'S MEM MEDIUM
Figures represent the means of 12 experiments; standard deviations in parentheses.
Enzyme Enzyme activity (nmoles/min/mg protein)
Ham's FIO Eagle's MEM
















Arylsulphatase A 2.38 2.70
(0.73) (1.08)
Protein (mg/ml) 0.083 0.059
(0.009) (0.013)
The levels of the lysosomal enzymes in amniotic fluid cells cultured in
Ham's FIO and Eagle's MEM medium are given in Table II. Whilst some of the
enzymes in certain of the cell strains showed differences between the two
media, a comparison of the results (t-test) indicated that there were no signifi¬
cant differences for any of the enzymes. However, the level of protein in cell
strains cultured in Ham's FIO was significantly higher (P< 0.05) than when
using Eagle's MEM.
The initial experiment on the effects of pH showed that there were no
significant differences between the lysosomal enzyme activities of amniotic
fluid cells when monolayer cultures were maintained at three different pH
values (7.0; 7.4; 7.9) for 24 h. The results of the second experiment in which
cell strains were cultured for up to 9 days at these three pH values are given in
Figs. 1—3. The pattern of activity with time in culture of some of the enzymes,
such as a-mannosidase (Fig. 2) and arylsulphatase A (Fig. 3), was different for
the two cell strains. Inspection of Figs. 1—3 indicated that for only (3-glucuroni-
dase was there an apparent effect of pH, in that the enzyme activity at pH 7.9
was lower than that at 7.4 and 7.0 after 5 days of culture. However, a compari¬
son (analysis of variance) of the mean enzyme activities throughout the period
of culture indicated that there was no significant difference between the en¬
zyme levels at the three pH values.
STRAIN I




Fig. 1. The levels of acid phosphatase, JV-acetyl-0-D-glucosaminidase, /3-galactosidase and ^-glucuronidase
in amniotic fluid cells cultured for 9 days in medium at three pH values.
Discussion
Apart from the effects of culture time [2—4], the study of variations in
lysosomal enzyme activity of amniotic fluid cells with culture variables has
been neglected. The effect of serum concentration on cell growth and enzyme
activity has been largely confined to cell lines requiring very low levels of serum
and few studies have been undertaken using high concentrations [10,11].
Growth of rat fibroblasts was shown [10] to increase as the serum was in¬
creased from 5 to 30% with a concomitant increase in mucopolysaccharide
production. A change in serum from 10 to 20% had no effect on the growth
rate of human fibroblasts, but an increase to 30% led to a reduction in cell
growth [11]. In the present study cell growth, as judged by protein levels,
increased with serum concentration from 15 to 30% although enzyme specific
STRAIN 1 STRAIN II
Fig. 2. The levels of a-galactosidase, a-arahinosidase, a-mannosidase and a-glucosidase in amniotic fluid
cells cultured for 9 days in medium at three pH values.
activity remained constant. A possible explanation for this is that the cell
strains used were adapted to growing in 30% serum. Attempts to increase the
serum concentration to 30% once amniotic fluid cells were adapted to growing
in 15% were unsuccessful, due to marked reduction in cell growth. In view of
these effects of serum concentration on cell growth and metabolism, it is
perhaps surprising that the lysosomal enzymes of amniotic fluid cells are unaf¬
fected; the statistically significant finding for |3-galactosidase is probably fortui¬
tous and of little biological significance. The finding [12] that the level of acid
phosphatase in mouse fibroblasts remained unaltered when the serum concen¬
tration was changed from 0 to 10% is in accord with the present study.
The effect of using different types of media on enzyme activity has re-
STRAIN I STRAIN II
OATS AFTER SUBCULTURE
Fix- 3. The levels of /3-glucosidase and arylsulphatase A in amniotic fluid cells cultured for 9 days in
medium at three pH values.
ceived little attention [5,13,14]. The specific activity of lactate dehydrogenase
and glucose-6-phosphate dehydrogenase has been shown [13] to be affected by
the type of medium in which Earle's L cells were cultured. In cultured human
fibroblasts the level of /3-glucosidase was lower in cells grown in Ham's FIO than
Eagle's MEM [5,14]. In the present study bn amniotic fluid cells the level of
acid phosphatase was found to be unaffected by these two media, in agreement
with a finding for cultured human fibroblasts [14]. Although the level of
arySulphatase A has been found to be lower in fibroblasts [14] cultured in
Ham's FIO, no such affect was observed in amniotic fluid cells. The higher
protein levels for amniotic fluid cells grown in Ham's FIO may reflect a genuine
difference in the ability of these two media to support amniotic fluid cell
culture , but it is more likely to be a consequence of having used cell strains
adapted to growing in Ham's FIO.
Although the effect of the pH of the medium on lysosomal enzyme activi¬
ty has been little investigated, its affects on other aspects of metabolism have
been studied. Collagen synthesis by human fibroblasts was found [15] to be
greater at pH 7.4 and 8.0 than at 7.0. The effect of pH on mucopolysaccharide
metabolism is perhaps of more relevance to studies involving lysosomal en¬
zymes. The production of mucopolysaccharides by rat fibroblasts was found
[16] to be greater at pH 6.6 than pH 7.4. It was also shown [16,17] that
[3 5S] sulphate was incorporated differently into the various mucupolysaccha-
rides at these pH values. In contrast, human fibroblast mucopolysaccharide
content was found to increase with a change in the pH of the medium from
6.65 to 7.9 and this, appeared to be due to a difference in degradation rather
than synthesis [18]: This resulted in a great increase in intracellular mem¬
brane-bound bodies producing an abnormal ultrastructure in cells growing at
their optimal pH. As acid phosphatase, a lysosomal marker, was shown [19]
histochemically to be increased in activity at the higher pH there seems to be a
paradox of increased lysosomal enzyme activity and at the same time decreased
mucopolysaccharide degradation. In the present study biochemical assay of
lysosomal enzyme levels did not reveal any difference between the activity in
amniotic fluid cells cultured at about pH 7.8 as compared to lower pH values.
However, the demonstration of enzyme activity in a cell homogenate or by
histochemical techniques does not necessarily prove that the enzyme is func¬
tional in the living cell. It should be borne in mind that the changes in growth
and metabolism of cells in a normal culture system which occur as the pH of
the medium falls, may be the result of the accumulation of a metabolite, such
as lactate [20], rather than to a pH change as such.
The lack of any changes in lysosomal enzyme activity of amniotic fluid
cells due to the serum concentration, type of medium (Ham's FIO, Eagle's
MEM) and the pH of the medium indicates that these factors are unrelated to
previously observed [2-4] fluctuations in these enzymes during amniotic fluid
cell culture.
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